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This thesis is concerned with the design and synthesis of a novel, injectable 
proteoglycan analogue for tissue repair.  This is of particular relevance to the 
restoration of disc height to a degraded nucleus pulposus of the intervertebral disc.  
The focus is on the use of sulfonate monomers as proteoglycan analogues, in 
particular sodium 2-acrylamido-2-methylpropane sulfonic acid and the potassium salt 
of 3-sulfopropyl acrylate.   
 
For most biomedical applications, synthetic hydrogels need to show dimensional 
stability to changes in pH, osmolarity, and temperature.  This is readily achieved by 
neutral structures however ionic sulfonate containing hydrogels are responsive to 
environmental change which renders them difficult to manage in most tissue 
replacement applications.  In this case osmotic responsiveness rather than stability is 
desirable.  Therefore sulfonate based materials possess advantageous properties.  This 
is a result of the sulfonate becoming an ideal surrogate for the sulfate group present 
within the structure of natural proteoglycans. 
 
This thesis reports polymerisation studies based on the production of a redox initiated 
copolymer system capable of polymerising in situ within a timescale of circa. 5-7 
minutes.  The rheological properties, osmotic drive, and residual monomer content of 
successful compositions is analysed.  Properties are adapted to mimic those of the 
target natural tissue. 
 
The adaptation of the material for use as an injectable intra-ocular lens, with 
hyaluronic acid as an interpenetrate is reported.  The synthesis of a radiopaque 
macromer to allow visibility of the repair system once in situ is investigated and 
discussed. 
 
The results presented in this thesis describe a suitable proteoglycan tissue analogue 
which is injectable, biomimetic, osmotically responsive and mechanically stable in its 
desired application. 
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 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For my Family 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
Acknowledgements 
 
I would like to express my sincere appreciation to my supervisor Professor Brian 
Tighe for all his encouragement and support during my time at Aston.  In particular 
the opportunity to conduct a PhD within the Biomaterials Research Unit after 
completing an MSc project within the group.  I am very grateful for the opportunities 
I have received during my studies including the attendance of many conferences.  It 
has been a great privilege to work and learn from someone who is so respected and 
admired within his field. 
 
I would also like to give thanks to all the members of the Biomaterials Research Unit 
for the assistance and encouragement they have given me along the way.  In particular 
Dr Val Franklin for all her hard work in making the group work smoothly, and the 
advice and support she provided along the way.  I also thank Dr Gareth Ross for his 
support and encouragement throughout my studies, in particular the writing up period. 
 
Thank you also to my family and close friends who are always there to lend an ear 
when times have been difficult, and also to Ade whose support has been invaluable 
over the last three years. 
 
I thank EPSRC and Vista Optics for their financial support for the duration of my 
work. 
 
 
 
 
 
 
 
 
 
 
 
 5 
Table	  of	  Contents	  
 
THESIS ABSTRACT…………………………………………………………………2 
DEDICATION………………………………………………………………………...3 
ACKNOWLDEGEMENTS…………………………………………………………...4 
TABLE OF CONTENTS……………………………………………………………...5 
LIST OF FIGURES…………………………………………………………………..10 
LIST OF TABLES…………………………………………………………………...15 
Chapter	  One...................................................................................................................... 17	  
Introduction ..................................................................................................................... 17	  
1.1	  Introduction .............................................................................................................. 18	  
1.2	  Hydrogels ................................................................................................................... 19	  
1.2.1	  History	  of	  hydrogels .....................................................................................................19	  
1.2.2	  Synthetic	  hydrogels ......................................................................................................19	  
1.2.3	  Synthetic	  hydrogels ......................................................................................................21	  
1.2.4	  Natural	  hydrogels..........................................................................................................23	  
1.3	  Intervertebral	  disc	  (IVD) ...................................................................................... 23	  
1.3.1	  Intervertebral	  disc	  degeneration ............................................................................27	  
1.3.2	  Current	  methods	  of	  disc	  repair.................................................................................28	  
1.4	  The	  cornea	  and	  crystalline	  lens ......................................................................... 31	  
1.4.1	  Cataract	  formation	  and	  subsequent	  surgery .......................................................32	  
1.4.2	  Intra-­ocular	  lenses........................................................................................................33	  
1.4.3	  The	  problem	  of	  accommodation ..............................................................................35	  
1.5	  Articular	  cartilage ................................................................................................... 36	  
1.6	  The	  role	  of	  proteoglycans(PGs)	  and	  glycosaminoglycans(GAGs)	  in	  the	  
extracellular	  matrix ...................................................................................................... 36	  
1.7	  Redox	  polymerisation............................................................................................ 38	  
1.7.1	  The	  effect	  of	  oxygen	  within	  a	  redox	  system .........................................................39	  
1.7.3	  Free	  radical	  polymerisation:	  types	  relevant	  to	  this	  research ........................42	  
1.7.4fotopolymerisation ........................................................................................................43	  
1.8	  The	  testing	  of	  materials:	  rheology..................................................................... 43	  
 6 
1.9	  A	  brief	  insight	  into	  radio-­opaque	  contrast	  media,	  types	  and	  uses......... 45	  
1.10	  The	  scope	  and	  objectives	  of	  the	  work	  presented	  in	  this	  thesis............. 47	  
Chapter	  Two..................................................................................................................... 48	  
Materials	  and	  Methods ................................................................................................. 48	  
2.1	  Reagents ..................................................................................................................... 49	  
2.1.1	  Initiators...........................................................................................................................49	  
2.1.2	  Monomers	  and	  crosslinking	  agents	  [supplier	  in	  brackets] ............................50	  
2.2	  Methods ...................................................................................................................... 52	  
2.2.1	  Typical	  gel	  procedure ..................................................................................................52	  
2.2.3	  Swelling	  procedure.......................................................................................................53	  
2.2.4	  Rheology...........................................................................................................................54	  
2.2.5	  Residual	  monomer	  analysis.......................................................................................55	  
2.2.6	  FTIR....................................................................................................................................55	  
2.2.7	  Medac	  CHN	  analysis ......................................................................................................56	  
2.2.8	  NMR....................................................................................................................................57	  
2.3	  Synthetic	  routes	  to	  sulfonated	  monomers...................................................... 57	  
2.3.1	  The	  synthesis	  of	  KSPA..................................................................................................57	  
2.3.2	  The	  synthesis	  of	  NaAMPs ............................................................................................58	  
Chapter	  Three.................................................................................................................. 60	  
The	  Design	  and	  Synthesis	  of	  a	  Proteoglycan	  Analogue:	  Experimental	  
Considerations ................................................................................................................ 60	  
3.1	  Introduction .............................................................................................................. 61	  
3.1.1	  Monomer	  selection-­	  the	  rationale	  for	  the	  use	  of	  sulfonates ...........................62	  
3.2	  The	  investigation	  of	  suitable	  monomer	  systems,	  experimental	  
considerations................................................................................................................. 66	  
3.2.1	  Investigation	  of	  an	  NaAMPs	  polymer......................................................................66	  
3.2.2	  The	  homopolymerisation	  of	  KSPA...........................................................................69	  
3.2.3	  The	  copolymerisation	  of	  NaAMPs/KSPA	  based	  systems..................................69	  3.2.3.1	  The	  effect	  of	  initiator	  concentration	  and	  volume	  on	  an	  NaAMPs/KSPA	  and	  NaAMPs	  based	  system ........................................................................................................................70	  3.2.3.2	  The	  effect	  of	  varying	  of	  the	  ratio	  of	  NaAMPs:KSPA	  in	  a	  copolymer	  system .72	  
 7 
3.3	  Copolymerisation	  of	  NaAMPs	  with	  PEG	  acrylate .......................................... 74	  
3.4	  The	  effect	  of	  incorporating	  KSPI	  as	  a	  co-­monomer	  with	  NaAMPs .......... 76	  
3.5	  Initiator	  variation ................................................................................................... 78	  
3.5.1	  The	  use	  of	  benzoyl	  peroxide	  and	  dimethyl	  toluidine	  as	  a	  redox	  pair .........78	  
3.5.2	  The	  use	  of	  hydrogen	  peroxide	  and	  dimethyl	  toluidine	  as	  a	  redox	  pair ......79	  
3.5.3	  The	  use	  of	  tertiary	  butyl	  hydroperoxide	  with	  dimethyl	  toluidine	  as	  a	  redox	  
pair................................................................................................................................................80	  
3.5.4	  The	  use	  of	  TEMED	  and	  potassium	  persulfate	  as	  a	  redox	  pair ........................82	  
3.5.5	  Additional	  initiation	  systems ....................................................................................84	  
3.6	  Choice	  of	  crosslinking	  agent ................................................................................ 86	  
3.7	  Discussion.................................................................................................................. 89	  
Chapter	  Four .................................................................................................................... 92	  
The	  Design	  and	  Synthesis	  of	  a	  Proteoglycan	  Analogue:	  Refinement	  of	  the	  
Injectable	  System ........................................................................................................... 92	  
4.1.	  Introduction ............................................................................................................. 93	  
4.2.1.	  Refinement	  of	  the	  composition ...............................................................................93	  
4.2.2	  The	  storage	  of	  components:	  environmental	  effects ..........................................95	  
4.3	  The	  use	  of	  dipicolinic	  acid	  as	  a	  stabiliser	  within	  the	  copolymer	  system
.............................................................................................................................................. 98	  
4.4	  The	  injection	  process:	  effect	  of	  needle	  length	  and	  diameter..................101	  
4.5	  Injection	  into	  a	  surrogate	  cavity ......................................................................102	  
4.6	  The	  incorporation	  of	  Histodenz	  into	  the	  gels	  and	  its	  subsequent	  effect	  
on	  gelation	  time ............................................................................................................104	  
4.6.1	  The	  visibility	  of	  Histodenz	  within	  the	  polymerised	  gel................................. 105	  
4.7	  The	  residual	  monomer	  content........................................................................108	  
4.8	  Discussion................................................................................................................112	  
Chapter	  Five ...................................................................................................................114	  
The	  Design	  and	  Synthesis	  of	  a	  Proteoglycan	  Analogue:	  Mechanical	  
Properties .......................................................................................................................114	  
 8 
5.1	  Introduction ............................................................................................................115	  
5.2	  Rheological	  behaviour	  of	  different	  monomer	  compositions..................116	  
5.3	  Initiator	  variation .................................................................................................119	  
5.3.1	  The	  variation	  of	  ascorbic	  acid	  and	  oxone	  conentration................................ 119	  
5.3.2	  The	  variation	  of	  TEMED	  and	  potassium	  persulfate	  concentration ........... 120	  
5.4	  Water	  content	  variation......................................................................................123	  
5.5	  Crosslinker	  variations .........................................................................................125	  
5.6	  The	  incorporation	  of	  DPA	  as	  a	  stabiliser.......................................................129	  
5.7	  Incorporation	  of	  histodenz ................................................................................130	  
5.8	  The	  swell	  and	  subsequent	  compression	  behaviour	  in	  varying	  osmotic	  
media ................................................................................................................................132	  
5.9	  Dynamic	  mechanical	  analysis	  of	  excised	  sheep	  disc	  in	  three	  different	  
states:	  intact	  nucleus,	  nucleus	  removed,	  and	  containing	  injected	  gel .......133	  
5.10	  Discussion .............................................................................................................137	  
Chapter	  Six......................................................................................................................139	  
Towards	  Development	  of	  an	  Injectable	  Accommodating	  IOL .......................139	  
6.1	  Introduction ............................................................................................................140	  
6.2	  Current	  Materials ..................................................................................................141	  
6.3	  An	  injectable	  IOL ...................................................................................................145	  
6.3.1	  Incorporation	  of	  hyaluronic	  acid	  into	  the	  “disc”	  gel....................................... 145	  
6.4	  The	  incorporation	  of	  a	  commercially	  available	  viscoelastic	  into	  the	  gel	  
composition....................................................................................................................151	  
6.5	  Discussion................................................................................................................153	  
Chapter	  Seven................................................................................................................155	  
Development	  of	  a	  Radio-­opaque	  Macromer	  for	  Incorporation	  into	  the	  
Proteoglycan	  Analogue...............................................................................................155	  
7.1	  Introduction ............................................................................................................156	  
 9 
7.2	  The	  reaction	  of	  N-­hydroxymethyl	  acrylamide	  (NMA)	  and	  histodenz..156	  
7.3	  The	  addition	  of	  histodenz-­NMA	  into	  a	  linear	  polymer .............................162	  
Chapter	  eight..................................................................................................................164	  
Summary	  and	  Conclusions ........................................................................................164	  
8.0	  Summary	  and	  conclusions .................................................................................165	  
References ......................................................................................................................177	  
 10 
 
List of Figures 
 
Fig 1.2.2.1 A physical gel represented by entangled free chains and a chemical 3D 
network where the red lines represent cross-links ...............................................21	  
Fig 1.2.3.1 Examples of commonly used monomers and polymers used to make 
hydrogels..............................................................................................................22	  
Fig 1.3.1 A representation of the spinal column illustrating the position of the 
intervertebral disc ................................................................................................24	  
1.3.2 The nucleus pulposus of the intervertebral disc..................................................24	  
Fig 1.3.3 Chondroitin and keratan sulfate repeating units where Gal, galactose; 
GalNAc-6s, N-acetylgalactosamine 6-sulfate; GlcUA, D-glucuronic acid; 
GlcNAc-6s, N-acetylglucosamine 6-sulfate ........................................................26	  
Fig 1.3.1.1 The stages of disc degeneration.................................................................28	  
Fig 1.3.2.1 A representation of laminectomy ..............................................................29	  
Fig 1.3.2.2 The artificial ProDisc-L.............................................................................30	  
Fig 1.4.1 The structure of the eye ................................................................................31	  
Fig 1.4.2.1 Examples of existing IOL designs.............................................................34	  
Fig 1.6.1 The ECM and the role of proteoglycans.......................................................37	  
Fig. 1.7.2.1 The oxidation reactions of ascorbic acid ..................................................39	  
Fig. 1.7.2.2 The reducing action of ascorbic acid........................................................40	  
Fig. 1.7.2.3 The reaction between ascorbic acid and potassium persulfate(37) ............40	  
Fig 1.7.2.4 The action of the ascorbate radical ............................................................40	  
Fig 1.7.2.5 The persulfate radical ................................................................................41	  
Fig 1.9.1 Diatrizoic acid, metrizoic acid, and iothalmic acid, the basis of most modern 
contrast media. .....................................................................................................46	  
Fig 1.9.2 Iohexol (Histodenz) ......................................................................................46	  
Fig 2.2.6.1 A typical FTIR spectra for water...............................................................56	  
Fig 2.3.1 The production of potassium salt of 3-sulfopropyl acrylate.........................58	  
Fig 2.3.2 The production of sodium 2-acrylamido-2-methylpropane sulfonic acid ....59	  
Fig 3.1.1 The sulfate and sulfonate functional groups, repsectively ...........................62	  
Fig 3.1.1 Acryloylmorpholine (ACMO)......................................................................64	  
Fig 3.1.2 Poly(ethyleneglycol) acrylate (PEGA).........................................................64	  
Fig 3.1.3 Potassium salt of 3-sulfpropyl acrylate (KSPA) ..........................................64	  
 11 
Fig 3.1.4 Potassium salt of 3-sulfopropyl methacrylate (KSPM)................................64	  
Fig3.1.5 Dipotassium salt of bis (3-sulfopropyl) itaconate (KSPI) .............................65	  
Fig3.1.6 N,N, Dimethyl N-(2-methacryloyloxyethyl)-N-(3-sulfopropyl) ammonium 
betaine (SPE) .......................................................................................................65	  
Fig 3.1.7 1-(3-Sulfopropyl)-2-vinylpyridinium betaine (SPV) ...................................65	  
Fig 3.1.8 Sodium 2-acrylamido 2-methylpropane sulfonic acid (NaAMPs) ...............65	  
Fig 3.2.1.1 The swell behaviour of NaAMPs based gel A in water and PBS .............68	  
Figure 3.2.1.2 The viscous and elastic modulii of NaAMPs based Gel A ..................69	  
Fig 3.3.1 The swell behaviour of NaAMPs/PEGA copolymer gel Peg3 in water and 
PBS ......................................................................................................................75	  
Figure 3.3.2 The viscous and elastic modulii of NaAMPs/PEGA based Peg1 ...........75	  
Fig 3.4.1 Nelfilcon A, modified PVA .........................................................................78	  
Fig 3.6.1 Poly (ethyleneglycol) diacrylate.  Typically n~575 .....................................86	  
Fig. 3.6.1 The difference in swell behaviour of an NaAMPs/KSPA copolymer with 
2% PEG diacrylate and 2% modified PVA .........................................................88	  
Fig 4.2.1 The dual syringe system ...............................................................................94	  
Fig 4.2.2.2 The effect of the removal of oxygen on the mechanical properties of the 
gels .......................................................................................................................98	  
Fig 4.3.1 The structure of dipicolinic acid...................................................................99	  
Fig 4.5.1 Balloon and finger cot models as surrogate cavities ..................................103	  
Fig 4.5.2 An excised sheep disc.................................................................................104	  
4.6.1 An example of an x-rayed gel sample composition Rf1 with 5% histodenz w/w
...........................................................................................................................106	  
Fig. 4.6.2 The visibility of the gel within an excised disc segment, samples 1 and 2 
contain no dye, samples 3 and 4 contain 5% histodenz.....................................107	  
Fig 4.7.1 Residual NaAMPs calibration curve calculated by refractive index..........108	  
Fig 4.7.2 Residual KSPA calibration curve calculated by refractive index ..............109	  
Fig 4.7.3 Residual NaAMPs/KSPA mixture analysed by refractive index ...............110	  
Fig 5.2.1 A comparison of viscous, elastic, and complex modulii recorded at ~10Hz 
for an NaAMPs based polymer vs an NaAMPs:KSPA copolymer of similar 
solid:water polymerisation ratios ~1:1, crosslinking agent PEG400DA at 2% 
w/w, initiated via AA and Oxone 0.1M.............................................................116	  
Fig 5.2.2.1 A comparison of the viscous, elastic, and complex modulii recorded at 
~10Hz of three different ratios of NaAMPs:KSPA, 3:2, 1:1, and 2:3 respectively.  
 12 
Each composition consisted of similar water and crosslinking agent levels (1%), 
initators used were AA and Oxone 0.1M ..........................................................117	  
Fig 5.2.2.2 The effect of increasing KSPA content on Tan delta ..............................118	  
Fig 5.3.1 The effect of increasing the AA Oxone concentration on the rheological 
properties of an NaAMPs KSPA copolymer recorded at ~10Hz ......................119	  
Fig 5.3.2.1 The effect of varying TEMED initiator concentration whilst keeping KPS 
constant at 0.18M, on viscous, elastic, and complex modulii recorded at ~10Hz
...........................................................................................................................120	  
Fig 5.3.2.2 The effect of varying KPS initiator concentration whilst keeping TEMED 
constant at 0.4M, on viscous, elastic, and complex modulii recorded at ~10Hz
...........................................................................................................................121	  
Fig 5.3.2.3 The effect of varying both initiator concentrations where A= 0.1M 
TEMED:0.18M KPS, B= 0.2M TEMED 0.18M KPS, C= 0.4M TEMED, 0.12M 
KPS, and D=0.4M TEMED and 0.18M KPS, recorded at ~ 10Hz ...................122	  
Fig 5.3.2.4 A comparison between TEMED/KPS initiated NaAMPS:KSPA 
copolymer system and an AA/Oxone initated system recorded at ~ 10Hz .......123	  
Fig 5.4.1 The effect of reducing the water component of the gel composition, 
recorded at ~ 10Hz.............................................................................................124	  
Fig 5.4.2 A comparison of the viscous, elastic and complex modulii of a normal 
unswollen gel, a similar swolled gel, and an unswollen gel which was 
polymerised in the absence of ambient oxygen.  Recorded at ~ 10Hz ..............125	  
Fig 5.5.1 Tan delta demonstrating the effect of inclusion of an increased percentage of 
Nelfilcon macromer as a crosslinking agent......................................................126	  
Fig 5.5.2 The viscous, elastic and complex modulii of an NaAMPs/KSPA, AA/Oxone 
initiated copolymer with increasing levels of PEG575DA crosslinking agent, 
recorded at ~10Hz..............................................................................................126	  
Fig.5.5.3 Tan delta, the ratio of viscous to elastic modulus for the increase of 
crosslinking agent PEGDA................................................................................127	  
Fig 5.5.4 The viscous, elastic and complex modulii of an NaAMPs/KSPA, 
TEMED/KPS initiated copolymer with increasing levels of PEG1000DMA 
crosslinking agent, recorded at ~10Hz...............................................................128	  
Fig.5.5.5 Tan delta, the ratio of viscous to elastic modulus for the increase of 
crosslinking agent PEGDA................................................................................128	  
 13 
Fig.5.6.1 The incorporation of DPA into the TEMED/KPS system as a stabiliser, 
recorded at ~10Hz..............................................................................................129	  
Fig 5.7.1 The effect of the inclusion on increasing levels of Histodenz on the viscous, 
elastic, and complex modulii of an NaAMPs:KSPA, AA/Oxone initiated gel with 
2% PEG575DA crosslinking agent....................................................................130	  
Fig 5.7.2 The effect of the inclusion on increasing levels of Histodenz on the viscous, 
elastic, and complex modulii of an NaAMPs:KSPA, TEMED/KPS initiated gel 
with 2% PEG1000DMA crosslinking agent ......................................................131	  
Fig 5.7.3 Tan delta for the increase in Histodenz on NaAMPs/KSPA, TEMED/KPS 
initiated gel with 2% PEG1000DMA ................................................................131	  
Fig 5.8.1 The compression modulus of an NaAMPs/KSPA AA/Oxone initiated gel 
with 1% PEG575DA, tested over a range of time .............................................132	  
Fig 5.8.2 The compression behaviour of an NaAMPS/KSPA TEMED/KPS gel with 
1% crosslinking agent PEG1000DMA swollen in varying osmotic media.......133	  
Fig 5.9.1 DMA testing kit with disc under load ........................................................135	  
Fig 5.9.2. A comparison of the storage stiffness with and without the nucleus 
pulposus and with the gel to demonstrate the restoration of a degree of elasticity
...........................................................................................................................136	  
Fig 6.2.1 The elastic modulus of Bausch and Lomb acrylic and silicone based IOLs
...........................................................................................................................141	  
Fig. 6.2.2 The viscous modulus of Bausch and Lomb acrylic and silicone IOLs .....142	  
Fig 6.2.3 A comparison of the elastic and viscous modulii of Bausch and Lomb 
acrylic and silicone IOLs ...................................................................................143	  
Fig 6.2.4 The rheological behaviour of an acrylic IOL material with a Tg in the range 
of use..................................................................................................................143	  
Fig 6.2.5 A DSC trace for a acrylic IOL material with Tg ~ 24oC............................144	  
Fig 6.3.1 The structure of hyaluronic acid.................................................................146	  
Fig 6.3.1 The elastic and viscous modulii of gel I1 containing decreasing amounts of 
HA......................................................................................................................147	  
Fig 6.3.2 The elastic and viscous modulii of gel I2 containing decreasing amounts of 
HA......................................................................................................................148	  
Fig 6.3.3 The swell capacity of gels I1a,b,c, in PBS and 10% PEG 35000...............149	  
Fig 6.3.4 The swell behaviour of I2 a,b,c gels in PBS and 10% PEG35000.............150	  
 14 
Fig 3.6.5 The response under compression of gel I1a after swelling in varying osmotic 
media..................................................................................................................150	  
Fig 3.6.6 The compression behaviour of an NaAMPS/KSPA TEMED/KPS gel with 
1% crosslinking agent PEG1000DMA swollen in varying osmotic media.......151	  
Figure 6.4.1 The rheological behaviour of gel I3 containing Healon, tested at a range 
of temperatures ..................................................................................................152	  
Fig 6.4.2 The swell capacity of gels I1a,b,c, in PBS and 10% PEG 35000 compared to 
I3 containing Healon..........................................................................................153	  
Fig 7.2.1 The structure of histodenz ..........................................................................156	  
Fig 7.2.2 The reaction of histodenz with NMA.........................................................157	  
Fig 7.2.3 The FTIR spectrum of histodenz(blue) and NMA 48% solution (red) ......158	  
Fig 7.2.4 The spectrum of histodenz (pink) and histodenz-nma reaction (red).........159	  
Fig 7.2.5 The spectra of histodenz –NMA reaction conducted in basic conditions ..160	  
Fig 7.2.6 The mass spec analysis of the histodenz-NMA reaction............................161	  
Figure 7.3.1 Water suppresion NMR analysis of histodenz ......................................163	  
Fig 8.1 Iodinated benzoyl chloride ............................................................................174	  
Fig 8.2 Diiodobenzoic acid ........................................................................................175	  
Fig 8.3 N- (hydroxy methyl) acrylamide ...................................................................175	  
Fig 8.4 Diatrizoic acid ...............................................................................................176	  
 15 
List of Tables 
 
Table 2.1.1 Initiators ....................................................................................................49	  
Table 2.2.7.1 Medac analysis results ...........................................................................56	  
Table 3.2.1 Possible homo and co-polymer compositions: combining column 1 and 2
.............................................................................................................................66	  
Table 3.2.1.1. NaAMPs polymer composition ............................................................67	  
Table 3.2.3.1 The copolymerisation of NaAMPs with KSPA: The effect on 
polymerisation .....................................................................................................70	  
Table 3.2.3.1.1 The effect of initiator concentration and volume on the 
copolymerisation of NaAMPs and KSPA ...........................................................71	  
Table 3.2.3.1.2 The polymerisation time of an NaAMPs system in response to 
initiator volume and temperature, time to complete gelation is recorded visually
.............................................................................................................................72	  
Table 3.2.3.2.1 The effect of varying KSPA content in an NaAMPs copolymer system
.............................................................................................................................73	  
Table 3.3.1 The effect of using PEGA as a co-monomer with NaAMPs ....................74	  
Table 3.4.1 The effect of incorporating  KSPI as a copolymer with NaAMPs on gel 
formation..............................................................................................................77	  
Table 3.5.1.1 The effect of benzoyl peroxide and dimethyl toluidine as initiators in the 
polymerisation of an NaAMPs/KSPA copolymer ...............................................79	  
Table 3.5.2.1 Hydrogen peroxide and dimethyl toluidine in the polymerisation of an 
NaAMPs/KSPA copolymer .................................................................................80	  
Table 3.5.3.1 Tertiary butyl peroxide and dimethyl toluidine in the polymerisation of 
a NaAMPs/KSPA copolymer ..............................................................................81	  
Table 3.5.4.1 The use of N’N’N’N tetramethyethylenediamine (TEMED) and 
potassium persulfate (KPS) in the polymerisation of a NaAMPs/KSPA 
copolymer ............................................................................................................83	  
Table 3.5.5.1 Redox pairs investigated........................................................................84	  
Table 3.6.1 Crosslinking agent variations: effect on gel formation.............................87	  
Table 4.2.1 Refinement of the compositions: effective formulations..........................94	  
Table 4.2.2.1 Factors which affect the storage of components....................................95	  
Table 4.2.2.1 The stability of initiator stock solutions ................................................96	  
Table 4.2.2.2 Suitable pregel compositions .................................................................97	  
 16 
Table 4.2.2.3 The effect of oxygen levels on polymerisation time .............................98	  
Table 4.3.1 A summary of gel compositions incorporating DPA ...............................99	  
Table 4.3.2 The effect of incorporating DPA on shelf life of initiator solutions.......100	  
Table 4.4.1 The effect of injection on polymerisation time.......................................101	  
Table 4.6.1 The effect of the addition of Histodenz to Rf1 and Rf2 gel compositions
...........................................................................................................................104	  
Table 4.6.1 The visibility of Histodenz within gel Rf1 .............................................105	  
Table 4.7.1 Residual NaAMPs calibration by refractive index .................................108	  
Table 4.7.2 Residual KSPA calibration calculated by refractive index.....................109	  
Table 4.7.3 Mixture calibration for KSPA and NaAMPs calculated by refractive index
...........................................................................................................................110	  
Table 4.7.4 The residual content of gel Rf1 calculated by refractive index ..............110	  
Table 4.7.5 the residual content of gel Rf2 calculated by refractive index ...............111	  
Table 6.3.1 The generic analogue composition .........................................................146	  
Table 6.3.2 The incorporation of HA ........................................................................147	  
Table 6.4.1 Replacement of water with Healon.........................................................152	  
Table 7.2.1 FTIR analysis of histodenz and NMA 48% solution..............................158	  
Table 7.3.1 The elemental analysis of a linear polymer containing histodenz ..........162	  
 
 
 
 17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter One 
 
Introduction 
 
 
 
 
 
 
 
Introduction 
18 
 
1.1 Introduction 
 
This thesis is concerned with the design and synthesis of a proteoglycan analogue for 
tissue repair and regeneration.  The initial focus of the research was to identify a 
polymer composition with properties similar to that of specific natural tissue such as 
the nucleus pulposus of the intervertebral disc and crystalline lens of the eye.  This 
was further refined to produce a system suitable for successful injectable delivery to 
the target area.  The concept of biomimesis was an important aspect of this research.  
It was important to understand the nature, composition and responsiveness of the 
target tissues in order to successfully design the analogue.  A unique property of the 
natural tissues is their osmotic responsiveness, particularly under compression, which 
will be discussed in detail along with further mechanical properties of the analogues 
created. 
 
Due to the intended use of the material as an implant of sorts, the incorporation of an 
X-ray contrast medium was also investigated as part of this research.  It is a desirable 
advantage if an implant can be observed throughout its implantation/injection and 
subsequent lifetime.  Attempts were made to synthesise a multifunctional macromer 
from an existing contrast agent (Histodenz) so that it would form part of the polymer 
structure, this was however not a major focus of this research. 
 
It is important to mention that the concept of an injectable intervertebral disc repair 
system already existed prior to the research conducted in this thesis due to an EPSRC 
collaboration between Aston University, University of Oxford, and Robert Jones and 
Agnes Hunt Orthopaedic Hospital Oswestry.  Where data that resulted from this 
collaboration has been used, it has been clearly acknowledged.  
 
The concept of creating a synthetic proteoglycan tissue analogue is an important one 
because no existing hydrogel-based implant exhibits osmotically responsive 
behaviour.  The utilisation of redox polymerisation allows the implant to be injectable 
as a liquid, which will polymerise in situ, enabling the surgical process to be 
minimally invasive.  It also reduces the constraints of the manufacturing process on 
the end mechanical properties of the material. 
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This introduction will briefly introduce the origin of hydrogels, commonly used 
materials and their uses, and the role of natural hydrogels within the body.  The target 
areas; nucleus pulposus of the intervertebral disc and structure of the crystalline lens 
will be discussed in further detail. There will be an overview of the methods of 
polymerisation relevant to this thesis, followed by the subsequent techniques used to 
test the resultant materials.  Finally the nature of currently available X-ray contrast 
media will be discussed. 
 
1.2 Hydrogels 
 
1.2.1 History of hydrogels 
 
Harold Ridley was an ophthalmologist who worked in the Royal Air Force during 
World War II.   Upon removing splinters of acrylic from the eyes of pilots he noticed 
there was no adverse reaction to the presence of this material.  This was the first 
suggestion that a material of this nature might not cause an adverse reaction upon 
implantation.  Therefore he proposed the use of a similar material to treat cataracts 
and was the first to complete such an implant in 1949(1).  However it was the 
pioneering work of Otto Wichterle some fifty years ago that introduced interest in 
hydrogels and biomimesis.  His work was one of the first examples of biomimesis: the 
use of a natural system for the production of a synthetic analogue.  He developed 
hydrogel materials in an attempt to produce ocular implants that more closely 
resembled natural tissue than the rigid plastics and metals that were in use at the time.  
A precursor monomer (2-hydroxyethylmethacrylate) – HEMA was developed which 
was used to produce cross-linked water swollen polymers, which were stable to 
changes in pH, osmolarity, and temperature.  This led to the development of HEMA 
based hydrogels as tissue replacement materials and soft contact lens(2). 
 
1.2.2 Synthetic hydrogels 
Hydrogels can be best described as cross-linked hydrophilic polymer networks that 
are able to imbibe large amounts of water or biological fluids but do not dissolve in 
them(3). They are hydrophilic, three dimensional networks and due to their ability to 
imbibe large quantities of water or biological fluid, they are able to largely resemble 
natural structures(4).  Hydrogels contain tetrahedral sp3 carbon atoms to form a 
Introduction 
20 
backbone structure which incorporates other atoms such as hydrogen, oxygen, 
nitrogen and sulfur(5).  The biocompatibility of hydrogels makes them interesting 
materials with applications in pharmaceutical delivery, wound dressings, tissue 
engineering, dental restoration, biomedical electrodes, and ophthalmic materials(6,7,8,9). 
They occupy a unique position in the field of biomaterials due to the way in which the 
polymer surface properties are greatly influenced by the absorbed water. Hydrogels 
are flexible, non antigenic and permeable to water and metabolites.  Structural 
variations allow for a degree of control over the water content and water binding 
behaviour which is arguably the most important factor in hydrogel design.  Water 
within a hydrogel can act in several different ways: 
1. A plasticiser – behaving as an internal lubricant allowing chains to rotate 
hence conferring flexibility. 
2. A transport medium for dissolved species such as oxygen and water soluble 
metabolites 
3. A surface energy ‘bridge’ between natural and synthetic systems thereby 
enhancing bio tolerance 
4. A lubricant – reducing the coefficient of friction at the surface 
 
Within the hydrogel structure, initially water is strongly bound to specific sites on the 
polymer chain such as hydroxyl and/or ester groups, this water also interacts with the 
crosslinking agent if used.  It behaves both thermodynamically and dynamically as 
part of the polymer.  Further water is preferentially structured around the polymer 
network and is weakly bound to available hydrophilic sites while any remaining water 
behaves in bulk.  Interfacial water content will increase with increasing crosslink 
density.  The structure is dependant on the hydrophilicity of the hydrogel which in 
turn depends upon the functional groups incorporated into the polymer– the order of 
decreasing hydrophilicity being sulfonate >> carboxylate > amide > hydroxyl. 
 
A hydrogel may consist of two types of gel: a physical gel and a chemical gel.  
Physical gels are entangled chains that are not linked together in any way.  There may 
be ionic or hydrogen bonding in place but there are no covalent crosslinks, which are 
present in a chemical gel.  The hydrogels studied in this investigation are chemical 
gels consisting of ionic monomers cross-linked primarily with poly(ethyleneglycol) 
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diacrylate (PEGDA).  Cross-linking occurs in a free radically mediated process, in 
situ as part of the polymerisation reaction used to form the hydrogel.   
 
Fig 1.2.2.1 A physical gel represented by entangled free chains and a chemical 3D 
network where the red lines represent cross-links 
 
1.2.3 Synthetic hydrogels 
 
Figure 1.2.3.1 shows some common monomers used to make hydrogels, and polymers 
used as interpentrants and precursors to macromers used in hydrogel formation. This 
is not a complete list, but it illustrates a variety of materials highlighting in particular 
the presence of polar hydrophilic functional groups that are a common feature of 
hydrogel structures. 
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-
Fig 1.2.3.1 Examples of commonly used monomers and polymers used to make 
hydrogels 
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1.2.4 Natural hydrogels 
 
Examples of natural hydrogels include the nucleus pulposus of the intervertebral disc 
which is the central gel-like part of the disc responsible for cushioning and spacing to 
allow passage of nerves, the cornea and articular cartilage.  
 
1.3 Intervertebral disc (IVD) 
 
The spine provides support for the body.  It is composed of twenty-six bones that 
extend in a line from the base of the skull to the pelvis.  Twenty-four of these bones 
are ‘free’ and known as vertebrae.  The lower part of the spine known as the sacrum 
consists of five fused vertebrae between the hip bones and the coccyx, which itself 
has between three and five fused bones at the lower tip. These bones are aligned so as 
to provide a passageway for nerves and the spinal cord and to allow a person to stand 
upright, bend and twist. On the back of the vertebral body the lamina and pedicle 
forms a protective ring around the spinal canal.  The intervertebral discs lie between 
the vertebrae providing a ‘cushion’ between vertebrae and also act as a ‘spacer’ to 
allow nerves to exit the spinal canal.  The solid matrix of the intervertebral disc is 
composed of a gelatinous nucleus pulposus and a highly organised angle-ply laminate 
structure of the annulus pulposus(26). Facet joints are located on the back of the main 
part of the vertebra formed from a part of the vertebra above and below it, they 
connect each vertebra together and permit forward and backward motion.  
 
The position of the intervertebral disc within the spine is shown below in figure 1.3.1, 
followed by a close up of the annulus fibrosus and nucleus pulposus in figure 1.3.2. 
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Fig 1.3.1 A representation of the spinal column illustrating the position of the 
intervertebral disc(10)  
1.3.2 The nucleus pulposus of the intervertebral disc(11) 
 
The nucleus pulposus is an example of a hydrogel composite.  It is the innate ability 
of the gel-like structure to retain its water content which maintains disc height during 
its diurnal cycle between sleeping and activity.  The ability of the disc to remain 
hydrated while exposed to mechanical load and atmospheric dehydration is in part 
due to the presence of natural proteoglycans such as keratan sulfate, chondroitin 4-
sulfate and hyaluronic acid.  The subsequent mechanical properties of the 
intervertebral disc are controlled by this composition.   
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Up to 95% of the extracellular matrix of the disc consists of collagen, proteoglycans 
and water.  Collagen provides the strong fibrous framework which encases, within the 
matrix, proteoglycans and water.  Collagen has a triple helix structure and nine 
different forms exist in the disc. Types I, II, III, V and VI are all fibril forming 
collagens(12) which are present in abundance within the intervertebral disc, 
contributing to its fibrous structure. They have repeating glycine X-Y sequences and 
have a long central helical domain.  The X and Y amino acids are usually proline and 
hydroxyproline respectively(13).  
 
Only 1% of the composition of the disc consists of cells, these are however still 
important as they provide constituents which control matrix composition and cell 
turnover.  About 70-75% by mass of the disc is water, predominantly found in the 
nucleus.  The level of water in a disc can vary as much as 10-20% in a diurnal 
depending on the person.  This is in part due to pressure on the disc being lowest 
when a person is lying down sleeping, pressure then rises and varies greatly 
depending on a persons daily activities.  As with the water concentration, the level of 
proteoglycans present in the disc decreases from the centre towards the outer of the 
disc.  The greater presence of proteoglycans within the nucleus pulposus creates a 
high negative fixed charged density that controls hydration levels and enables 
compression resistance.  Figure 1.3.3 shows the structures of the most abundant 
proteoglycans in the IVD, chondroitin and keratan sulfate respectively 
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Fig 1.3.3 Chondroitin and keratan sulfate repeating units where Gal, galactose; 
GalNAc-6s, N-acetylgalactosamine 6-sulfate; GlcUA, D-glucuronic acid; GlcNAc-6s, 
N-acetylglucosamine 6-sulfate 
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1.3.1 Intervertebral disc degeneration 
 
Spinal stenosis is a narrowing of spaces in the spine that results in pressure on the 
spinal cord and or nerve roots.  It usually occurs in one or more of the following three 
areas of the spine: 
 
o The canal in the centre of the column of bones, also known as the vertebral or 
spinal column 
o The canals at the base of the roots of nerves branching out from the spinal 
cord 
o The openings between vertebrae through which the nerves leave the spine and 
go to other parts of the body 
 
It is most common in men and women over fifty years of age but can occur in those 
born with a natural narrowing of the spine, or after an injury. 
 
Degenerative disc disease may be defined as changes in wear of the individual discs 
of the spine.  It is one of the most common causes of lower back pain.  However disc 
degeneration is a natural part of aging, but can also result from trauma and or 
infection.  Degeneration may result in localised pain, stiffness and loss of mobility 
Changes in disc height can have both local and global effects.  On a local – cellular 
level, decreased disc height and volume results in increased load on the remaining 
nucleus pulposus which can lead to a decrease in cell matrix synthesis and an increase 
in cell necrosis and apoptosis(27).  Strenuous work/exercise or being overweight has an 
effect on IVD degeneration, in fact animal models have shown that overloading of the 
intervertebral disc can initiate disc degeneration(28,29).  Lumbar spinal stenosis is the 
most frequently encountered and clinically important degenerative spinal disorders in 
the ageing population.  
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When degradation has occurred and the annulus fibrosus is no longer structurally 
intact, this is known as a herniated disk, this has three main stages: 
 
o A bulge -- The gel has been pushed out slightly from the disk and is evenly 
distributed around the circumference.  
o Protrusion -- The gel has pushed out slightly and asymmetrically in different 
places.  
o Extrusion -- The gel balloons extensively into the area outside the vertebrae or 
breaks off from the disk.  
The stages of disc degeneration are demonstrated in figure 1.3.1.1 
Fig 1.3.1.1 The stages of disc degeneration(30) 
 
1.3.2 Current methods of disc repair 
 
Primary management of degeneration involves the use of non-steroidal anti-
inflammatory and exercise, which may be used to strengthen both abdominal and 
spinal muscles. 
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Surgical intervention becomes an option when non-operative care is no longer able to 
relieve pain.  The most common surgery performed is a Laminectomy.  If nerves have 
become compressed or narrowing of the spinal cord has occurred, the lamina can be 
removed to create space.  This is represented diagrammatically in figure 1.3.2.1  
Fig 1.3.2.1 A representation of laminectomy  
 
An incision is made into the muscle and ligaments either side of the spine exposing 
the laminae.  The lamina is then trimmed until sufficient bone is removed which frees 
the compressed nerve by increasing available space.  
 
A more radical method that can be used is Posterior Lumbar Interbody Fusion, the 
affected disc is removed and bone graft material is inserted into the space between the 
two vertebrae where the disk was removed.  The graft is held in place with a ‘fusion 
cage’.  The main goal of the procedure is to stimulate the vertebrae to grow together 
into one solid bone, creating a rigid column in the problem area.  Unfortunately fusion 
has the potential to accelerate degradation of surrounding discs associated with the 
loss of mobility and flexibility. 
 
Implants are a possible alternative yet there are none currently available on the 
markets that do not require extensive surgery.  Due to the materials they are 
constructed of they are also poor mimics for the natural tissue.  An example of an 
artificial ProDisc-L is shown in figure 1.3.2.2.  This consists of two metal cobalt 
chrome alloy endplates which implant into vertebrae above and below the affected 
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disc.  An ultra high molecular weight polyethylene is inserted between the two 
endplates and acts as a ‘ball’(32). 
 
 
Fig 1.3.2.2 The artificial ProDisc-L(32) 
 
In comparison to the drastic treatment available (prostheses are implanted through the 
abdomen), and/or the lack of effective treatment, it is clear that the treatment of disc 
degeneration could be improved by the production of a minimally invasive injectable 
repair system designed for use in the early onset stage, this is the aim of the work 
described in this thesis. 
 
The most studied nucleus pulposus replacement currently in trial is the Prosthetic 
Disc Nucleus or PDN marketed by Raymedica, Minneapolis.  It consists of a hydrogel 
pellet encased in a polyurethane jacket. The implant has been shown to perform 
favourably in terms of biological compatibility and biomechanical testing.  In one 
particular trial conducted in Korea, 48 patients underwent nucleus replacement 
surgery and the success rate was reported as 78%. 
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1.4 The cornea and crystalline lens 
 
The structure of the eye is shown in figure 1.4.1.  The cornea covers the transparent 
front part of the eye that encompasses the iris, pupil, and anterior chamber.  In 
addition to the lens, the cornea refracts light, accounting for around two thirds of the 
eyes optical power.  The cornea consists of Type III, IV and VII collagen plus 
hyaluronic acid and stromal proteoglycans(14). The architecture of the collagen fibres 
coupled with an intact endothelium are the main components responsible for corneal 
hydration and transparency. 
 
 
Fig 1.4.1 The structure of the eye(15) 
 
The lens consists of approximately 65% water and 35% protein, it has a central 
thickness of ~4mm and an equatorial diameter of ~ 9mm(16).  It is totally transparent 
and enclosed in a thin membrane capsule that is suspended between the aqueous 
humour and the vitreous body by equatorial zonular fibres. 
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The lens of the eye, unlike any other ocular tissues, keeps growing throughout life.  In 
lens growth new cells are laid over existing fibre cells which are then displaced 
towards the centre of the lens(17).  As the lens continues to grow, and cells continue to 
be compacted, that there is a loss of water in the lens along with the increase in 
protein content causing an increase in refractive index.  This results in an increase in 
stiffness of the lens and reduces the ability of the eye to accommodate.  The actual 
values of stiffness are believed to increase from 70Pa at birth to 2700Pa in a 65 year 
old(18).  Protein contents in the lens are in the range of between 17% and 38% in the 
outer cortex and nucleus respectively(19). Water contents due to this alteration in 
protein range from 50% to 85%.  Due to the alteration in protein and water content RI 
rises to about 1.418 but not usually higher, and appears to plateau in the centre of the 
lens(20).  
 
1.4.1 Cataract formation and subsequent surgery 
 
Cataract formation is an opacification of the natural lens which occurs due to 
metabolic changes of the crystalline lens fibres over time.  The lens is made mostly of 
water and protein.  The protein is arranged to let light pass through and focus on the 
retina.  Sometimes some of the protein clumps together which can start to cloud small 
areas of the lens blocking some light from reaching the retina and interfering with 
vision.  During cataract surgery the cloudy natural lens is removed and replaced with 
a synthetic intraocular lens to restore transparency. 
 
Types of cataract: 
• Age related 
• Congenital – some babies are born with cataracts or develop them in 
childhood, often they do not affect vision but must be reduced anyway 
• Secondary cataract – cataracts are more likely to develop in people who have 
certain medical problems such as diabetes.  They can also be linked to the use 
of medications such as steroids.  Long term unprotected exposure to sunlight 
is also believed to contribute to the development of cataracts 
• Traumatic cataracts – cataracts can develop soon after an eye injury or years 
later(33). 
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With an ageing population the number of people who are suffering with cataracts is 
on the increase.  Cataract blindness is the most common cause of blindness in the 
world today; the World Health Organisation(WHO) estimates that of the 45 million 
people who are blind, cataracts cause half. 
 
Modern cataract surgery is today one of the most common surgical procedures 
performed; with millions performed each year.  Most of these surgeries occur in the 
western world where people can afford the operation.  In developing and third world 
countries people who suffer from cataract blindness are unable to afford the relatively 
simple operation which could allow them to see again.  Cataract surgery consists of 
the clouded lens being removed from the eye and an IOL being inserted to replace the 
removed lens.  
 
A summary of the surgical process is shown below(33) 
1. Anaesthesia 
2. Exposure of the eyeball using a lid speculum 
3. Entry into the eye through a minimal incision (corneal or sclera) 
4. Viscoelastic injection to stabilise the anterior chamber and to help maintain 
the eye pressurisation 
5. Capsulorhexis- removal of the lens 
6. Hydrodissection pie- removal of the lens in segments 
7. Hydro-delineation- injection of fluid into the cavity 
8. Ultrasonic destruction or emulsification of the cataract after nuclear cracking 
or chopping, cortical aspiration of the lens, capsular polishing 
9. Implantation of the artificial IOL 
10. Entration of IOL – usually foldable 
11. Viscoelastic removal 
12. Wound sealing/hydration if needed 
 
1.4.2 Intra-ocular lenses 
 
Intraocular lenses are artificial lenses used to replace the natural lens after cataract 
surgery.  IOLs have been around since the 1960’s although the year the FDA first 
approved an IOL was 1981.  Traditional IOLs are monofocal- they offer vision at one 
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distance only.  Multifocal and accommodating lenses are now available.  The incision 
size for insertion of an IOL depends on the nature of the IOL.  There are two main 
types – those that are foldable and those that are not.  The incision size for a foldable 
IOL can range from 1.8mm to 3.5mm.  For a rigid PMMA lens this may increase to 5-
7mm.  PMMA was for a long time the material of choice due to its low weight and 
inherent biocompatibility due to a relatively low surface energy.  It does however 
result in corneal endothelial damage on insertion, and post -operative adhesion of 
inflammatory cells to the IOL structure.  Attempts have been made to improve IOL 
materials including polishing the surface, using NVP and or HEMA, and reducing the 
surface energy by coating with perfluoropropane or phosphorylcholine, and or 
binding heparin and HA to the outer surface of the lens(34). 
 
Foldable IOLs are usually made of silicone or acrylic material of an appropriate 
refractive power.   They are inserted either by folding in half using special forceps or 
via the use of a special insertion device that rolls the IOL and injects it slowly into the 
capsular bag.  Examples of currently used foldable IOLs are shown in figure 1.4.2.1 
 
 
Fig 1.4.2.1 Examples of existing IOL designs(35) 
 
The central viewing zone is called the optic, the clear round disc measures 5.5-6.5mm 
in diameter.  On both sides haptics act like tension loaded springs to automatically 
centre the lens once implanted.  As shown above, overall shapes vary. 
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The development of an injectable IOL, which would polymerise in situ would be 
advantageous, as it would reduce the incision size needed and simplify the operation, 
desirable for an ageing population and those patients with underlying health issues.  
Benefits of a small incision include: 
 
• Less trauma to the eye 
• Little discomfort during or after surgery 
• Often does not require stitches 
• Can aid in reducing astigmatism and provide better vision 
 
The utilisation of an injectable IOL would also reduce the manufacturing constraints 
on the material, it would no longer need to withstand lathe cutting in the case of 
acrylics and/or moulding in the case of silicone materials.  This should therefore 
allow a greater control over desirable mechanical properties.  Hydrophilic materials, 
of which this analogue is based on, have been shown to be less damaging to the 
corneal endothelium and produce less of an inflammatory response.   
 
1.4.3 The problem of accommodation 
 
Accommodation is the ability of the eye to focus on near and far objects in order to 
produce a sharp retinal image.  This is achieved via the contraction of the cilliary 
muscles which in turn contract and relax the zonular fibres.  As the lens becomes 
stiffer with age it becomes more difficult, and eventually impossible for the muscles 
to alter the shape.  Therefore the eye no longer has the ability to accommodate, known 
as presbyopia.  Currently a patient who has been fitted with a standard IOL will suffer 
the same degree of presbyopia due to the stiffness of the IOL material, the eye cannot 
accommodate.  The use of an injectable material with low mechanical strength has the 
potential to allow the eye to accommodate.  
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1.5 Articular cartilage 
 
Articular cartilage covers the ends of bones in synovial joints and provides a shear 
resistant and resilient weight-bearing surface that is essential for normal joint 
function.  It is composed of 75%-80% water with the remainder consisting of 
proteoglycans (87% chondroitin sulfate, 6% keratan sulfate and 7% protein) arranged 
around collagen fibrils(21). Mechanically the collagen fibrils restrain excessive 
expansion of the negatively charged hydrophilic proteoglycans forming a compact but 
highly hydrated extracellular matrix(22). The transport of nutrients, enzymes, cytokines 
and growth hormones, to name a few, are extremely important in the maintenance of 
cartilage cell structure and viability.  Degenerative joint disease involves an increase 
in water content and a decrease in proteoglycan content of the cartilage structure, thus 
detrimentally effecting transport of nutrients.  New proteoglycans are synthesised 
however they do not aggregate as readily as in healthy tissue.  This affects not only 
the mechanical stability of the matrix but also the mobility of solutes that are essential 
for cell viability. 
 
1.6 The role of proteoglycans(PGs) and glycosaminoglycans(GAGs) in the 
extracellular matrix  
 
The extracellular spaces – particularly of connective tissue such as cartilage, tendons, 
skin and blood vessel walls consist of collagen and elastin suspended in a gel matrix.  
This matrix is made up of GAGs and PGs and is known as the extracellular matrix.  
The large sulfated GAG polysaccharide chain in PGs has a strong negative charge 
environment that binds Na+ ions.  This allows the drawing of large amounts of water 
into the GAG matrix by osmosis.  Therefore PGs are essentially an immobilised 
aqueous environment that allows flow of water and its solutes subject to the negative 
charge generated by the sulfate group.  A representation of the ECM is shown below 
in Figure 1.6.1 
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Fig 1.6.1 The ECM and the role of proteoglycans(23) 
 
The study of the structure and functions of GAGs and PGs has greatly increased 
understanding of the roles they play in biological processes such as cell proliferation, 
differentiation and wound healing.  GAGs such as heparin, heparan sulfate and 
dermatan sulfate serve as key biological response modifiers by acting in four different 
interconnecting roles.  
 
1. Act as stabilisers, co-factors/co-receptors for growth factors, cytokines and 
chemokines 
2. Regulate enzyme activity 
3. Act as signalling molecules in response to stresses such as cellular damage 
due to wounding, infection and or tumorigenesis 
4. Behave as targets for bacterial, viral and parasitic virulence factors for 
attachment, invasion and immune system invasion(24,25). 
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The method of polymerisation which allows the best control for an injectable 
application which is required for the minimally invasive methods of repair desired for 
the applications described in this thesis is redox.  The next section of the introduction 
will introduce and discuss this topic. 
 
1.7 Redox polymerisation 
 
In order for the material to be delivered via injection as a low viscosity pre-gel, 
polymerisation must occur in-situ to give complete reliable polymerisation.  Therefore 
there are three possible methods of free radical initiation that could be employed; 
thermal, UV, and redox.  Due to the application as a tissue repair system thermal 
initiation can immediately discounted due to damage subsequent heat would cause to 
surrounding tissues.  UV polymerisation also creates a problem as firstly, most UV 
based initiators are organic and could cause toxicity issues if used in the presence of 
bodily tissues prior to consumption.  Also with respect to the disc, initiation of 
polymerisation would require the implantation of a UV probe which, is both 
impractical and defeats the object of developing an injectable repair system.  
Therefore this leads to the choice of redox initiation. 
 
Redox initiators produce free radicals in an effective, mild and controlled way that is 
required for this application.  This occurs via a one on one electron transfer 
reaction(37).  Redox initiation requires a much lower activation energy; typically 40-80 
kJmol-1 in comparison to that of thermal initiation which requires energies of 12-160 
kJmol-1.  The milder conditions of redox initiation lower the possibility of side 
reactions occurring, producing a polymer in a good yield with a higher molecular 
weight than might be expected from thermal polymerisation(38).  However initiation 
must still be efficient, ensuring that each initiating radical produces a high enough 
conversion of monomer to polymer to avoid high residual monomer levels after 
completion. 
 
The use of water soluble redox initiators is advantageous for use with hydrophilic 
monomers. The large hydration shell of the monomer allows excellent access for 
water soluble intiators to continually propagate the polymer chain.  The level of 
solvation of both initiator and crosslinking agent is important as insufficiently 
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solvated systems tend to micellise and as a result areas of high crosslink density occur 
within the polymer network.  Commercially available free radical initiators tend to be 
soluble in organic media rather than aqueous.  
 
1.7.1 The effect of oxygen within a redox system 
 
The presence of molecular oxygen within a redox system tends to increase the 
induction period, however in some cases, in particular in the use of potassium 
persulfate/ascorbic acid redox pair, oxygen may act as a cocatalyst with the ability to 
reduce the induction period.  Oxygen is used at atmospheric levels favourably to 
assist in the degradation of ascorbic acid, however there must be control over the level 
of oxygen within the system so as to avoid the production of low molecular weight 
polymers due to oxygen acting as a chain terminator.   It was discovered very early on 
within the polymerisation studies that although eradication of oxygen within both 
stock monomer solutions and initiator solutions produces a much more uniform gel, 
an initial nucleus of gelation is formed instantaneously rendering the application of an 
injectable unsuitable due to blockage of the needle. 
 
Focusing on ascorbic acid and potassium persulfate as a redox pair, when ascorbic 
acid is in the presence of oxygen the following autocatalytic reactions shown in below 
in figure 1.7.2.1 occur.  
Fig. 1.7.2.1 The oxidation reactions of ascorbic acid 
 
Where AH2, AH, and A represent ascorbic acid, ascorbate radical and 
dehydroascorbic acid respectively(38) . 
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In aqueous solution ascorbic acid dissociates into ionic fragments and it is the 
monohydroascorbate ion which is mainly responsible for the strong reducing action of 
AA shown in figure 1.7.2.2 
 
Fig. 1.7.2.2 The reducing action of ascorbic acid 
 
The chain reaction involving ascorbic acid and potassium persulfate during free 
radical polymerisation is shown below in figure 1.7.2.3 
  
Fig. 1.7.2.3 The reaction between ascorbic acid and potassium persulfate(37) 
The action of the ascorbate radical represented by A
.
is shown below in figure 1.7.2.4.    
 
Fig 1.7.2.4 The action of the ascorbate radical  
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The persulfate radical generation is represented below in figure 1.7.2.5 
Fig 1.7.2.5 The persulfate radical 
 
Incorporating the monomers, the polymerisation can be represented by figure 1.7.2.6 
Fig 1.7.2.6 A representation of free radical polymerisation using ascorbic acid and 
potassium persulfate redox pair 
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1.7.3 Free radical polymerisation: types relevant to this research 
 
Initiation is the creation of free radicals capable of propagating a polymer chain.  Two 
reactions occur, the initiator splits into two free radicals, each fragment may then 
react with a monomer unit initiating the polymerisation.  Upon addition to the carbon-
carbon bond of the monomer (breaking the pi bond), the radical with be present on the 
most substituted carbon atom (36).  
 
I          2R•           
R• + M           RM• 
 
Propagation, the next step, involves continuous addition of monomer at the end of a 
free radical to regenerate the structure of the propagating species 
 
RM• + M               RM2• 
RMn• + M               RMn+1• 
 
Termination of a radical may occur via two routes, combination with another polymer 
radical known as bimolecular termination, or via disproportionation. 
 
RMn• + RMm•             R2Mn+m 
RMn• + RMm•             RMn+ RMm 
 
I= initiator 
R•= radical species 
M= monomer 
RM•= monomer with radical as chain end 
RM2•= 2 monomer units with radical as chain ends 
RMn•= n monomer units with radical as chain ends 
RMm•= m monomer units with radical as chain ends 
 
The kinetics of reaction were not investigated in this research, however typically in 
free radical polymerisation, the rate of propagation is proportional to the monomer 
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concentration, radical propagation, and the propagation rate constant.  An assumption 
is made that radical reactivity is independent of chain length.  
 
1.7.4fotopolymerisation 
 
Ultra –violet (UV) can also be termed light induced polymerisation.  The first step in 
a photopolymerisation reaction is the absorption of a photon.  If absorption of specific 
energy occurs then the electron becomes excited to a higher energy state.  The 
electronic transitions that occur may cause the molecule to split, thus generating free 
radicals(39). This method of initiating polymerisation is predominantly used in the 
production of coatings and adhesives(40).  The properties, quality and performance of a 
UV cured polymer are directly related to the formulation and the curing conditions 
under which it was made(40).  High concentrations of photo initiator can lead to 
yellowing, accelerated ageing and occasionally odour issues.  This has the potential to 
compromise overall product quality and shelf life (41).  
 
1.8 The testing of materials: rheology 
 
Rheology is the study of the deformation and flow of matter under the influence of 
externally imposed mechanical forces.  There are two limiting types of behaviour.  
Deformation may spontaneously reverse which is termed elastic behaviour; mainly 
rigid solids exhibit this.  The energy that is used to cause the deformation is stored, 
and then recovered once relaxation has occurred.  Towards the other extreme, the 
material begins to flow and the energy to initiate this is non recoverable.  This is 
viscous behaviour and is characteristic of a liquid.  The viscoelastic properties of the 
hydrogel are measured via the application of a torque and deforming the gel with an 
applied stress, which results in a strain, measured as a function of frequency.  Varying 
the applied frequency (5-25Hz) applies an oscillating force to the sample and a 
sinusoidal strain is generated. Measurement of the amplitude of deformation at the 
peak of the sine wave, and the log between the stress and strain waves allows the 
calculation of complex, viscous, and elastic modulii. Division of the viscous modulus 
by the elastic modulus calculates the tangent of the phase shift.  Where the phase shift 
is the difference between the shear stress sine wave and the shear strain sine wave.  
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The modulus calculated via this form of testing is not to be confused with the Youngs 
Modulus that is calculated from the slope of a typical stress strain curve. 
 
Tanδ =
! 
G"
G'   
G” = Viscous modulus 
G’= Elastic modulus 
Shear stress =Force/Area 
Shear rate = Change in shear strain/change in time 
Shear strain= gel displaced/gap height 
Viscosity= shear stress/Shear rate (Nm-2s or Pas) 
 
Parallel plates are used to test under compression if the sample is primarily elastic.  If 
the sample is of a viscous or liquid nature and the angle is very small then a cone and 
plate is used at 1o or 4o to allow the generation of a homogenous strain across the 
sample. 
 
Ideally materials that exhibit elastic behaviour will yield a linear response where the 
modulus is independent of load and loading rate.  When the material becomes placed 
under tension, the linear region is followed by a curve that is caused by necking of the 
sample and its subsequent drawing out 
 
Molecularly the dashpot in the spring and dashpot model represents the resistance of 
the chains to uncoiling.  The spring represents the thermal vibration of chain segments 
that seek the lowest energy arrangement.  At low frequencies the resultant curve is 
observed to be fairly flat and it can be said that the sample is exhibiting Newtonian 
behaviour.  At this low frequency viscosity is dependent more on molecular weight 
than it is on the application of a strain.  As the testing frequency is increased the 
sample begins to behave in an increased elastic fashion and is no longer behaving in a 
Newtonian manner.  At some point increasing the frequency will begin to irreversibly 
degrade the polymer by actually breaking chains. 
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1.9 A brief insight into radio-opaque contrast media, types and uses 
 
Contrast media are by default known as drugs.  This makes their use in new materials 
for biological applications a tricky one.  Their primary use is to enhance the 
diagnostic information provided by medical imaging systems.  The structures 
represented in figure 1.6.1 demonstrate the most common contrast media that are 
used, or modified to form the basis of contrast media. 
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Fig 1.9.1 Diatrizoic acid, metrizoic acid, and iothalmic acid, the basis of most 
modern contrast media(42). 
 
Current contrast media make opacification of practically any vascular and 
parenchymal structure possible with relatively low levels of toxicity(43).  One of the 
drawbacks of iodinated contrast media is that in order to be visible they must be used 
in rather high concentrations so as to maximise their iodine content.  This results in a 
solution with a very high osmolarity, often six or seven times greater than that of 
natural tissue. 
 
The use of non-ionic contrast media (water soluble) allows the preparation of 
solutions with a much lower osmolarity.  The compound focused on in this research 
was iohexol (Histodenz), structure shown below in figure 1.9.2 this has a molecular 
weight of 821 with iodine comprises 46.4% of this atomic mass.  A 300mgI/ml 
solution results in an osmolarity of 690 mOsm, almost twice that of natural tissue but 
relatively low for contrast media. 
 
Fig 1.9.2 Iohexol (Histodenz) 
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1.10 The scope and objectives of the work presented in this thesis 
 
The aim of the work reported in this thesis was to design and develop a novel 
intervertebral disc repair system.  The requirements are that it should be: 
 
o Injectable 
o Polymerise in situ 
o Form a complete gel within 3-7 minutes 
o Biomimetic, based on the natural sulfate in proteoglycans 
o Osmotically responsive to restore disc height 
o Mechanically stable with properties similar to the nucleus pulposus 
o Must not degrade 
o Must not be cytotoxic to surrounding tissues 
 
The technology can be further adapted to the production of an injectable intraocular 
lens. In addition to the synergistic requirements above the material must fill the cavity 
without damage to the capsular bag, and mimic the mechanical properties of the 
natural lens to restore the ability of the eye to accommodate.  
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Chapter Two 
 
Materials and Methods 
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2.1 Reagents 
 
2.1.1 Initiators 
 
Table 2.1.1 Initiators   
Reagent Formula Supplier 
L-ascorbic acid (AA) C6H8O6 Sigma 
Aldrich 
Oxone 2KHSO5.KHSO4.K2SO4 Sigma 
Aldrich 
Potassium persulfate K2S2O8 Sigma 
Aldrich 
Iron II lactate hydrate C6H10FeO6aq Fluka 
Iron II gluconate C12H22FeO14aq Fluka 
Dimethyl paratoluidine (DMT) C9H13N Sigma 
Aldrich 
2,2 azo bis (2-methyl propionamide) 
dihydrochloride 
C8H18N6.2ClH Sigma 
Aldrich 
N’N’N’N tetramethylene diamine 
(TEMED) 
C6H16N2 Sigma 
Aldrich 
Benzoyl peroxide (BP) C14H10O4 Sigma 
Aldrich 
Tertiary-butyl hydroperoxide C4H10O2 Sigma 
Aldrich 
Ammonium persulfate (NH4)2S2O8 Sigma 
Aldrich 
Hydrogen peroxide H2O2 Sigma 
Aldrich 
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2.1.2 Monomers and crosslinking agents [supplier in brackets] 
 
 
Potassium salt of 3-sulfopropyl acrylate (KSPA), [Raschig GmbH] 
 
Sodium 2-acrylamido 2-methylpropane sulfonic acid (NaAMPs), [58% solution 
supplied by Lubrizol, 50% solution Sigma-Aldrich] 
 
Dipotassium salt of bis (3-sulfopropyl) itaconate (KSPI) [Raschig GmbH] 
 
 
Poly(ethyleneglycol) acrylate (PEGA), [Sigma-Aldrich] 
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Acryloylmorpholine (ACMO), [Sigma-Aldrich]  
 
Poly (ethyleneglycol) diacrylate.  typically n~575, [Sigma- Aldrich] 
 
 
Nelfilcon - modified PVA [Cibavision] 
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Poly (ethyleneglycol) dimethacrylate, typically n= 1000, [Sigma-Aldrich] 
 
2.2 Methods 
 
2.2.1 Typical gel procedure 
 
For example a typical composition consists of:  
 
Gel NaAMPs 
(50%) 
KSPA 
 
Water 
 
Crosslinking 
agent 
PEG575DA 
Ascorbic acid 
0.1M 
 
Oxone 
0.1M 
 
Rf1 3.7 
1.6 x 10-3 mol 
1.4g 
0.6 x 10-3 
mol 
3.6g 
0.2 mol 
0.2g 
3.5 x 10-4 mol 
 
0.65g 
6.5 x 10-5 mol 
0.65g 
6.5 x 10-5 mol 
 
For the injection procedure to take place, the components need to form two pregel 
solutions, for example:  
 
Redox A: 
o Monomer 1 
o Water 
o Redox initiator A 
 
Redox B: 
o Monomer 2 
o Water 
o Crosslinking agent 
o Redox initiator B 
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So for the composition above, stock solutions of initiators were prepared, a 0.1M 
solution of ascorbic acid and Oxone was prepared from the solid material to form a 
10ml standard solution.  This was then vortexed to ensure complete solubilisation.   
 
In two separate vials the two redox A and redox B solutions are weighed out, the 
water component is split between the two stock solutions to create equal volumes. 
 
Redox A 
3.7g 50% NaAMPs 
0.65g of AA 0.1M stock solution 
0.75g distilled water 
 
Redox B 
1.4g KSPA 
0.2g PEG575DA 
0.65g of Oxone 0.1M stock solution 
2.85g distilled water 
 
Each stock solution was vortexed to ensure all components were thoroughly mixed. 
 
If at this point the removal of oxygen was required, each pregel solution had nitrogen 
bubbled through for 10 minutes.   
 
To form a gel, measures of each stock solution, Redox A and Redox B (equal 
measures for this composition) were placed into separate sides of a dual syringe, and 
injected into the required cavity typically via a 19 gauge needle. 
   
2.2.3 Swelling procedure 
 
For free swelling experiments, discs of gel of diameter 20mm were cut from the gels 
prepared within the Petri dishes using a number 13 cork borer.  The discs were 
weighed and then placed into a jar with an excess of the swelling medium, which was 
typically phosphate buffered saline solution or distilled water.  The discs of gel were 
removed at selected time intervals, the surfaces dabbed with filter paper to remove 
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any surface liquid, and then reweighed.  The percentage increase in mass per allocated 
time was used as a measure to determine swell capacity. 
 
Swell procedure for compression testing 
Typical pre-gel compositions (volume circa 3ml) were injected into dialysis tubing 
(12,000 mol wt cut off) using the dual syringe method. The dialysis bags were sealed 
with clips and the polymers were allowed to cure. The dialysis bags were then placed 
into PEG solutions of different osmolarities (ranging from 300-1500mOsm) and 
allowed to swell under osmotic pressure at room temperature for 72 hours 
Compression tests were carried out on the dialysis bags containing the swollen 
polymers using a Hounsfield S-series H10KA dual column bench top tensiometer. 
The thickness of each sample is measured and corresponding displacement set to 
between 5 and 50%; tests were carried out at a speed of 1.0mm/min.  
 
2.2.4 Rheology 
 
To assess the viability of the gels mechanically, the elastic and viscous modulii were 
recorded using a Bohlin CVO Rheometer. Initial Stress values were calculated 
following amplitude sweeps from 2.66Pa-20kPa carried out at 0.5 Hz and 30Hz.  An 
initial stress was chosen that lay within the linear region for both the high and low 
frequency runs.  This ensured that the material can be continuously excited without 
exceeding the strain value that destroys its structure.  The applied stress is 
continuously adjusted so that the resultant strain is kept at a specific value.   
 
Gels were prepared within Petri dishes allowing a flat circular structure from which 
discs of 20mm diameter and approximately 2mm thickness were cut using a no 13 
cork borer.  These ‘discs’ were then placed onto the bohlin rheometer using a parallel 
plate method commonly used for samples displaying elastic behaviour.  All tests were 
carried out at 37oC to mimic body temperature.  Samples were then subjected to an 
oscillating frequency between 0.5 and 25Hz (the frequency required to complete a 
sine wave) to observe the ability of the material to maintain its structural integrity. 
The normal force was set at 100g. All tests were repeated to ensure reproducibility. 
The storage modulus (G’) and the loss modulus (G’’) corresponding to the elastic and 
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viscous components respectively were measured. The loss tangent (tan δ) which is the 
phase angle was calculated as the ratio between the G’’ and the G’ 
 
2.2.5 Residual monomer analysis 
 
Gels were prepared within Petri dishes, and 10mm discs of gel were cut out.  The 
discs were then placed in 10ml of HPLC grade water for 2weeks.  Standards of 
NaAMPs and KSPA were prepared from 0.0001% concentration to 5% to allow a 
calibration to be made.  After the time had elapsed the liquid was filtered and 
analysed via the following techniques. Residual monomer levels were assessed 
typically by ion chromatography (Dionex DX600 system with GP50 gradient pump, 
EG50 eluent generator, PDA-100 photodiode array and ED50 electrochemical 
detectors); or refractive index (Index Instruments automatic refractometer GPR 11 – 
37X). 
 
 2.2.6 FTIR 
 
Infra-red analysis was conducted on samples as either solid, liquid, or gel using a 
Nicolet-380 FTIR Spectrophotometer with a diamond attenuated total reflectance 
attachment.  The required amount of sample ~ 0.1g was placed on the plate above the 
laser and held in place by screwing down the relevant tip which is adjusted according 
to the nature of the  sample, to provide maximum surface contact.  If sampling a 
liquid, a volatile cover is placed over the sample instead of the tip.  Each spectra is set 
to run 60 scans per sample.  A typical spectra for water is shown in figure 2.2.6.1 
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Fig 2.2.6.1 A typical FTIR spectra for water 
 
2.2.7 Medac CHN analysis 
 
Samples based on functionalised histodenz discussed in chapter seven were sent to 
Medac for CHN elemental analysis to assess for iodine content.  The method is based 
on combustion analysis as a method of determining sample purity.  Typical sample 
size was 5mg of solid material.  Results are supplied in the format below in table 
2.2.7.1. 
 
Table 2.2.7.1 Medac analysis results 
ELEMENT C H N S Cl	   Br I O  Na 
% Theory            
% Found 1  2.68 11.68 0.46 0.68   1.24   0.15 
% Found 2  2.91 11.65 0.51 0.63   1.28   0.17 
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2.2.8 NMR 
 
NMR was conducted on histodenz samples introduced in chapter seven using a 
Bruker 300MHz NMR instrument.  For this application the method used was based on 
the WATERGATE water suppression technique which is facilitated by gradient 
tailored excitation.  This removes resonance exhibited by the solvent but retains that 
of the sample. 
  
2.3 Synthetic routes to sulfonated monomers 
 
2.3.1 The synthesis of KSPA 
 
This process is for the commercial production of KSPA and was not reproduced 
within the laboratory. 
 
Salts of sulfoalkyl acrylate can be produced in high purity by reacting salts of acrylic 
acid (produced by neutralising the acid in this case with potassium hydroxide) with 
1,3 propane sultone at 110-120oC, in the presence of acrylic acid (1).  1,3 propane 
sultone is used as a chemical intermediate to introduce the sulfopropyl group into 
molecules and also to provide or improve water solubility along with ionic character.    
Although a suspected carcinogen, it is used as an intermediate in the production of 
fungicides, insecticides, cation exchange resins, dyes, vulcanisation accelerators and a 
variety of other chemicals(45)(46). The product salts out of the reaction solution and is 
collected via filtration and washing with acetone.  Yield is typically ~ 99% with 
purity ~ 98% (44).  The reaction scheme for which is shown on the following page in 
figure 2.3.1. 
Materials and Methods 
58 
 
 
Fig 2.3.1 The production of potassium salt of 3-sulfopropyl acrylate 
 
Alternative methods exist utilising the esterification of acrylic acid or the reaction of 
an acrylic halide, with a hydroxyalkanesulfonate.  These reactions have disadvantages 
in the solubility and undesirable halide reactions respectively.  
 
2.3.2 The synthesis of NaAMPs 
 
This describes a commercial process and was not reproduced in the laboratory. 
 
The synthesis of sodium 2-acrylamido 2-methylpropanic sulfonic acid (AMPA) 
requires the combination of acrylonitrile and isobutylene with fuming sulfuric acid.  
The reaction mixture is initially maintained at approximately -20oC for 2 hours before 
being allowed to reach room temperature.  After ~ 2 hours a dense white solid is 
formed AMPA, this is filtered off and washed with acetonitrile.  Typical yields are 
usually ~86%(47).  The resultant acid AMPA, is then neutralised with sodium 
hydroxide to provide the sodium salt.  The mechanism is shown in figure 2.3.2 
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Fig 2.3.2 The production of sodium 2-acrylamido-2-methylpropane sulfonic acid 
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Chapter Three 
 
The Design and Synthesis of a Proteoglycan Analogue: Experimental 
Considerations 
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3.1 Introduction 
 
To design a material suitable material for use as a proteoglycan analogue for use in 
applications such as intervertebral disc (IVD) repair or as an injectable intraocular 
lens (IOL) the material must meet several requirements, which will be discussed in 
this chapter. 
 
In order to be feasible as a novel injectable material, it is important that the 
components are readily available, and advantageous if they have previously 
demonstrated compatibility in a biological environment with no cytotoxic response.  
The materials must be capable of polymerising under conditions that are suitable for 
the end use of the material, allowing it to be injected in to the respective cavity as a 
liquid that will then polymerise completely in situ.  In addition to this, the method of 
polymerisation used must result in complete reproducible polymerisation with 
minimal residual monomer remaining, the method employed must also cause no 
adverse effects to the cavity in which it is to be used.  Finally, the materials used must 
create a highly hydrophilic network capable of imbibing water or biological fluids, 
have mechanical strength similar to that of the target natural structure and maintain 
integrity whilst under compression.  The full requirements of the system are: 
 
o Deliverable via injection 
o Low viscosity to enable use of a small diameter discography needle 
o To provide complete gelation in situ 
o Have appropriate mechanical properties to match that of target tissue 
o Stable to enzymatic and hydrolytic degradation 
 
This chapter will begin by discussing monomer selection criteria and investigations, 
followed by the method and nature of free radical polymerisation to be employed.  
The choice of cross-linking agent will be discussed, and the subsequent affect this has 
on the end polymer.  Finally variables which have the potential to influence the 
polymerisation, delivery, stability, and lifetime of the material will be discussed. 
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3.1.1 Monomer selection- the rationale for the use of sulfonates 
 
Conventional neutral synthetic hydrogels such as those based on hydroxy ethyl 
methacrylate and N-vinyl pyrollidone for example have been proved to be very 
effective soft tissue biomaterials for a range of applications.  However these materials 
fail to match the behaviour of natural tissue in its ability to retain water when 
compromised.  Natural tissue such as cornea, cartilage or intervertebral disc show a 
remarkable ability to retain water content whilst compromised.  Conventional 
hydrogels in comparison, lose water relatively rapidly.  The exception to this is found 
in synthetic hydrogels which contain sulfonate groups, which show an ability to retain 
their water content.   
 
For most biomedical applications, hydrogels need to show dimensional stability to 
changes in, osmolarity and temperature.  PolyHEMA is successful as a material 
because it behaves well in these conditions.  Sulfonate-containing materials, in 
comparison, are responsive to environmental changes which render them unsuitable 
or at most difficult to manage for most tissue replacement or tissue augmentation 
applications. 
 
The biomimetic approach of the work detailed in this thesis will be based on the use 
of the synthetic sulfonate as a surrogate for the sulfate group present in natural 
proteoglycan structures, structures of which are shown below in figure 3.1.1, using 
two precursor monomers the sodium salt of   2-acrylamido 2 methylpropane sulfonic 
acid (NaAMPS) and the potassium salt of 3-sulfopropyl acrylate (KSPA). 
 
 
Fig 3.1.1 The sulfate and sulfonate functional groups, repsectively 
 
The molecular structures of alkyl sulfate and alkyl sulfonate are very alike – both 
have very much larger hydration shells than either hydroxyl or carboxyl groups which 
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means that they are able more effectively to “shield” the hydrocarbon backbone. The 
hydration shell of the sulfonate group has been shown to extend over a larger portion 
of the hydrocarbon chain than that of the sulfate in simple alkyl derivatives. Various 
aspects of sulfate and sulfonate chemistry in compounds that come into bodily contact 
have been explored over many years. This is because of their use in the surfactant 
field. The ability of these groups to completely solubilise hydrocarbons in water 
beyond C10 contrasts with the fact that the hydroxyl group cannot completely 
solubilise more than a C3 chain. There is a long history of use of both sulfates and 
sulfonates without evidence of toxicity-related problems associated with either group. 
Since this is a commercially driven field greater versatility of synthesis and ease of 
production has led to a dominance of sulfonate-based over sulfate-based products. On 
the basis of the long history of surfactant use and performance it seems clear that 
there are huge practical advantages and no perceived disadvantages in using 
sulfonates as water binding groups in hydrogel-based proteoglycan mimics.  
 
NaAMPs and KSPA are currently used in wound dressing applications.  Due to the 
presence of the amide group within the structure and its subsequent interaction with 
the sulfonate group of an adjacent chain.  KSPA is less cohesive due to the absence of 
the amide group.  Further inclusion of monomers such as acrylic acid further enhance 
the cohesive forces within the hydrogel.  
 
Monomers used in the preparation of generic and sulfonate based hydrogel materials 
are illustrated in figures 3.1.1 to 3.1.8. 
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Fig 3.1.1 Acryloylmorpholine (ACMO)  
 
 
Fig 3.1.2 Poly(ethyleneglycol) acrylate (PEGA) 
 
 
Fig 3.1.3 Potassium salt of 3-sulfpropyl acrylate (KSPA) 
 
 
Fig 3.1.4 Potassium salt of 3-sulfopropyl methacrylate (KSPM) 
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Fig3.1.5 Dipotassium salt of bis (3-sulfopropyl) itaconate (KSPI) 
 
 
Fig3.1.6 N,N, Dimethyl N-(2-methacryloyloxyethyl)-N-(3-sulfopropyl) ammonium 
betaine (SPE)  
 
 
Fig 3.1.7 1-(3-Sulfopropyl)-2-vinylpyridinium betaine (SPV) 
 
 
Fig 3.1.8 Sodium 2-acrylamido 2-methylpropane sulfonic acid (NaAMPs)  
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Alternative sulfonate monomers are illustrated in the previous figures, however 
NaAMPs and KSPA were deemed the most suitable monomers for the applications 
discussed within this thesis.  This was due to the current use of both materials in a 
biological environment, such as wound dressings, amongst many others.  Materials 
such as SPV and SPE, whilst sulfonate structures, possess toxicity characteristics that 
render them unsuitable for a biological application. 
 
3.2 The investigation of suitable monomer systems, experimental considerations 
 
Desirable properties as aforementioned are hydrophilicity (and thus swell behaviour) 
and mechanical strength, along with the obvious ability to polymerise under the 
required reaction conditions. The copolymer compositions which have been 
investigated in the scope of this research are represented in table 3.2.1.  Initially 
homopolymerisation of just NaAMPs and KSPA was investigated followed by 
copolymer compositions. 
 
Table 3.2.1 Possible homo and co-polymer compositions: combining column 1 and 2 
Monomer 1 Monomer 2 
NaAMPs  
KSPA  
NaAMPs KSPA 
KSPA ACMO 
ACMO NaAMPs 
NaAMPs ACMO 
NaAMPs PEGA 
KSPA PEGA 
NaAMPs KSPI 
 
3.2.1 Investigation of an NaAMPs polymer 
 
Logically the first composition investigated was based on using NaAMPs on its own.  
The composition investigated is represented in table 3.2.1.1 below.  The composition 
consisted of NaAMPs in a ratio of 1:2 with water, with 2% PEG575diacrylate 
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crosslinking agent.  The sample was prepared using the method described in section 
2.2.1, which consists of the mixing of the components: water, NaAMPs 58% solution, 
and crosslinking agent, within a glass sample vial in the presence of ambient oxygen.  
The redox initiators were then added to the vial, which was then inverted three times, 
and the contents transferred to a plastic petri dish at room temperature for 
polymerisation to occur.  The petri dish is sealed with parafilm to prevent contact with 
excess oxygen during the polymerisation process.  
 
 Oxone and ascorbic acid were used as the redox pair, as these were known to produce 
relatively reproducible polymerisation.  
 
Table 3.2.1.1. NaAMPs polymer composition 
Gel NaAMPs (58%) 
 
H2O 
(g) 
PEG575DA 
(g) 
Oxone 0.1M 
(g) 
AA 0.1M 
(g) 
A 6g 
2.6 x 10-2 mol 
3 
0.16 
mol 
0.1 
1.7 x 10-4 mol 
0.65 
6.5 x 10-5 mol 
0.65 
6.5 x 10-5 
mol 
 
Gelation was successful and reproducible in a timescale of circa. 2 minutes.  This was 
as expected as acrylamide monomers are known to polymerise rapidly and efficiently 
even under mile conditions such as redox.  Gelation occurred quickly suggesting that 
this composition would be rendered unsuitable for injection as the delivery may not 
occur in less than two minutes.  The composition also has a very high water content 
that may not be mechanically suitable. Decreasing or removing the additional water 
would be advantageous but the time for gelation to occur would decrease due to the 
reduction in dilution of the system. 
 
The swell behaviour of this partially hydrated material was investigated.  This 
involved the cutting of 20mm discs of gel, and placing in water and 300 mOsm 
phosphate buffered saline respectively, at room temperature, the full procedure is 
detailed in section 2.2.1.  The swell behaviour is illustrated in figure 3.2.1.1.  
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Fig 3.2.1.1 The swell behaviour of NaAMPs based gel A in water and PBS 
 
The swell behaviour was relatively aggressive, often increasing in mass >4 fold in 
water and >2.5 in physiological saline, due to the presence of both Na+ and the amide 
group (the gel was already partially hydrated due to the presence of water within the 
polymerisation system). The charge repulsion between both the sulfonate and the 
amide group provide this extra swelling capacity in comparison to a material 
containing simply one or the other. 
 
When 20mm diameter discs were rheologically tested, the stiffness of the material 
also appeared to be greater than that required.  The general procedure for rheology is 
detailed in section 2.2.  Figure 3.2.1.2 illustrates the high stiffness of Gel A ~ 
29000Pa whereas the stiffness of the natural nucleus pulposus is not expected to 
surpass 20000Pa.   
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Figure 3.2.1.2 The viscous and elastic modulii of NaAMPs based Gel A 
 
3.2.2 The homopolymerisation of KSPA 
 
The polymerisation of KSPA was investigated as a 1:1 water to monomer mix, with a 
similar method to NaAMPs Gel A.  No gel formed at room temperature or at 37oC, in 
the presence or absence of atmospheric oxygen.  
 
3.2.3 The copolymerisation of NaAMPs/KSPA based systems 
 
NaAMPs is available commercially as either a 58% or 50% solution due to its 
hygroscopic behaviour it is difficult to purify and supply as a solid material. The 
incorporation of a copolymer allows the percentage dry weight monomer in the final 
product to be increased.  It also has the potential to reduce the fixed charge density of 
the polymer, thus reducing the aggressive swell behavior.  Table 3.2.3.1 details the 
copolymerisation of NaAMPs and KSPA using ascorbic acid and Oxone as the 
initiation system, and crosslinking agent PEG575DA at 2%.  Samples were prepared 
in a similar fashion to the previous experiment. Components were mixed in a sample 
vial prior to the addition of initiators, solutions 1 to 1b were then transferred to petri 
dishes for polymerisation to occur.  Compositions 1c and 1d were left in the glass 
vials to polymerise.  Gels 1, 1a, and 1c were allowed to polymerise at room 
temperature while 1b and 1d were polymerised at 32oC 
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Table 3.2.3.1 The copolymerisation of NaAMPs with KSPA: The effect on 
polymerisation 
Gel  NaAMPs 
(58%) (g)  
KSPA 
(g) 
H2O 
(g) 
PEG575DA 
(g) 
Oxone 
0.1M (g) 
AA 
0.1M 
(g) 
Observations 
1 3 1.4 4.3 0.2 0.65 0.65 20oC, O2 no gel 
1a 3 1.4 4.3 0.2 0.65 0.65 20oC, no O2, 
complete gel 
1b 3 1.4 4.3 0.2 0.65 0.65 37oC, O2, partial gel 
1c 3 1.4 4.3 0.2 0.65 0.65 20oC, O2, partial gel, 
glass   
1d 3 1.4 4.3 0.2 0.65 0.65 37oC, O2, complete 
gel, glass 
Where n= NaAMPs 1.3 x10-2mol, KSPA 6 x 10-3mol, H2O 0.24 mol, PEG575DA 3.5 x 10-4 mol, 
Oxone 6.5 x 10-5 and AA 6.5 x 10-5mol. 
 
At 20oC in the presence of ambient oxygen the polymerisation was not reproducible, 
on occasion an incomplete gel was formed.  In comparison when the system was 
purged with nitrogen prior to addition of the initiators, as was the case in 1b, a 
complete gel was formed.  Gelation also appeared much more reproducible at 37oC.  
This set of experiments introduced the obstacles involved in polymerising 
acrylamide/acrylate copolymers using a redox method. 
 
3.2.3.1 The effect of initiator concentration and volume on an NaAMPs/KSPA and 
NaAMPs based system 
 
For the next set of experiments the concentration and volume of initiators were varied 
whilst the monomer composition of the gels remained similar.  This was to investigate 
the effects of increasing the initiator concentration and/or adding a larger volume of a 
less concentrated initiator to assess the effect of dilution.  The compositions were 
prepared in a similar way as previously described in section 2.2.1, each 
polymerisation was carried out in a plastic petri dish, at room temperature, in ambient 
oxygen.  Compositions are detailed in table 3.2.3.1.1. 
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Table 3.2.3.1.1 The effect of initiator concentration and volume on the 
copolymerisation of NaAMPs and KSPA 
Gel NaAMPs 
(58%)(g) 
KSPA 
(g) 
H2O 
(g) 
PEG575D
A 
Oxone 
 
AA  Observations 
3p 3 1.4 4.3 0.2 0.1M 
0.7g 
0.42% 
7 x 10-5 
mol 
0.1M 
0.7g 
0.42% 
7 x 10-5 
mol 
 partial gelation 
3pa 3 1.4 4.3 0.2 0.1M 
0.75g 
0.46% 
7.5 x  10-5 
mol 
0.1M 
0.75g 
0.46% 
7.5 x 
10-5 mol 
 partial gelation 
3pb 3 1.4 4.3 0.2 0.1M 
0.8g 
0.48% 
8 x 10-5 
mol 
0.1M 
0.8g 
0.48% 
8 x 10-5 
mol 
 partial gelation 
3pc 3 1.4 4.3 0.2 0.15M 
0.45g 
0.414% 
6.8 x 10-5 
mol 
0.15M 
0.45g 
0.414% 
6.8 x 
10-5 mol 
partial gelation 
3pd 3 1.4 4.3 0.2 0.15M 
0.50g 
0.460% 
7.5 x 10-5 
mol 
0.15M 
0.50g 
0.460% 
7.5 x 
10-5 mol 
complete gelation 
3pe 3 1.4 4.3 0.2 0.15M 
0.55g 
0.506% 
8.3 x 10-5 
mol 
0.15M 
0.55g 
0.506% 
8.3 x 
10-5 mol 
complete gelation 
Where n= NaAMPs 1.3 x10-2mol, KSPA 6 x 10-3mol, H2O 0.24 mol, PEG575DA 3.5 x 10-4 mol, 
 
This yields similar results when Oxone is replaced with potassium persulfate. 
  
From this set of experiments it can be deduced that a smaller volume of initiator at a 
higher concentration produced more effective polymerisation in comparison to the 
larger volume of a weaker initiator that still provides radicals at a similar percentage.  
This is likely due to the probability of radicals coming into contact with monomer 
being greater in a less dilute solution. 
 
As NaAMPs was previously deemed to be more reactive than with KSPA as a co-
monomer, the following experiments represented in table 3.2.3.1.2 detail the effect of 
reducing the volume of initiator on the polymerisation time of an NaAMPs 
homopolymer.  The polymerisation was carried out using the same method as 
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previous experiments at both room temperature and at 37oC to mimic body 
temperature. 
 
Table 3.2.3.1.2 The polymerisation time of an NaAMPs system in response to initiator 
volume and temperature, time to complete gelation is recorded visually 
Gel NaAMPs 
(58%)(g) 
H2O 
(g) 
PEG575DA 
(g) 
AA 0.1M 
(g) 
Oxone 
0.1M (g) 
Temperature and time 
to complete gelation 
6 
 
6 3 0.2 0.65 0.65 20oC, O2, 2 min 0 sec 
6a 
 
6 3 0.2 0.5 0.5 20oC, O2 2 min 23 sec 
6b 
 
6 3 0.2 0.5 0.5 37oC, O2 1 min 30 sec 
6c 
 
6 3 0.2 0.4 0.4 20oC, O2 2 min 35 sec 
6d 
 
6 3 0.2 0.4 0.4 37oC, O2, 2 min 0 sec 
6e 
 
6 3 0.2 0.3 0.3 20oC, O2, 3 min37 sec 
6f 
 
6 3 0.2 0.3 0.3 37oC, O2, 4 min 30 sec 
Where n= NaAMPs 2.6 x10-2mol, H2O 0.17 mol, PEG575DA 3.5 x 10-4 mol, AA and Oxone 6.5-3 x 
10-5mol respectively 
 
All compositions were successful, the time taken to achieve complete gelation as 
observed visually, is given in the observation column. Experiments were carried out 
at both 20oC and 37oC to assess the effect of temperature on the time taken for 
complete gelation to occur. Typically due to the energy supplied to the system by 
increasing the temperature to 37oC, the experiments carried out at this composition 
demonstrated a quicker gelation time.  As expected, decreasing the volume of 
initiators increased the time taken for complete gelation to occur.  
3.2.3.2 The effect of varying of the ratio of NaAMPs:KSPA in a copolymer system  
 
As the previous NaAMPs/KSPA copolymer systems were based on a mass ratio of 
1.74NaAMPs to 1.4KSPA the next step was to vary the copolymer composition.  The 
compositions investigated are detailed in table 3.2.3.2.1  The initiator concentrations 
were increased to 0.15M to increase reproducibility of polymerisations due to the 
production of more radicals, reactions were carried out at room temperature in the 
presence of ambient oxygen, prepared in a similar method to previous gels 
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Table 3.2.3.2.1 The effect of varying KSPA content in an NaAMPs copolymer system 
Gel NaAMPS 
(58%)  
KSPA 
 
H2O 
 
PEG575DA 
 
AA 
0.15M 
Oxone 
0.15M 
Observations 
3pd 3g 
1.3 x 10-2 
mol 
1.4g 
6 x 10-3 
mol 
4.3g 
0.24 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 
7.5 x 10-5 
mol 
0.5g 
7.5 x 10-5 
mol 
complete gel 
2a 2g 
8.7 x 10-3 
mol 
2g 
8.6 x 
10-3 
mol 
4.7g 
0.26 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 
7.5 x 10-5 
mol 
0.5g 
7.5 x 10-5 
mol 
complete gel, not 
reproducible 
2b 1.5g 
6.5 x 10-3 
mol 
2g 
8.6 x 
10-3 
mol 
5.2g 
0.29 
mol 
 
0.2g 
3.4 x 10 -4 
mol 
0.5g 
7.5 x 10-5 
mol 
0.5g 
7.5 x 10-5 
mol 
partial gel 
2c 1.5g 
6.5 x 10-3 
mol 
3g 
1.3 x 
10-2 
mol 
4.2g 
0.23 
mol 
 
0.2g 
3.4 x 10 -4 
mol 
0.5g 
7.5 x 10-5 
mol 
0.5g 
7.5 x 10-5 
mol 
no gel 
2ca 1.5g 
6.5 x 10-3 
mol 
3g 
1.3 x 
10-2 
mol 
3.2g 
0.18 
mol 
0.2g 
3.4 x 10 -4 
mol 
1.0g 
1.5 x 10-4 
mol 
1.0g 
1.5 x 10-4 
mol 
no gel 
2d 4g 
1.7 x 10-2 
mol 
1g 
4.3 x 
10-3 
mol 
3.7g 
0.21 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 
7.5 x 10-5 
mol 
0.5g 
7.5 x 10-5 
mol  
complete gel  
 
The formation of a complete and reproducible gel was clearly influenced via the 
increase in KSPA content.  As a rule, when the KSPA content was above a ratio of 
3:2 with NaAMPs a successful gel was not formed.  This may be due to the fact that 
KSPA is less reactive to polymerisation via a redox mechanism under these mild 
conditions.  This is supported by the inability of KSPA to form a homopolymer. 
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3.3 Copolymerisation of NaAMPs with PEG acrylate 
 
NaAMPs and poly-(ethylene glycol) acrylate copolymers were investigated at low 
levels of PEGA ~5-15% due to its low aqueous solubility.  Compositions are 
represented below in table 3.3.1.  Each reaction was carried out in a similar manner to 
previous experiments at room temperature with ambient oxygen.  Initiator 
concentrations were kept high to enable efficient reproducible polymerisation. 
 
Table 3.3.1 The effect of using PEGA as a co-monomer with NaAMPs 
Gel NaAMPs 
(58%)   
PEGA 
 
H2O 
 
PEG575DA 
 
AA 
0.15M 
Oxone 
0.15M 
Observations 
Peg1 6g 
2.6 x 10-2 
mol 
0.5g 
1.3 x 
10-3 
mol 
2.3g 
0.13 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 0.5g gel formed 
Peg2 6g 
2.6 x 10-2 
mol 
1.0g 
2.7 x 
10-3 
mol 
1.8g 
0.10 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 0.5g gel formed 
Peg3 6g 
2.6 x 10-2 
mol 
1.5g 
4 x 10-
3 mol 
1.3g 
0.07 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 0.5g gel formed, PEGA 
slightly miscible 
AA and Oxone were 7.5 x 10-5 mol respectively 
 
Polymerisation was successful in all cases. 
 
The swell behaviour of the gels was investigated in a similar manner to previous gels.  
Results are illustrated in figure 3.3.1.  Gels were produced which exhibited low swell 
ability in comparison to a fully ionic copolymer.  This was due to the reduced 
hydrophilicity and fixed charged density of the material suggesting that the use of a 
non ionic co-monomer may not be desirable for this application. 
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Fig 3.3.1 The swell behaviour of NaAMPs/PEGA copolymer gel Peg3 in water and 
PBS 
 
The viscous and elastic behaviour of the NaAMPs/PEG acrylate copolymer was also 
investigated.  This is illustrated in figure 3.3.2 . 
 
 
Figure 3.3.2 The viscous and elastic modulii of NaAMPs/PEGA based Peg1 
 
The high mechanical strength is observed this could be due to reduced rotation of the 
structure due to the incorporation of a neutral monomer.  As polymerisation is slow 
when incorporating PEG it is possible that the chains formed are quite long producing 
a material of higher mechanical strength in comparison to a NaAMPs/KSPA gel with 
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a similar w/w monomer content.  Given that the human nucleus pulposus has a 
stiffness of less than 20000Pa this composition is likely to be unsuitable, particularly 
as this rheology trace represents the lowest percentage inclusion of PEGA 
investigated 
 
Similar results were obtained with the incorporation of low levels of acryloyl 
morpholine (ACMO), also a neutral organic monomer (investigations were conducted 
by a previous MSc student and the results are not reported here).  The incorporation 
of PEGA or ACMO with KSPA did not result in polymerisation(58). 
 
3.4 The effect of incorporating KSPI as a co-monomer with NaAMPs 
 
To improve the ability of the material to be biomimetic, incorporating the dipotassium 
salt of bis (3-sulfopropyl) itaconate (KSPI) in the proteoglycan analogue would 
increase the sulfonate content in comparison to a NaAMPs polymer or 
NaAMPs/KSPA copolymer.  This has the potential to increase the responsiveness of 
the polymer in a biological environment, in particular its ability to imbibe and 
maintain water content, this is due to the water shielding behaviour of the sulfonate 
group.  The charge repulsion of the two sulfonate groups enables the structure to exist 
in an extended form, however it does restrict rotation which in turn has the potential 
to affect the reactivity of the monomer.  
 
Due to KSPA being discovered as less reactive it was assumed that KSPI would also 
have low reactivity.  Therefore the inclusion of KSPA in the system to produce a 
tripolymer was not investigated, instead NaAMPs was the sole comonomer.  
Compositions are detailed in table 3.4.1 KSPI is commercially available as a 100% 
solid.  Reactions were carried out in a similar manner to previous experiments, 
however due to the reported unreactivity of KSPI in oxygen rich environments, all 
reaction components were purged of oxygen using nitrogen, and polymerisation was 
carried out at 37oC. Initiators were used at the higher concentration of 0.15M, and 
water content kept low to increase probability of radical-monomer interaction. 
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Table 3.4.1 The effect of incorporating  KSPI as a copolymer with NaAMPs on gel 
formation 
Gel 
 
NaAMPs 
(58%)  
KSPI 
 
H2O 
 
PEG575DA 
 
AA 
0.15M 
Oxone 
0.15M 
Observations 
K1 6g 
2.6 x 10-2 
mol 
1g 
2 x 10-3 
mol 
1.8g 
0.1 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 
7.5 x 10-5 
mol 
0.5g 
7.5 x 10-5 
mol 
viscous gel formed 
K2 5.5g 
2.4 x 10-2 
mol 
2g 
4 x 10-3 
mol 
1.3g 
0.07 
mol 
0.2g 
3.4 x 10 -4 
mol 
0.5g 
7.5 x 10-5 
mol 
0.5g 
7.5 x 10-5 
mol 
no gel 
K3 5.5g 
2.4 x 10-2 
mol 
2g 
4 x 10-3 
mol 
0.3g 
0.02 
mol 
0.2g 
3.4 x 10 -4 
mol 
1.0g 
1.5 x 10-4 
mol 
1.0 
1.5 x 10-4 
mol 
viscous gel formed 
K4 5g 
2.2 x 10-2 
mol 
2g 
4 x 10-3 
mol 
0.3g 
0.02 
mol 
0.2g 
3.4 x 10 -4 
mol 
1.25g 
1.9 x 10-4 
mol 
1.25g 
1.9 x 10-4 
mol 
partial viscous gel 
formed 
K5 4g 
1.7 x 10-2 
mol 
3g 
7 x 10-3 
mol 
0 0.2g 
3.4 x 10 -4 
mol 
1.5g 
2.3 x 10-4 
mol 
1.5g 
2.3 x 10-4 
mol 
no gel 
 
As reported in the table, despite increasing initiator volume and concentration to often 
threefold that used in NaAMPs/KSPA gels, a complete polymer was not formed.  
Whilst there was evidence of some polymerisation occurring due to a visible increase 
in viscosity of the component solution, this was not complete, confirming that the use 
if KSPI as a comonomer was not suitable. 
 
Utilising the more reactive nelfilcon, the structure of which is shown in figure 3.4.1, 
as a crosslinking agent instead of PEGDA did improve gelation, however often a 
nucleus of gelation was formed instantaneously possibly preferentially incorporating 
the NaAMPs, and the remainder of the solution did not polymerise.  This was 
consistent with bit UV and redox initiation.  It was concluded that although KSPI 
incorporation has the potential to produce a gel with advantageous properties, the 
constraints of initiation render KSPI unsuitable.   
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Fig 3.4.1 Nelfilcon A, modified PVA (50) 
 
3.5 Initiator variation 
 
3.5.1 The use of benzoyl peroxide and dimethyl toluidine as a redox pair 
 
This set of experiments aimed to assess whether additional redox pairs would create a 
more efficient polymerisation system.  The first pair investigated were benzoyl 
peroxide and dimethyl toluidine.  Benzoyl peroxide is typically used in dental 
applications whereas dimethyl toluidine is a catalyst in epoxy resin formation.  Gels 
were prepared as described previously.  The volume and concentration of benzoyl 
peroxide was kept constant as this was found to be the maximum concentration 
compatible for use in an aqueous environment, the initiator was made up using poly 
(ethyleneglycol) acrylate as the solvent due to its poor aqueous solubility.  Gels 4 and 
4a were polymerised at room temperature in the presence of ambient oxygen, and 4b 
and 4c at 37oC after degassing with nitrogen prior to addition of the initiators.  The 
compositions are represented in table 3.5.1.1 
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Table 3.5.1.1 The effect of benzoyl peroxide and dimethyl toluidine as initiators in the 
polymerisation of an NaAMPs/KSPA copolymer 
Gel NaAMPS 
(58%) (g) 
KSPA 
(g) 
H2O 
(g) 
PEG400DA  DMT  BP   
2M 
Observations 
4 3 1.4 4.3 0.2g 
5 x 10-4 mol 
0.05g 
3.7 x 
10-4 
mol 
0.65g 
1.3 x 10-3 
mol 
20oC, O2, partial gel 
4a 3 1.4 4.3 0.2g 
5 x 10-4 mol 
0.1g 
7.4 x 
10-4 
mol 
0.65g 
1.3 x 10-3 
mol 
20oC, no O2, non 
uniform complete gel 
4b 3 1.4 4.3 0.2g 
5 x 10-4 mol 
0.05g 
3.7 x 
10-4 
mol 
0.65g 
1.3 x 10-3 
mol 
37oC, O2, partial gel 
4c 3 1.4 4.3 0.2g 
5 x 10-4 mol 
0.1g 
7.4 x 
10-4 
mol 
0.65g 
1.3 x 10-3 
mol 
37oC no O2, non 
uniform complete gel 
Where n= NaAMPs 1.3 x10-2mol, KSPA 6 x 10-3, H2O 0.24 mol, PEG400DA 5 x 10-4 mol, AA and 
Oxone 6.5-3 x 10-5mol respectively 
 
At 20oC in both the presence and absence of oxygen, a uniform complete gel was not 
formed, this was assessed visually.  It is possible that this was due to the low level of 
initiator used, controlled by the organic nature of both the benzoyl peroxide and 
dimethyltoluidine.  Increasing temperature did improve gelation but not sufficiently.  
Polymerisation in the absence of oxygen at 37oC produced a gel but with a brittle non-
uniform structure.  This can be attributed to both the poor solubility of initiators, 
when initiation did occur it tended to be rapid resulting in an erratic short chain 
polymer.  This initiator was therefore deemed unsuitable for this application.   
 
3.5.2 The use of hydrogen peroxide and dimethyl toluidine as a redox pair 
 
In the next set of experiment BP was replaced with aqueous hydrogen peroxide and 
the volume of both DMT and hydrogen peroxide increased up to a point.  All 
experiments were carried out in a similar manner to previous, and all components 
were purged with nitrogen prior to use, to minimise the interference of oxygen in the 
polymerisation.  The compositions are detailed in table 3.5.2.1. 
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Table 3.5.2.1 Hydrogen peroxide and dimethyl toluidine in the polymerisation of an 
NaAMPs/KSPA copolymer 
Gel NaAMPs 
(58%) (g) 
KSPA 
(g) 
H2O  PEG400DA 
(g) 
DMT  H2O2 
8.8M 
Observations 
5 
 
3 1.4 4.3g 
0.24 
mol 
0.2 0.02g 
1.5 x 
10-4 
mol 
0.046g 
4 x 10-4 
mol 
20oC, no gel 
5a 
 
3 1.4 4g 
0.22 
mol 
0.2 0.1g 
7.4 x 
10-4mol 
0.33g 
2.9 x 10-3 
mol 
20oC, no gel 
5b 
 
3 1.4 3.9g 
0.22 
mol 
0.2 0.2g 
1.5 x 
10-3 
mol 
0.66g 
5.8 x 10-3 
mol 
37oC, no gel 
5c 
 
3 1.4 3.2g 
0.18 
mol 
0.2 0.5g 
3.7 x 
10-3 
mol 
1.65g 
1.5 x 10-2 
37oC, no gel 
Where n= NaAMPs 1.3 x10-2mol, KSPA 6 x 10-3, PEG400DA 5 x 10-4 mol 
 
Water content was adjusted accordingly to allow for water present in the H2O2 to 
allow the concentration of H2O2 used to reach 0.2%, 1%, 2% and 5% respectively. 
 
Despite increasing initiator inclusion to high levels, ~10% w/v H2O2, no gel was 
formed.  It would be detrimental to include a higher level of initiator so investigations 
were halted.  This system was deemed unsuitable. 
 
3.5.3 The use of tertiary butyl hydroperoxide with dimethyl toluidine as a redox pair 
 
Tertiary butyl-hydroperoxide is another commercially available peroxide initiator, 
typically used in the oxidation of ketones.  This was used as a pair with DMT.  All 
reactions were carried out at 37oC in the presence of ambient oxygen, or after all 
components had been purged of nitrogen with oxygen.  The compositions are 
represented in table 3.5.3.1. 
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Table 3.5.3.1 Tertiary butyl peroxide and dimethyl toluidine in the polymerisation of a 
NaAMPs/KSPA copolymer 
Gel NaAMPs 
(58%) (g) 
KSPA (g) H2O (g) PEG575DA 
(g) 
DMT TbutH Observations 
8 3 1.4 4.3 0.2 0.5g 
3.7 x 
10-3 
mol 
0.5g 
5.5 x 10-3 
mol 
O2, no gel 
8a 3 1.4 4.3 0.2 0.5g 
3.7 x 
10-3 
mol 
0.5g 
5.5 x 10-3 
mol 
no O2, no gel 
8b 3 1.4 4.3 0.2 1.0g 
7.4 x 
10-3 
mol 
1.0g 
1.1 x 10-2 
mol 
O2, no gel 
8c 3 1.4 4.3 0.2 1.0g 
7.4 x 
10-3 
mol 
1.0g 
1.1 x 10-2 
mol 
no O2, no gel 
8d 3 1.4 4.3 0.2 1.5g 
1.1 x 
10-2 
mol 
1.5g 
1.7 x 10-
3 mol 
O2, no gel 
8e 3 1.4 4.3 0.2 1.5g 
1.1 x 
10-2 
mol 
1.5g 
1.7 x 10-
3 mol 
no O2, no gel 
8f 3 1.4 4.3 0.2 2.0g 
1.5 x 
10-2 
mol 
2.0g 
2.2 x 10-3 
mol 
O2, no gel 
8g 3 1.4 4.3 0.2 2.0g 
1.5 x 
10-2 
mol 
2.0g 
2.2 x 10-3 
mol 
no O2, no gel 
Where n= NaAMPs 1.3 x10-2mol, KSPA 6 x 10-3, H2O 0.24 mol, PEG575DA 3.4 x 10-4 mol 
 
The Design and Synthesis of Proteoglycan Analogues: Experimental Considerations 
82 
As demonstrated in the table, no gelation was successful and increasing initiator 
concentration further to over 5% of the end product would be detrimental to both the 
structure and surrounding tissues.  This thus deemed an unsuitable redox pair.   
 
3.5.4 The use of TEMED and potassium persulfate as a redox pair 
 
A suitable redox pair for investigation was potassium persulfate (KPS) and N’N’N’N 
tetramethy ethylenediamine (TEMED).  These initiators are used together as a pair to 
initiate gelation within electrophoresis SDS page gels.  The procedure for preparation 
was similar to previous gel compositions, polymerisation was carried out at room 
temperature in the presence of ambient oxygen.  The compositions are detailed in 
table 3.5.4.1 
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Table 3.5.4.1 The use of N’N’N’N tetramethyethylenediamine (TEMED) and 
potassium persulfate (KPS) in the polymerisation of a NaAMPs/KSPA copolymer 
Gel NaAMPs 
(58%) (g) 
KSPA 
(g) 
H2O 
(g) 
PEG575DA 
(g) 
TEMED 
 
KPS 
 
Observations 
9a 3 1.4 4.3 0.2 0.1M 
0.65g 
6.5 x 10-
5 mol 
0.1M 
0.65g 
6.5 x 10-5 
mol 
Complete gel, slow 
polymerisation 
9b 3 1.4 4.3 0.2 0.15M 
0.65g 
9.8 x 10-
5 mol 
0.15M 
0.65g 
9.8 x 10-5 
mol 
Complete gel, 
relatively slow 
polymerisation 
9c 3 1.4 4.3 0.2 0.2M 
0.65 
1.3 x 10-
4 mol 
0.15M 
0.65g 
9.8 x 10-5 
mol 
Complete gel 
9d 3 1.4 4.3 0.2 0.2M 
0.65 
1.3 x 10-
4 mol 
0.2M 
0.65 
1.3 x 10-4 
mol 
Complete gel, 
 polymerised less than 
10 minutes  
9e 3 1.4 4.3 0.2 0.3M 
0.65g 
2 x 10-4 
mol 
0.2M 
0.65g 
1.3 x 10-4 
mol 
Complete gel 
polymerised ~ 3 
minutes 
9f 3 1.4 4.3 0.2 0.4M 
0.65g 
2.6 x 10-
4 mol 
0.18M 
0.65g 
1.2 x 10-4 
mol 
Complete gel 
polymerised ~ 5 
minutes 
Where n= NaAMPs 1.3 x10-2mol, KSPA 6 x 10-3, H2O 0.24 mol, PEG575DA 3.4 x 10-4 mol 
 
Although successful gels were produced for all initiator variations, the most effective 
and reproducible was the 0.4M TEMED and 0.18M KPS.  The slightly slower 
polymerisation time for composition 9f suggests that the initiation depends more on 
the concentration of KPS than TEMED. 
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3.5.5 Additional initiation systems 
 
A full list of redox pairs investigated is represented in table 3.5.5.1 
 
Table 3.5.5.1 Redox pairs investigated 
Redox A Redox B 
Ascorbic acid (AA) 
 
Oxone 
Ascorbic acid (AA) 
 
Potassium persulfate (KPS) 
Ascorbic acid (AA) 
 
Ammonium persulfate 
Iron (II) lactate hydrate 
 
Oxone 
Iron (II) lactate hydrate 
 
T-but hydroperoxide 
Iron (II) gluconate 
 
Oxone 
Iron (II) gluconate 
 
tert-butyl hydroperoxide 
Dimethyl- toluidine (DMT) 
 
tert-butyl hydroperoxide 
Dimethyl- toluidine (DMT) 
 
Hydrogen peroxide 
Dimethyl toluidine  (DMT) 
 
Oxone 
Dimethyl toluidine (DMT) 
 
Benzoyl peroxide 
2,2 azo bis (2-methylpropionamidine) dihydrochloride 
 
Oxone 
N’N’N’N tetramethyethylenediamine (TEMED) 
 
Potassium persulfate (KPS) 
 
It seems unnecessary to discuss in detail all compositions that were investigated if 
they were immediately deemed to be unsuitable for the application.  For instance the 
use of iron lactate and or gluconate with a peroxide pair resulted in a nucleus of 
gelation forming almost instantly even in the presence of atmospheric oxygen.  
However gelation was not always complete with water contained in the composition 
often left not included in the polymer structure due to the initial aggressive nature of 
radical formation.  The production of a nucleus of gelation within any system that is 
designed for use as an injectable is undesirable, the material simply would not be able 
to pass through the needle.  For this reason these compositions were unsuitable. 
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Further hydroperoxides were investigated such as cumene hydroperoxide, but were 
immiscible in aqueous solution and were therefore inhibited in becoming part of the 
polymerisation due to the monomers being highly aqueous. 
 
2,2-Azo bis (2-methylpropionamidine) dihydrochloride and oxone redox pair did not 
produce a gel even at levels of initiator higher than 5% of the total composition.  The 
same was true for the use of DMT with oxone.  
  
The active part of oxone is 2KHSO5.   Oxone is already used as an initiator in some 
applications(37)(48) and is readily soluble in aqueous solution.  This is due to its relative 
stability, easy handling and non toxic nature; one of the uses of Oxone in a biological 
environment is to clean dentures, this highlights its non toxic nature(49).  KPS is 
similar in its active component but is both less soluble and less stable to storage in 
aqueous environment than Oxone, when used with AA. Oxone, potassium persulfate 
and ammonium persulfate all yield similar results.  Ammonium persulfate has a 
greater degree of aqueous solubility, however gels formed appear visibly to have a 
less uniform structure.  Therefore it was discovered that the two most suitable redox 
pairs were oxone and AA and, TEMED and potassium persulfate.  
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3.6 Choice of crosslinking agent 
 
Two main crosslinking agents were investigated PEG diacrylate, and the modified 
PVA –nelfilcon, The structure of PEGDA is shown below in figure 3.6.1, nelfilcon 
has been previously represented in figure 3.4.1. These crosslinking agents were 
chosen as they have been previously used in biomedical applications using similar 
monomer materials.  Longer chain cross linking agents also allow for a greater 
incorporation of water in the composition and the potential for further swelling in 
aqueous media after gelation has occurred.  
 
 
Fig 3.6.1 Poly (ethyleneglycol) diacrylate.  Typically n~575 
 
PEG diacrylate is an efficient di-functional crosslinking agent. Nelfilcon , or modified 
PVA is a multifunctional macromer, therefore it is capable of producing a greater 
number of crosslinks per unit weight.  This has the advantage that an intricate network 
structure will be produced, but the disadvantage that due to its high proportion of 
reactive sites, polymerisation is often induced much more rapidly than without it.  To 
assess the effect of varying both the percentage of initiator incorporated and the type 
of initiator had on the polymerisation a series of gels were made.  The monomer and 
water composition and method of polymerisation remained similar to previous 
experiments, in the presence of ambient oxygen at room temperature. The results are 
represented in table 3.6.1. 
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Table 3.6.1 Crosslinking agent variations: effect on gel formation 
Gel NaAMPs 
(58%) 
(g) 
KSPA  
(g) 
H2O 
(g) 
Crosslinking  
agent 
 
AA 
(0.1M) 
(g) 
Oxone 
(0.1M) 
(g) 
Polymerisation 
time 
10a 3 1.4 4.3 PEG575DA 
0.05g 
8.7 x 10-5 mol 
0.65 0.65 ~ 7 minutes 
10b 3 1.4 4.3 PEG575DA  
0.1g 
1.7 x 10-4 mol 
0.65 0.65 ~ 7 minutes 
10c 3 1.4 4.3 PEG575DA 
0.15g 
2.6 x 10-4 mol 
0.65 0.65 ~ 7 minutes 
10d 3 1.4 4.3 MPVA  
0.02g 
1.4 x 10-6 mol 
0.65 0.65 No gel 
10e 3 1.4 4.3 MPVA  
0.05g 
3.6 x 10-6 mol 
0.65 0.65 Incomplete gel 
10f 3 1.4 4.3 MPVA  
0.1g 
7.1 x 10-6 mol 
0.65 0.65 ~ 2 minutes 
10g 3 1.4 4.3 MPVA  
0.2g 
1.4 x 10-5 mol 
0.65 0.65 ~ 1minute 
Where n= NaAMPs 1.3 x10-2mol, KSPA 6 x 10-3, H2O 0.24 mol, AA and Oxone 6.5 x 10-5 mol 
respectively 
 
The results with 2% PEG diacrylate are not reported, this composition is represented 
in table 3.2.3.1 as gel 1. 
 
It can be seen from the results above, the level of difunctional crosslinking agent 
included in the composition does not affect the polymerisation time, providing there is 
a high enough level to produce a crosslinked gel structure.  However in the case of 
modified PVA, the high availability of reactive groups meant that initial gelation was 
almost immediate as it reacted with NaAMPs upon contact. This often resulted in a 
nucleus of gelation forming which would not allow the pregel to be injected.  The 
highly crosslinked structure also results in a high stiffness and reduced swell capacity, 
as investigated by rheology, which is demonstrated in Figure 3.6.1. 
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Fig. 3.6.1 The difference in swell behaviour of an NaAMPs/KSPA copolymer with 2% 
PEG diacrylate and 2% modified PVA 
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3.7 Discussion  
 
The aim of the work conducted in this chapter was to find suitable monomer materials 
for the synthesis of the proteoglycan analogue.  The sulfonate groups within NaAMPs 
and KSPA aim to mimic the natural sulfate groups found in proteoglycans.  The 
natural structures are termed allyl sulfates and the synthetic alternatives alkyl 
sulfonates.  It is not possible to provide a synthetic sulfate, and as an added advantage 
the carbon linked sulfur is much more stable to hydrolytic degradation than an oxygen 
linked sulphur atom.  Sulfonates are advantageously the most hydrophilic monomers, 
the ability of the functional group to hydrophilically shield the carbon backbone is 
much greater than that of a hydroxyl or carbonyl group.  Of the sulfonate monomers 
commercially available, NaAMPs and KSPA are the most cost effective and 
successfully synthesised, making them the ideal choice. 
 
NaAMPs was initially investigated as a homopolymer, however the availability of the 
material as either a 50% or 58% solution warrants the addition of a comonomer to 
allow manipulation of the solid monomer content of the end gel.  In addition the 
presence of both an amide group and the sulfonate produces an extremely large swell 
capacity.  This was to such a degree to also suggest the use of a copolymer.  Due to 
the requirements of the material to be osmotically responsive a neutral material would 
not be suitable as a comonomer. 
 
Water is an important component of the polymer system.  There is evidence to 
suggest that water in polymers can exist in more than one state. These states of water 
can affect the properties of the polymer.  The water in hydrogel membranes can be 
characterised by the terms freezing and non-freezing.  The analysis of the melting 
endotherms obtained by differential scanning calorimetery (DSC) have the ability to 
differentiate between freezing and non-freezing water. The water that is strongly 
associated with polar groups in the polymer matrix is bound and unable to freeze and 
would not, therefore, contribute to the melting endotherm.  To further elaborate on 
this theory, the nature of water in a polymer can be considered as a combination of 
states which lies between the two extremes. The non-freezing water hydrogen bonds 
to the polar groups of the polymer matrix and has some interaction with the ionic 
residues. The freezing water lacks the interaction with the polymer matrix but 
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possesses characteristics similar to pure water due to its occupation of large pores and 
level of hydrogen bonding.  
 
NaAMPs and KSPA are examples of acrylamides and acrylates, of which the 
reactivity of the monomers to each other is dependent on 3 factors: monomer 
reactivity, radical resonance stabilisation and steric hindrance(51).  Steric hindrance 
affects the ability of the monomer to react with the propagating radical, NaAMPs and 
KSPA – have similar steric bulk and would be expected to behave in a similar manner 
where reactivity is concerned.  “The rate of reaction is proportional to the activated 
complex (propagating radical monomer) therefore it is not affected by mobility, 
viscosity or diffusion rate”(52).  However, despite these similarities their reactivity is 
in fact different and by experiment KSPA has been found to be preferentially 
incorporated into the polymer chain with the reactivity ratios KSPA to NaAMPs 
1.7:0.55 respectively(53). 
 
A range of initiators were investigated with two successful systems discovered as a 
result.  These were ascorbic acid and oxone and TEMED and potassium persulfate.  
They produced the most reproducible systems.  Initiators based on transition metals 
paired with peroxides are known as effective redox pairs.  However for this 
application the formation of instant gels is detrimental to the ability of the gel to be 
injected. No other system investigated produced reliable results.  An interesting 
observation was the effect of dilution of initiators on the efficacy of polymerisation. 
 
The effect of dilution of the proteoglycan analogue must be discussed in two separate 
instances.  There is both the dilution of the monomer containing system and the 
initiator containing system.  Hydrogels are unique in their ability to swell with water 
yet not dissolve.  Through the production of the ideal gel it was important to form a 
balance between the volume of water added to the gel to be included in the 
polymerisation, and the capability of the polymerised gel to swell when placed in 
water.  It was clear that although a dehydrated gel was able to swell to great extent 
when placed in water, it was not possible to polymerise a gel with this volume of 
water.  This is related to both dilution of free radical species and the constraints of 
forming a loosely cross-linked gel structure. 
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Dilution can also be related to the molarity of the initators.  It was of little surprise to 
discover that the use of a larger volume of a weaker initiator will not produce gelation 
in comparison to the use of a smaller volume of a stronger initiator (even when the 
end calculated percentage of initiator is the same).  This is due to the dilution of the 
free radicals, and the reduction in the probability of contact between monomer and 
radical.  This arises due to the radical pairs undergoing oscillation while surrounded 
by water molecules before they diffuse apart.  The greater the number of water 
molecules the larger the ‘cage’ around the pair of radicals and therefore contact 
between monomer and radicals is less likely. 
 
Polymerisation was only investigated at physiological pH due to this being the 
environment in which the analogue was designed for use. Altering the pH of the 
system would alter the ionicity of the polymer and thus the biocompatibility.  
Differences in pH would also have an affect on the production and dissociation of 
radical species via redox, for instance lowering pH will give a reduction in the 
production of AH radicals(37). 
 
Having discussed the effect that oxygen has on the initiating systems, it would seem 
logical to purge the system of oxygen via degassing with nitrogen.  However this is 
also no advantageous, primarily due to the resulting instantaneous gelation that did 
not allow time for any form of injection of the pregel to occur.  Instantaneous gelation 
also resulted in solution remaining on the surface of the formed gel due to 
polymerisation occurring so rapidly that water was excluded from the structure.  
 
The final investigations reported were the effect of different crosslinking agents.  Two 
types were assessed, multifunctional and difunctional, modified PVA and PEG 
diacrylate respectively.  Whilst a multifunctional macromer crosslinker may produce 
a more intricate network structure, its ability to induce polymerisation immediately 
renders it unsuitable for an injectable application.    
 
To build on the discoveries made within this chapter the following will aim to refine 
the system to produce a workable injectable system. 
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Chapter Four 
 
The Design and Synthesis of a Proteoglycan Analogue: Refinement of 
the Injectable System 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Design and Synthesis of a Proteoglycan Analogue: Refinement of the Injectable System  
93 
 
4.1. Introduction 
 
The previous chapter dealt with variations in composition of the proteoglycan 
analogue.  This chapter will focus on developing these compositions into successful 
injectable systems.  The reproducible systems and their subsequent storage stability 
will be discussed, in addition to variables that affect the efficacy of the polymerisation 
process.  
 
4.2.1. Refinement of the composition 
 
Of all initiator systems investigated, the two redox pairs seen to have the greatest 
efficacy and reproducibility were ascorbic acid and oxone, gel 1 table 3.2.3.1 and 
TEMED potassium persulfate gel 9f table 3.5.4.1 with the respective concentrations 
being 0.1M:0.1M and 0.4M:0.18M respectively.  Initiator solutions are used at a total 
of 13% per polymer and resultant levels of initiator in the polymerised product are 
0.0065M for ascorbic acid oxone and 0.032M:0.014M for TEMED potassium 
persulfate respectively.  
 
The first point of investigation was to refine the compositions, in particular as the 
NaAMPs used for these investigations was available at 50% only.  The rationale 
behind refining the compositions was to decide on two variations which provided 
reproducible gelation after injection, whilst providing mechanical properties similar to 
those of the natural nucleus pulposus.  Two variations were needed to present the idea 
commercially, in particular the ability of the system to be modified to produce a range 
of properties depending on commercial market preference.  The compositions were 
modified as represented in table 4.2.1 below.  They are now referred to as Rf1 and 
Rf2 which denoted refined formulation one and refined formulation two.  It was 
decided at this point, due to commercial interest and discussions with collaborators at 
Oxford, Oswestry and Keele, also to introduce another cross-linking agent to enable a 
difference between the two compositions.  A PEG dimethacrylate with a chain length 
of 1000 was chosen for use with the TEMED potassium persulfate system.  The 
increased length of this crosslinking agent will mean less cross-links per volume used, 
and therefore will not be suitable for use at levels as low as the PEGE575 diacrylate.  
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This was another deciding factor in including it in the amine initiated system, which is 
a more efficient producer of radicals than ascorbic acid, so therefore will create more 
of a reproducible network with this type of cross-linking agent. 
 
Table 4.2.1 Refinement of the compositions: effective formulations 
Gel NaAMPs (50%) KSPA 
 
Water 
 
Crosslinking 
agent 
Initiator 1 
 
Initiator 2 
 
Rf1 3.7g 
1.6 x 10-2 mol 
1.4g 
6 x 10-3 
mol 
3.6g 
0.2 mol 
0.025 – 0.2g 
PEG575DA 
4.3 x10-5 mol – 
3.4 x 10-4 mol 
AA 0.1M 
0.65g 
6.5 x 10-5 mol 
Oxone 0.1M 
0.65g 
6.5 x 10-5 mol 
Rf2 3.7g 
1.6 x 10-2 mol 
1.4g 
6 x 10-3 
mol 
3.6g 
0.2ml 
0.05-0.2g 
PEG1000DMA 
5 x 10-5 mol –  
2 x 10-4 mol 
TEMED 0.4M 
0.65g 
2.6 x 10-4 mol 
KPS 0.18M 
0.65g 
1.2 x 10-4 mol 
 
Both systems allow crosslinking agent to be used over a range of 0.5% to 2%, and 
polymerisation is reproducible in a time scale of 3-7 minutes. 
 
In order to allow the analogue to be used in an injectable application, a method of 
delivery must be devised.  As the polymerisation method is based upon redox, the 
primary requirement is the separation of the two initiating components prior to the 
time at which gelation is required.  It follows from this then, that a two-pack system 
has the potential to offer the desired solution.  To deliver this a dual syringe system 
may be used similar to that which delivers fibrin glue(54).  For this to be effective the 
compatibility of components which will form each pre-gel solution was thoroughly 
investigated, and will be discussed in the following sections.  A picture of the fibrin 
glue delivery system is shown below in figure 4.2.1. 
 
 
Fig 4.2.1 The dual syringe system 
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4.2.2 The storage of components: environmental effects  
 
The factors which affect the storage of the components are represented in table 4.2.2.1 
below 
 
Table 4.2.2.1 Factors which affect the storage of components 
Component Implications 
Redox initiators Heat, light, oxygen 
NaAMPs Oxygen, presence of initiator 
KSPA Oxygen, presence of initiator 
Water N/A 
Crosslinking agent Light (if photoactive component is present) presence of monomer 
and/or initiator 
 
The presence of oxygen is by far the most important factor when investigating storage 
stability. Oxygen is produced via the decomposition of peroxydisulfate ions, this in 
turn will be consumed by ascorbic acid which has the potential to decrease the 
induction period.  Too much oxygen however will monopolise the radical species thus 
reducing the probability of contact with monomer and therefore polymerisation.  
Transition metals have also been shown to have a negative affect on the stability of 
Oxone(55).  This was an important factor to consider where the components may be 
stored in a container with a metal component, and also during the injection through a 
metal needle. 
 
Although potassium persulfate has similar activity to oxone in relation to the active 
species 2KHO5, potassium peroxomonosulfate, oxone, upon investigation of storage 
of 0.1M, 0.15M, and 0.2M solutions, produced a more uniform gel after longer 
periods of storage.  Potassium persulfate appeared to become degraded after 14 days 
(investigated each time with fresh redox B and monomer stock) polymerisation is 
visibly slower circa 30 seconds to 1 min, whereas there appears to be no degradation 
in the Oxone to 18 days.  Both initiators do however produce a gel for up to 1 month 
providing they have been stored in optimal conditions, refrigerated at approximately 
4oC, in the dark, in a vessel where there is minimal air i.e. not a large gap between the 
solution and the lid of the vessel, with polymerisation carried out at 37oC.   
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Similar experiments were carried out using ascorbic acid.  Ascorbic acid was found to 
be highly light and heat sensitive with oxygen degradation being less of a problem, 
again the initiator produced a reproducible polymerised gel for up to one month.  
TEMED did not seem to degrade in a similar manner to the other initiators, 
continuing to produce a reproducible gel, the constraints of the other redox constituent 
are the limiting factor in the use of this intitiator.  It is important to note that amongst 
other factors, due to potassium persulfate being more readily degraded than Oxone, a 
system of optimal reliability was formed using oxone as the redox agent not 
potassium persulfate as coupling the degradation of ascorbic acid and potassium 
persulfate produced a less reproducible system.  A summary of the stabilities is shown 
in table 4.2.2.1 below. 
 
Table 4.2.2.1 The stability of initiator stock solutions 
Redox A Redox B Viability time (days) 
AA Fresh Oxone 19 
AA Oxone 17 
AA Fresh KPS 17 
AA KPS 12 
Fresh AA Oxone 18 
Fresh AA KPS 14 
TEMED Fresh KPS 30+ 
TEMED KPS 14 
Fresh TEMED KPS 14 
NB. Where fresh is not denoted, the solution had been stored for a number of days to 
assess viability, viability denoting when time taken to polymerise became noticeably 
altered. 
 
With respect to monomer stability, NaAMPs and KSPA and also including in this 
section the crosslinking agent, which was either PEG575 diacrylate or PEG1000 
dimethacrylate, which essentially, where stability is concerned, behave in a similar 
manner.  Focusing on a dual-based system, stability was investigated in two ways.  
The first being to separate the monomers, incorporating the crosslinking agent with 
the least reactive monomer (KSPA as discussed in section 3.5), to make the two pre 
solutions of equal volume, the water component in each A and B was adjusted.  Initial 
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stability tests discovered that on occasion the crosslinking agent and NaAMPS would 
form a gel over time if in solution. This resulted in solutions of the following 
composition: 
 
Table 4.2.2.2 Suitable pregel compositions 
Solution A Solution B 
NaAMPs KSPA 
Water Water 
Redox A Crosslinking agent 
 Redox B 
 
This was a successful method when components were kept refrigerated ~4oC, and in 
the dark.  
 
Although it has already been discussed due to its unsuitability relating to the speed of 
polymerisation, the nelfilcon used had a photoactive agent attached to its modified 
structure.  This meant that its stability under storage was only suitable in aqueous 
solution.  It could not be stored for any length of time in presence of a monomer or an 
initiator pair. 
 
The removal of oxygen from the polymerisation systems also had an effect on 
mechanical properties of the resultant gels.  This is not surprising given that 
polymerisation often occurs much more rapidly which, would result in shorter chains, 
therefore a less elastic gel.  This is demonstrated in the graph below which is an 
KSPA/NaAMPs gel 1:1:1 NaAMPs:KSPA:water with 1% PEGDA400 as crosslinking 
agent, polymerised with 0.1M AA and 0.1M Oxone.  The monomer stock sample 
which was purged of oxygen had nitrogen bubbled through it for 10 minutes, as did 
the initiators separately prior to addition to the pregel.  An increase in stiffness can 
clearly be observed which is demonstrated in figure 4.2.2  
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Fig 4.2.2.2 The effect of the removal of oxygen on the mechanical properties of the 
gels 
  
A Mettler Toledo oxygen probe was used to measure the levels of oxygen in nitrogen 
purged, ambient, and oxygen saturated solutions, then the time taken to polymerise 
observed.  Nitrogen purged solutions produced instantaneous gelation, ambient circa 
5-10 minutes and oxygen saturated upwards of one hour, often resulting in incomplete 
gelation. This is represented below in table 4.2.2.3.  The percentages detailed are 
relative percentages  
 
Table 4.2.2.3 The effect of oxygen levels on polymerisation time 
Conditions of solution Percentage O2 Polymerisation time 
N2 purged 0.0% Instantaneous 
O2 saturated 28.8% Incomplete after 1 hour 
Ambient  8.5% ~ 5- 10 minutes 
 
4.3 The use of dipicolinic acid as a stabiliser within the copolymer system 
 
Ambient oxygen controls the rate of polymerisation in order to produce reproducible 
injectable gels in circa 3-7 minutes.  The use of dipicolinic acid DPA as a stabiliser to 
delay polymerisation for Oxone and KPS to assess whether oxygen could be removed 
from stock solutions whilst still allowing sufficient time for injection prior to gelation 
was investigated.  The structure of dipicolinic acid is shown in figure 4.3.1 
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Fig 4.3.1 The structure of dipicolinic acid 
 
Dipicolinic acid has been used to prevent the degradation of peracid solutions, 
reducing the loss of activity from 50% to 5% over a one month period, used at 
50ppm(3).  Increasing levels to 1000ppm does not offer a significant increase in 
stabilisation, although in general the greater the inclusion of stabiliser, the greater the 
stabilising effect.  As peracid has a strong oxidising potential, which is successfully 
stabilised by the dipicolinic acid, its affect on KPS and Oxone stability was 
investigated.  Subsequent stabilisers which also may be suitable but were not 
investigated are ethylenediaminetetra(methylenephosphonic acid) (EDTPA) which 
acts as a chelating agent, and those based on stannates(56).  The proposed action of 
DPA within the Oxone and or KPS containing stock solutions was to sequester any 
peroxides formed prematurely via decomposition of the initiator, in particular Oxone 
which is widely reported to be unstable over storage in an aqueous environment(5).  
Table 4.3.1 below illustrates the DPA containing compositions investigated 
 
Table 4.3.1 A summary of gel compositions incorporating DPA 
Percentage Redox solution A Redox solution B 
Constant NaAMPs KSPA 
Constant Water Water 
Constant AA/TEMED Oxone/KPS 
0.1-1%  DPA 
 
 
 
 
 
Initially the stability of Oxone and potassium persulfate solutions where investigated 
prior to use in the two pack system.  The results can be seen in table 4.3.2  
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Table 4.3.2 The effect of incorporating DPA on shelf life of initiator solutions 
Redox A Redox B Viability in days 
Fresh AA Oxone 0.1% DPA 18 
AA Oxone 0.1% DPA 18 
Fresh AA Oxone 0.4% DPA 27 
AA Oxone 0.4% DPA 27 
Fresh AA Oxone 0.7% DPA 28 
AA Oxone 0.7% DPA 27 
Fresh AA Oxone 1.0% DPA 25 
AA Oxone 1.0% DPA 21 
Each initiator solution was refrigerated at ~4oC in a light insulated glass vial. 
 
Initially, as demonstrated in the table above, DPA did improve the length of time 
which the solutions could be stored for and still produce a viable gel.  However once 
incorporated as part of the pregel solution redox B, it was apparent that DPA will 
degrade on contact with oxygen therefore unless used immediately after receiving,  
these degraded products prevented subsequent polymerisation.  This rendered the use 
of this particular stabiliser unsuitable for this application. 
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 4.4 The injection process: effect of needle length and diameter 
 
Because the injection process into the disc space will involve an analogue of the 
radiological process used to image potential flaws within the disc, the injection itself 
is a specific process.  Therefore it was necessary to investigate the effects this process 
had on the polymerisation of the specific gel formulations, specifically the small 
diameter of needle required for a minimally invasive procedure, and any problems 
which may occur relating to back pressure created by injection of the pre-gel solution.  
 
The pre-gel solutions Rf1 and Rf2, the most reproducible compositions chosen for 
investigation, were prepared as detailed in section 2.2.1 and placed in the dual syringe 
illustrated in figure 4.2.1.  The primary reasons for this investigation was to explore 
the time taken to polymerise and assess whether or not this would allow for injection 
into the intervertebral disc cavity.  The experiment was carried out at 37oC in ambient 
oxygen, and the results are illustrated below in table 4.4.1. 
 
Table 4.4.1 The effect of injection on polymerisation time 
Syringe size Needle diameter vs length Gelation time Rf1 Gelation time Rf2 
5ml 0.7 x 178mm (22) 3 mins 2.5 mins 
5ml 1.1 x 50mm (19) 3 mins 2.5 mins 
5ml 0.8 x 50mm 2.5 mins 2.25 mins 
5ml 0.5 x 16mm 1.5 mins 1 min 
1ml 1.1 x 50mm (19) 1 mins 1 min 
1ml 0.8 x 50mm 30-40 secs 35 secs 
1ml 0.5 x 16mm 30 secs 20- 30secs 
 
It is apparent from the decrease in polymerisation time in relation to the diameter and 
length of the needle that shear forces are acting on the pre-gel inducing 
polymerisation.  It is also feasible that metal mediated catalysis of the reaction is 
occurring. 
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4.5 Injection into a surrogate cavity 
 
In order to successfully design an injectable proteoglycan analogue and assess its 
effectiveness, a suitable cavity is desirable.  This was carried out in multiple stages. 
The first stage involved the injection of both Rf1 and Rf2 (compositions reported in 
table 4.2.1) into a balloon that had been flushed with nitrogen to represent the absence 
of atmospheric oxygen within the disc cavity.  Gels formed reproducibly.  As a larger 
volume was used, circa 5ml in total to inject into the balloon, it is feasible that this 
was not representative of the nucleus pulposus cavity.  Therefore the balloon model 
was replaced by injecting into a finger cot, to represent the smaller volume.  These are 
represented in figure 4.5.1 
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Fig 4.5.1 Balloon and finger cot models as surrogate cavities 
 
Due to the possibility of residual liquid within the disc cavity, a small volume of 
water was injected into both the balloon and the finger cot ~0.5ml to represent this.  
The injection process was then repeated, with successful polymerisation. 
  
The next logical step was to inject into the cavity of excised discs represented below 
in figure 4.5.2.  This was carried out as part of dynamic mechanical testing to assess 
whether the proteoglycan analogue was capable of restoring compressive strength to 
the excised discs similar to their intact structure.  The results are reported in the 
following chapter. 
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Fig 4.5.2 An excised sheep disc. 
 
4.6 The incorporation of Histodenz into the gels and its subsequent effect on 
gelation time 
 
In order for the gels to be visible throughout their lifetime it was deemed necessary to 
incorporate a radio-opaque material into the gel. The inclusion of a radio-opaque into 
the material was found to depend on both surgical and commercial preference.  
Histodenz was chosen as it is a readily available commercial radio-opaque marketed 
under the name Iohexol.  Investigations were conducted preparing gels Rf1 and Rf2 
with 2% crosslinking agent, to polymerise after injection into in a petri dish with 
varying amounts of radiopaque between 5 and 20% of the total gel volume, to see if 
the polymerisation was detrimentally effected. The results are represented in table 
4.6.1 below. 
 
Table 4.6.1 The effect of the addition of Histodenz to Rf1 and Rf2 gel compositions 
Gel 0% Histodenz 5% Histodenz 10% Histodenz 15% Histodenz 20% Histodenz 
Rf1 
 
~5 mins  ~5 mins 5 mins 15 secs 6 mins 10 mins 
Rf2 
 
~4 mins ~4 mins 4 mins 4 mins 40 secs 7 mins 
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The addition of histodenz did have an effect on the polymerisation time.  This could 
be attributed to the radiopaque acting as a diluent within the polymerisation.  At 20% 
there was visibly a slight difference in the gel structure, suggesting that use at such a 
high percentage in comparison to monomer content.  On addition to the TEMED/KPS 
initiated gels there was a brown colour change.  Initially this was suspected to be free 
iodine, however upon investigation with sodium thiosulfate titration this did not 
appear to be the case, and can be attributed to the presence of the aromatic amine 
initiator undergoing a form of oxidtive degradation. 
 
4.6.1 The visibility of Histodenz within the polymerised gel  
 
Discs of the samples above containing increasing amounts of Histodenz were X-rayed 
kindly by Birmingham Dental School using a Siemens Heliodent DS 7Ma 60kVp DC.  
The desitometry of the resultant X-rays was measured using a  Densitometer X-rite 
33.  The results are represented in table 4.6.1 
 
Table 4.6.1 The visibility of Histodenz within gel Rf1 
 
 
 
 
 
 
Figure 4.6.1 is an example of a large disc of gel x-rayed with smaller disc samples cut 
out.  The density of the image of the gel in this case was 10.8. 
Percentage Histodenz Density of image 
0 
 
0.87 
5 
 
1.01 
10 
 
10.4 
15 
 
10.8 
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4.6.1 An example of an x-rayed gel sample composition Rf1 with 5% histodenz w/w 
 
It appears that whilst histodenz does show within an X-ray at the levels used, there is 
little differentiation between the percentage increases.  A density of 4 is opaque, so it 
is debateable as to whether the gels would be visible when encased within endplates. 
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Fig. 4.6.2 The visibility of the gel within an excised disc segment, samples 1 and 2 
contain no dye, samples 3 and 4 contain 5% histodenz. 
 
Figure 4.6.2 represents excised sheep disc segments which were injected with pregel 
which was allowed to polymerise at room temperature prior to re-freezing in order to 
preserve the specimens.  There appears to be very little visible difference between 
samples 1, 2 and 4, however sample 3 does appear to be slightly more dense.  As the 
nucleus was removed prior to obtaining the samples, the efficiency of removal and 
size of the resultant cavity was not known.  It could be that this cavity contained more 
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gel so thus resulted in a more dense image, rather than the presence of the histodenz 
improving visible clarity. 
 
4.7 The residual monomer content 
 
To assess the suitability of the two systems the residual monomer content must be 
analysed.  This was conducted using discs of the two gel types Rf1 and Rf2 prepared 
with 2% crosslinking agent and polymerised within a petri dish.  The full procedure is 
detailed in section 2.5.  The calibration and subsequent results are detailed in figures 
and tables 4.7.1 through to 4.7.5 
 
Table 4.7.1 Residual NaAMPs calibration by refractive index 
NaAMPs conc RI1 RI2 RI3 Avg RI 
10% 
 
1.34824 1.34827 1.34825 1.34825 
 
5% 1.34030 1.34045 1.34035 1.34037 
 
1% 1.33420 1.33421 1.33419 1.33420 
 
0.50% 1.33333 1.33340 1.33335 1.33336 
 
0.10% 1.33267 1.33272 1.33270 1.33270 
 
0.05% 1.33258 1.33264 1.33260 1.33260 
 
0.01% 1.33249 1.33258 1.33250 1.33252 
 
 
Fig 4.7.1 Residual NaAMPs calibration curve calculated by refractive index 
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Table 4.7.2 Residual KSPA calibration calculated by refractive index 
KSPA conc RI1 RI2 RI3 Avg 
 
10% 1.34490 1.34490 1.34494 1.34491 
 
5% 1.33890 1.33880 1.33871 1.33880 
 
1% 1.33384 1.33393 1.33383 1.33387 
 
0.50% 1.33316 1.33320 1.33315 1.33317 
 
0.10% 1.33260 1.33267 1.33262 1.33263 
 
0.05% 1.33254 1.33264 1.33259 1.33259 
 
0.01% 1.33250 1.33256 1.33249 1.33252 
 
 
 
Fig 4.7.2 Residual KSPA calibration curve calculated by refractive index 
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Table 4.7.3 Mixture calibration for KSPA and NaAMPs calculated by refractive index 
 
Conc RI 1 RI 2 RI 3 avg 
 
10% mix 1.34656 1.34666 1.34665 1.34662 
 
5% mix 1.33953 1.33956 1.33954 1.33954 
 
1% mix 1.33402 1.33401 1.33398 1.33400 
 
0.5% mix 1.33327 1.33331 1.33328 1.33329 
 
0.1% mix 1.33262 1.33265 1.33267 1.33264 
 
0.05% mix 1.33266 1.33258 1.33256 1.33260 
 
0.01% mix 1.33250 1.33249 1.33256 1.33252 
 
 
 
Fig 4.7.3 Residual NaAMPs/KSPA mixture analysed by refractive index 
 
Table 4.7.4 The residual content of gel Rf1 calculated by refractive index 
RI minus 
background %R KSPA %R NaAMPs %R mix 
0.00054 0.43 0.34 0.43 
0.00055 0.44 0.35 0.35 
0.00058 0.47 0.41 0.41 
 
Average residual monomer content from a AA/Oxone initiated gel is 0.4% 
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Table 4.7.5 the residual content of gel Rf2 calculated by refractive index 
RI minus 
background 
%R KSPA %R NaAMPs %R mix 
0.00039 0.30% 0.24% 0.28% 
0.00038 0.30% 0.24% 0.28% 
0.00038 0.30% 0.24% 0.28% 
 
Average residual monomer content from a TEMED/KPS initiated gel is 0.27% 
KSPA 0.001% 
 
The results show very little residual content of the gels, especially if the structure of 
the ionic monomers are compared to sodium chloride of which typical physiological 
saline has a concentration of 0.9%.  It is not surprising however that the gel initiated 
via TEMED and KPS demonstrates a lower level of residual monomer content due to 
the fact that it is perceived to be a much more efficient initiation system in 
comparison to AA and Oxone. 
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4.8 Discussion 
 
The aim of the work described in this chapter was to refine the systems explored in 
the previous to produce systems that could be delivered via injection into the nucleus 
pulposus cavity.  This resulted in two gels of similar composition, with different 
initiator systems and different crosslinking agents.  These were denoted Rf1 and Rf2.  
Ascorbic acid and oxone with PEG575 diacrylate and TEMED and potassium 
persulfate with PEG1000 dimethacrylate.  The incorporation of ascorbic acid and 
potassium persulfate may seem feasible, but in fact produced a less reliable system. 
 
Methods of storage and stabilisation were explored with respect to monomers, 
initiators, and stock solutions as a whole.  The factors that have the potential to affect 
storage stability were identified as heat, light and temperature.  A cumulative affect of 
inclusion of certain components together was also discovered.  For example, due to 
the high reactivity of NaAMPs it is not possible to store this component in the 
presence of a highly reactive initiator such as Oxone or potassium persulfate.  Due to 
ascorbic acid possessing the ability to degrade when in direct light, it was deemed 
storage would only be suitable for an extended time period, in the dark.   
 
The presence of oxygen within any polymerisation has the potential to cause 
detrimental effects.  These could be either degradation of the initiator, which is 
particularly apparent in the case of ascorbic acid and potassium persulfate, which was 
discussed in the introduction.  Oxygen also has the capacity to scavenge radicals 
during the reaction, preventing them from being available to initiate polymerisation.  
In solutions which were saturated with oxygen and measured via the use of an oxygen 
probe, this was shown to be an obvious detrimental effect.  However the complete 
removal of oxygen from the system is also detrimental to the polymerisation reaction.  
This is particularly in this application which requires gelation to not commence until 
after at least 3 minutes.  The inclusion of a level of oxygen that allows this is 
therefore advantageous.  The desired result is that preparation and storage in ambient 
oxygen provide the most reliable reproducible systems.   
 
Storage under refrigeration at approximately 4oC hinders mobility of any radicals that 
are prematurely produced as a result of the presence of oxygen or just simply 
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degradation of the initiators.  Both systems therefore were discovered to be stable 
under refrigeration for up to one month.   
 
Injection into a suitable cavity was explored using both a balloon model and excised 
sheep disc and was deemed to be successful, and perceived not to alter the gelation 
time or efficacy. This was important especially in a tissue sample due to the presence 
of biological fluids and/or moisture on surfaces having the potential to dilute the 
polymerisation system and thus hinder polymerisation. The rationale for the selection 
of a sheep disc as a tissue model was due to the increasing reports in the literature of 
the behaviour of the disc being the closest analogue to that of human tissue. 
 
It is important to mention the injection process.  The use of different length and gauge 
of needle has a clear effect on the time taken to polymerise.  Usually the greater the 
needle length and lesser the bore of the needle, less time is taken for a nucleus of 
gelation and thus complete polymerisation to occur.  This could be an accumulative 
effect of surface area and shear forces. 
 
Addition of a radio-opaque into the monomer system to allow the analogue to be 
visible throughout its lifetime was desirable.  At levels up to 15% histodenz does not 
seem to detrimentally alter the properties of the gel.  Analysis via X-ray also suggests 
that at these levels the implant should be visible.  This was confirmed via both 
injection of free gel samples and x-ray of excised disc segments containing injected 
polymerised gel.  However further investigation into the visibility within bone would 
be advantageous. 
 
Finally the residual monomer content of the material was analysed via refractive 
index and perceived to be at an acceptable level.  This can be equated to the 
concentration of physiological saline ~0.9%, NaAMPs and KSPA are analogous to 
the salt solution and the residual content of 0.4% or less is highly unlikely to produce 
a detrimental cell response. 
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Chapter Five 
 
The Design and Synthesis of a Proteoglycan Analogue: Mechanical 
Properties 
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5.1 Introduction  
 
This chapter will illustrate and discuss the rheological behaviour, swell behaviour and 
osmotic responsiveness of the material compositions discussed in chapters 3 and 4.  
This chapter in particular, like the previous, is focussed mainly on the properties of a 
material which will be suitable as an analogue for the natural nucleus pulposus of the 
intervertebral disc.  The chapter follows the order of previous chapters, beginning 
with the effect of monomer variation, initiator variation, cross-linking agent variation, 
and water content variation before proceeding onto the swell behaviour and osmotic 
responsiveness of the compositions deemed the most suitable for the end application. 
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5.2 Rheological behaviour of different monomer compositions 
 
As mentioned previously, the difficulty with using NaAMPs is its availability only as 
an aqueous solution and not in a solid form, therefore for this application KSPA is 
used as a co-monomer to increase the w/w solid content of the gel.  The preparation of 
samples for rheology is discussed in section 2.2.4.   
 
Figure 5.2.1 demonstrates a comparison between the viscous, elastic, and complex 
modulus of a NaAMPs polymer and an NaAMPs:KSPA copolymer.  These are based 
on Gel 6 in table 3.2.3.1.2 for the NaAMPs gel and Gel Rf1 table 4.2.1 with 2% 
crosslinking agents.  Gels are prepared within a Petri dish to allow a uniform structure 
and thickness of approximately 2mm.  Discs of 20mm diameter are cut out before 
being tested on the rheometer through a frequency sweep of 5-25Hz at 37oC to mimic 
body temperature.  The results represented in the figure are taken at 10Hz.  For all 
mechanical data reported in this and future chapters, where error bars are present a 
minimum of five samples were tested and the statistical average used to calculate 
error. 
 
 
Fig 5.2.1 A comparison of viscous, elastic, and complex modulii recorded at ~10Hz 
for an NaAMPs based polymer vs an NaAMPs:KSPA copolymer of similar 
solid:water polymerisation ratios ~1:1, crosslinking agent PEG400DA at 2% w/w, 
initiated via AA and Oxone 0.1M 
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` 
It can be seen that there is very little difference in the mechanical properties of the 
material although NaAMPs tends polymerise quicker and produces a more 
reproducible network than its copolymer with KSPA. 
 
Varying the monomer ratio has an effect on the resultant properties of the gels as is 
demonstrated in figure 5.2.2.1.  These compositions are based on those detailed in 
table 3.2.3.2.1.  The materials are prepared in similar manner as previously.  
 
 
Fig 5.2.2.1 A comparison of the viscous, elastic, and complex modulii recorded at 
~10Hz of three different ratios of NaAMPs:KSPA, 3:2, 1:1, and 2:3 respectively.  
Each composition consisted of similar water and crosslinking agent levels (1%), 
initators used were AA and Oxone 0.1M 
 
The ration between the viscous and elastic modulus can be represented more clearly 
by the use of tan delta.  This is represented in figure 5.2.2.2. 
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Fig 5.2.2.2 The effect of increasing KSPA content on Tan delta 
 
The chart above demonstrates the effect of monomer variation, of particular interest is 
the increased mechanical strength of the gel containing more KSPA.  Although KSPA 
is reluctant to polymerise, it appears that when it is used at a higher percentage it 
favours crosslinking with the PEG diacrylate.  This can be explained by similar 
structures reacting more efficiently with each other, acrylate to diacrylate for instance.  
Gel samples were examined under a Dialux 20 Leitz microscope with darkfield 
illumination at x125 magnification, no particulates were visible suggesting that all the 
KSPA participated in the polymerisation therefore the increased mechanical stiffness 
was not due to particulates. 
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5.3 Initiator variation 
 
5.3.1 The variation of ascorbic acid and oxone conentration 
 
Whilst increasing the initiator concentration may increase the efficacy of 
polymerisation, it was important to assess the effect this has on the rheological 
properties of the gels, in particular the elastic modulus.  Compositions were 
investigated based on those detailed in table 3.2.3.2.1, varying the ascorbic acid and 
oxone concentrations at 0.1M and 0.15M 
 
 
Fig 5.3.1 The effect of increasing the AA Oxone concentration on the rheological 
properties of an NaAMPs KSPA copolymer recorded at ~10Hz 
 
It is clearly demonstrated that the use of a more concentrated initiator produces a gel 
with much less mechanical stiffness than a less concentrated initiator.  This 
corresponds to both gelation and thus complete polymerisation occurring at a much 
greater rate.  The chains that are formed are much shorter than those formed from the 
weaker initiator producing a weaker network structure and thus exhibiting a lesser 
degree of mechanical stiffness.  It is important to note that although weaker, the 
structural response of the copolymer due to its monomer composition is similar, in 
that the ratio of viscous to elastic modulus changes minimally between the two 
systems.  Therefore a 0.1M initiator system is not only more efficient due to the 
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degree of control it allows over the time taken for gelation to begin, but produces a 
stronger more intricate network. 
 
5.3.2 The variation of TEMED and potassium persulfate concentration 
 
The variation of the TEMED and potassium persulfate initiator systems requires a 
greater degree of investigation to fully understand the effect it has on the mechanical 
properties.  As discussed in chapter 4, observation of polymerisation time and 
efficacy indicated that a compromise of 0.18M potassium persulfate and 0.4M 
TEMED provided the most efficient system, although polymerisation appeared to 
have greater dependency on the potassium persulfate concentration.  Initially one 
concentration was kept constant, and then both were varied.  The compositions were 
based on those detailed in table 3.5.4.1, however incorporating 1% of the crosslinking 
agent PEG 1000 dimethacrylate.   
 
 
Fig 5.3.2.1 The effect of varying TEMED initiator concentration whilst keeping KPS 
constant at 0.18M, on viscous, elastic, and complex modulii recorded at ~10Hz  
 
As with altering the concentration of the ascorbic acid and oxone redox pair, when 
altering the concentrations of TEMED and potassium persulfate, the ratio between 
elastic and viscous modulii differs very little.  Essentially the gel properties with 
relation to their elastic behaviour remains similar, even if the gel produced is less 
stiff.  This suggests complete gelation in all cases.  Comparing figure 5.3.2.1 to figure 
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5.3.2.2 it becomes apparent that the initation and subsequent polymerisation has a 
greater dependence on the concentration of potassium persulfate as oppose to 
TEMED.  As demonstrated above the alteration in elastic stiffness is small circa 
2500Pa at most, in comparison to lowering the potassium persulfate concentration 
producing a gel nearly 10000Pa weaker. 
 
 
Fig 5.3.2.2 The effect of varying KPS initiator concentration whilst keeping TEMED 
constant at 0.4M, on viscous, elastic, and complex modulii recorded at ~10Hz 
 
It was necessary to investigate the accumulative effects of altering the concentration 
of both of the initiators to discover the most effective combination that was both 
stable to the requirements discussed in the previous chapter, and still able to produce a 
mechanically suitable tissue analogue.  Figure 5.3.2.3 below illustrates these 
investigations. 
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Fig 5.3.2.3 The effect of varying both initiator concentrations where A= 0.1M 
TEMED:0.18M KPS, B= 0.2M TEMED 0.18M KPS, C= 0.4M TEMED, 0.12M KPS, 
and D=0.4M TEMED and 0.18M KPS, recorded at ~ 10Hz  
 
Potassium persulfate is again confirmed to be the dominating initiator, which is 
demonstrated by composition C, whereas lowering the TEMED concentration still 
produces a mechanically strong gel.  These results support the decision that 0.4M 
TEMED and 0.18M potassium persulfate provide a suitable system for the tissue 
analogue. 
 
To illustrate that the mechanical properties of each system are very similar fig 5.3.2.4 
shows a comparison of the AA/Oxone initiated system based on the compositions Rf1 
and Rf2 detailed in table 4.2.1 with 2% of their respective crosslinking agents 
PEG575 diacrylate and PEG1000 dimethacrylate. 
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Fig 5.3.2.4 A comparison between TEMED/KPS initiated NaAMPS:KSPA copolymer 
system and an AA/Oxone initated system recorded at ~ 10Hz 
 
5.4 Water content variation  
 
The presence of water within a hydrogel is very important.  This water may be 
structurally bound to the polymer or it may just behave in bulk.  Figure 5.4.1 shows 
the effect on polymerising a similar monomer composition gel based on Rf2, the 
TEMED potassium persulfate initated gel with 1% crosslinking agent PEG 1000 
dimethacrylate, with 40% and 60% water.  The gel containing 60% water is 
noticeably less elastic, this may be due in part to water acting both as a spacing 
device, thus increasing the space between crosslinks, and as a plasticiser.  
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Fig 5.4.1 The effect of reducing the water component of the gel composition, recorded 
at ~ 10Hz 
 
The chart above focuses on the water that is polymerised as part of the gel structure, 
however the gel is capable of imbibing large amounts of liquid (water or biological 
fluids), the procedure for preparing swollen discs of gels is detailed in section 2.3 
Whilst the gel tested would never be expected to swell to a similar capacity in its 
application as a tissue analogue, it was necessary to test the maintenance of the 
mechanical properties once swollen.  The gel featured in this chart was of the 
composition Rf2 with 1% crosslinking agent PEG1000 dimethacrylate.  The swollen 
sample was prepared via swelling a whole petri dish size sample in phosphate 
buffered saline for 72 hours.  A disc of diameter 20mm was cut out to test after this 
time, and tested in the same manner as a similar unswollen sample which was 
polymerised alongside the swollen sample.  Also demonstrated in the chart is the very 
slightly increased mechanical strength of a gel, of the same unswollen composition, 
whose components were purged of oxygen prior to polymerisation.  It can be seen that 
whilst oxygen clearly does have a role in hindering the production of a strong 
network, the difference is not of such significance ~500Pa to necessitate 
polymerisation permanently in the absence of oxygen.  
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Fig 5.4.2 A comparison of the viscous, elastic and complex modulii of a normal 
unswollen gel, a similar swolled gel, and an unswollen gel which was polymerised in 
the absence of ambient oxygen.  Recorded at ~ 10Hz 
 
5.5 Crosslinker variations 
 
The three crosslinking agents under investigation were Nelfilcon (functionalised PVA 
macromer, PEGDA at either n=400 or 575, and PEG1000DMA.  As mentioned in 
section 3.3, the use of nelfilcon creates the problem of a rapid gelation point occurring 
but polymerisation can often be incomplete, this is particularly apparent when 
nelfilcon is used at a level higher than 0.5%, this is demonstrated in fig 5.5.1.  The 
monomer and water composition of each gel was kept constant.  Although 0.5% 
nelfilcon produces a less elastic gel than 0.5% PEG400DA, a complete network is 
formed in both cases and therefore the overall mechanical behaviour is similar, 
demonstrated by the similarity in the tan delta curves for both.  However for the 
inclusion of 1% of nelfilcon, the network formed was obviously incomplete and as the 
frequency of oscillation is increased, the elastic behaviour of the gel diminishes as 
demonstrated by the plummeting tan delta curve.  This reinforces the argument for not 
selecting Nelfilcon as a suitable  macromer-based crosslinking agent for the tissue 
analogue application.  The compositions in this analysis were based on those 
described in table 3.5.1. 
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Fig 5.5.1 Tan delta demonstrating the effect of inclusion of an increased percentage 
of Nelfilcon macromer as a crosslinking agent. 
 
The properties of both gel systems, the TEMED/KPS PEG1000 dimethacrylate, and 
AA/Oxone PEG575 diacrylate, can be manipulated less by altering the crosslink ratio.  
With respect to PEG575 diacrylate, this is represented in fig 5.5.2 below, and 
representative of the gels described in table 4.2.1. 
 
 
Fig 5.5.2 The viscous, elastic and complex modulii of an NaAMPs/KSPA, AA/Oxone 
initiated copolymer with increasing levels of PEG575DA crosslinking agent, recorded 
at ~10Hz 
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It is possible to incorporate quite a low level of crosslinking agent using PEG575 
diacrylate and still produce an intact structure. In contrast to the use of PEG 
dimethacrylate, which has a molecular weight of 1000.  Therefore it is assumed that 
per percentage of each, there would be more crosslinks formed when using PEG 
diacrylate.  This is demonstrated when comparing fig 5.5.2 and fig 5.5.4 below.  Each 
core gel composition is essentially very similar, so the differences in elastic modulus 
at 1% between each can be attributed to the crosslinking agent used with PEG 
diacrylate producing 21000Pa and PEG dimethacrylate 7500Pa respectively.  Tan 
delta in fig 5.5.3 in comparison to Fig 5.5.5 illustrates the use of PEG diacrylate has 
less of an effect  on gel properties between 0.5% and 1% crosslinking agent when 
using PEG diacrylate.  Neither composition is more advantageous than the other, both 
can be structurally manipulated to give a desired end product. 
 
 
Fig.5.5.3 Tan delta, the ratio of viscous to elastic modulus for the increase of 
crosslinking agent PEGDA. 
 
As more crosslinks are present within the gel structure, the material has a much 
greater elastic modulus, its viscous behaviour diminishes in comparison to lower 
levels and a considerably stiffer gel is the result.  The ratio of viscous to elastic 
modulus is clearer to see in fig 5.5.5, with a rapid decrease in tan delta between 0.5% 
and 1% crosslinker. 
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Fig 5.5.4 The viscous, elastic and complex modulii of an NaAMPs/KSPA, 
TEMED/KPS initiated copolymer with increasing levels of PEG1000DMA 
crosslinking agent, recorded at ~10Hz 
 
 
Fig.5.5.5 Tan delta, the ratio of viscous to elastic modulus for the increase of 
crosslinking agent PEGDA. 
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5.6 The incorporation of DPA as a stabiliser 
 
The use of dipicolinic acid to stabilise KPS was discussed in section 4.3, the 
compositions are represented in table 4.3.1. Although it was deemed to have a 
detrimental effect on the polymerisation, the effect on the mechanical properties was 
investigated as demonstrated in fig 5.6.1 below. 
 
 
Fig.5.6.1 The incorporation of DPA into the TEMED/KPS system as a stabiliser, 
recorded at ~10Hz  
 
The incorporation of DPA produces a gel with increased viscous and decreased elastic 
strength, this is probably due to the DPA interfering with the process of 
polymerisation.  This was reported via the cessation of any gelation once DPA had 
been stored within a stock solution for any amount of time. 
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5.7 Incorporation of histodenz 
 
The procedure for incorporating Histodenz into gels was introduced in section 4.6 
along with the subsequent x –ray visibility of the gels. This section will focus on the 
effect of the inclusion of Histodenz on the mechanical properties of the two gels 
whose components are illustrated in table 4.6.1. 
 
Adding Histodenz to the gel compositions does have a minor affect on their 
mechanical behaviour.  This is represented in Figure 5.7.1 and 5.7.2, below.  As 
Histodenz concentration increases, as a general trend, so does the elasticity of the 
material in contrast to the gel that contained no histodenz.  This is due to the increase 
in solid content of the gel but is not detrimental to the resultant properties.  Tan delta 
in Fig 5.7.3 does show an increase due to the slight increase in viscous modulus in 
comparison to the smaller increase in elastic modulus.  In a gel of similar composition 
in the absence of histodenz, for instance Rf1, recording at a similar frequency tan 
delta would be expected to remain constant.   
 
 
Fig 5.7.1 The effect of the inclusion on increasing levels of Histodenz on the viscous, 
elastic, and complex modulii of an NaAMPs:KSPA, AA/Oxone initiated gel with 2% 
PEG575DA crosslinking agent 
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Fig 5.7.2 The effect of the inclusion on increasing levels of Histodenz on the viscous, 
elastic, and complex modulii of an NaAMPs:KSPA, TEMED/KPS initiated gel with 
2% PEG1000DMA crosslinking agent 
 
 
 
Fig 5.7.3 Tan delta for the increase in Histodenz on NaAMPs/KSPA, TEMED/KPS 
initiated gel with 2% PEG1000DMA 
 
In the figure above it can clearly be seen that histodenz has had a slight interference in 
the polymer network formation.  This could also be attributed to some degree to the 
increase in solid content of the gel. 
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5.8 The swell and subsequent compression behaviour in varying osmotic media 
 
To assess the mechanical behavior of typical GAG-analogue hydrogels under 
different osmotic pressures various formulations were synthesized and prepared for 
compression monitoring as previously described in section 2.2.3. The two hydrogels 
were compressed to 50% and all remained intact after testing. The samples were 
swollen to different extents in response to the osmolarity of the solution displaying 
the osmotic driving potential of the sulfonated hydrogels. The samples displayed 
differing compression ratios, which is a function of their swell in response to the 
osmolarity of the solution.  
 
This differential swelling property indicates that the gels can respond to osmotic 
gradients, in a similar manner to the natural tissues. The osmotic driving potential of 
the synthesised hydrogels can be manipulated via alteration of its fixed charge 
density, this is affected by controlling the concentration of the sulfonate-containing 
monomer. Figure 5.8.1 is based on gel Rf1 (table 4.2.1), and shows the development 
of compression modulus as a function of time swelled in a 300mOsm PEG solution. 
Figure 5.8.2 is based on gel Rf2 (table 4.2.1) and illustrates the osmotic 
responsiveness to solutions of different osmolarities, after 3 days.  
 
 
Fig 5.8.1 The compression modulus of an NaAMPs/KSPA AA/Oxone initiated gel with 
1% PEG575DA, tested over a range of time 
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Fig 5.8.2 The compression behaviour of an NaAMPS/KSPA TEMED/KPS gel with 1% 
crosslinking agent PEG1000DMA swollen in varying osmotic media 
 
These results are pleasing as they demonstrate the ability of the gels to respond 
osmotically in different media without any detrimental effects.  In particular 
dehydration and/or sample collapse.  This is advantageous in suggesting that the 
material will be able to restore a degree of disc height when in situ. 
 
5.9 Dynamic mechanical analysis of excised sheep disc in three different states: 
intact nucleus, nucleus removed, and containing injected gel 
 
The storage stiffness of excised sheep disc segments was measured via DMA at the 
University of Birmingham at the permission of Dr Duncan Shephard.  Tests were 
conducted with the disc still intact, the nucleus removed, and after the nucleus has 
been replaced with a gel comprising of gel Rf1 with 1% crosslinking agend PEG 575 
diacrylate.  Samples were prepared as dual pre-gel solutions as detailed in section 2.2, 
and upon injection of the gel disc segments were left for 30 minutes to ensure 
complete gelation had occurred. 
 
Dynamic mechanical analysis determines the dynamic viscoelastic properties of 
materials or components as a function of a wide range of test conditions.  DMA 
application applies a sinusoidal excitation to the test specimen, collects timed data of 
force and displacement and provides viscoelastic analysis of the data based on Fourier 
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analysis techniques. To begin the test, the system ramps to a specified load hold level 
(-0.5) and records the current displacement feedback.  This reading is now used as a 
relative zero position for all subsequent commands and displacement feedback. Once 
the dynamic cycling has begun the specimen is precycled for a user specified time (in 
secs) (for this test 3 precycles were conducted).  This allows for amplitude control and 
specimen stabilisation to occur prior to data being taken. The WinTest DMA software 
uses a Fourier analysis technique to analyze the timed data of a reference and 
measured channel (in this case the reference is loading and measured displacement).  
The Fourier analysis technique models a measured signal as a series of sine functions 
of varying amplitude and phase. 
 
The following parameters are calculated  
o Dynamic stiffness K* 
o Phase between the reference channel and feedback- Delta 
o Storage stiffness K’ 
o Loss stiffness K” 
o Damping C 
o Hysteresis energy 
o Transmissibility- Tr 
 
The DMA testing machine used was BOSE Endura TEC ELF 3200.  It applies a mean 
compressive load of 40N with a dynamic amplitude of 4 and the dwell time set as 1 
minute.  Frequency is oscillated from 0.1Hz to 35Hz.  Eight disc segments were 
mounted in acrylic cold cure dental cement and surrounded by Ringers solution to 
maintain hydration.  Figure 5.9.1. shows a picture of the testing rig with a disc under 
load. 
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Fig 5.9.1 DMA testing kit with disc under load 
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The results are demonstrated in fig 5.9.2 below using an average from the eight 
results.   
 
 
Fig 5.9.2. A comparison of the storage stiffness with and without the nucleus pulposus 
and with the gel to demonstrate the restoration of a degree of elasticity 
 
As expected removal of the nucleus pulposus results in a stiffer disc.  This can be 
likened to the removal of a cushioning sponge between two plates.  When this is 
removed there is nothing to absorb and shock or spread the load, which is essentially 
the role of the nucleus pulposus.  Upon refilling of the cavity with the analogue gel at 
least two thirds of the properties of the natural nucleus pulposus were restored.  This 
proves that in theory, that as the gel has exhibited this response in an in-house testing 
model, it does have the ability to restore disc height. 
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5.10 Discussion 
 
The aim of this chapter was to illustrate the effects that the composition manipulations 
carried out in the previous two chapters have on mechanical properties.  It has been 
demonstrated that monomer composition has the ability to alter the mechanical 
strength, in particular with the use of similar reagents for example PEG diacrylate and 
KSPA.  Here the combination of like for like acrylate has the potential to produce a 
much more efficiently crosslinked network structure as is illustrated by the increase in 
stiffness.  This response to manipulation of monomer composition, is however 
negligible in comparison to the effect observed later on, on the variation of 
crosslinking agent content. 
  
The concentration of initiators has a considerable effect on the structure of the gel.  It 
has been reported that a higher concentration of ascorbic acid and Oxone produces a 
gel with much shorter chain lengths due to the rapid polymerisation which occurs.  
This suggests that initiators at a concentration of 0.1M are the most suited for this 
application, in comparison to a composition of 0.15M which coupled with its faster 
polymerisation times, produced a brittle gel structure.  With respect to TEMED and 
potassium persulfate, the initiators behave in a more synergistic manner, however 
appearing considerably more dependant on the potassium persulfate concentration.  
The best match was found to be TEMED at 0.4 M and potassium persulfate at 0.18M.   
 
The water content of resultant gels also has a clearly defined effect on their 
mechanical properties, with an increase in water content of 20% decreasing 
mechanical strength by almost a third.  This reiterates the behaviour of water both as a 
spacing device and a plasticiser.   Clearly here reduction in stiffness in response to the 
increase in water content suggests a behaviour in bulk, as oppose to participation in 
the structure of the gel.  Gels which were swollen in water still maintain their 
structure during mechanical testing, however exhibit a much lower modulus of 
elasticity, as would be expected. 
 
Varying the crosslink ratio between 0.25% and 2% for PEG diacrylate and 0.5 and 
2% for PEG dimethacrylate in compositions Rf1 and Rf2 respectively achieved gels 
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with a modulus of elasticity ranging between 3kPa and 28kPa. This dictates that 
achieving properties similar to that of the natural nucleus pulposus which is reported 
to have values between 7kPa and 20kPa(26) perfectly achievable.  The manipulation of 
crosslink ratio was by far the most influential method of altering the resultant 
properties of the gels. 
 
The effect of stabiliser, although deemed unsuitable prior to mechanical testing, 
reinforces the decision that they are unsuitable.  This is demonstrated by the increase 
in viscous modulii of these gels in response to ineffective gelation.  Polymerisation 
was unable to produce an effective elastic gel due to the presence of the additive. 
 
The incorporation of Histodenz was demonstrated to largely have no detrimental 
effect on the mechanical properties of both gel compositions when used at levels 
below 15%. 
 
Compression testing of the two compositions Rf1 and Rf2, swollen within dialysis 
membrane in solutions of varying osmotic media clearly demonstrates the 
responsiveness of the gels.  This resulted in compressive strengths of 800kPa in 
800mOsm media and 8kPa in 80mOsm media. 
 
Injection of the gel into excised sheep disc samples appeared to suggest the 
restoration of a degree of stiffness closer to that of the intact disc segment.  It is 
feasible to assume that the gel has demonstrated the ability to restore a degree of 
advantageous properties to the natural disc.  This supports the development of the 
injectable gel for nucleus pulposus repair. 
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Chapter Six 
 
Towards Development of an Injectable Accommodating IOL 
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6.1 Introduction 
 
The problem that exists with current IOL materials is their inherent stiffness due to 
their need to withstand manufacturing constraints.  For example, typical IOLs are 
based on three main types of material: rigid PMMA, foldable acrylics, and silicone.  
The first two are lathe cut, with the latter being cast moulded.  The reason for the 
difference in manufacturing methods is due to the glass transition temperature of the 
particular material.  Typically PMMA and acrylic based materials are harder materials 
with a relatively high Tg, whereas silicone materials are much more rubber like with a 
lower Tg.  These materials once implanted within the eye are too stiff to allow for 
natural accommodation.  This usually results in the patient being completely 
presbyopic.  The development of an injectable IOL, which does not have the rigid 
manufacturing constraints of current materials would allow for a softer material circa 
3-8kPa which would allow for some natural accommodation.  The use of injection 
would also further minimise required incision size thus reducing prospective 
complications during surgery.  
 
The material discussed in the previous chapters is already deliverable via injection as 
a low viscosity pregel, capable of polymerising in situ in an acceptable timeframe.  
The ability of the gel mechanical properties have clearly been demonstrated to be 
alterable depending on the crosslink ratio of the gels.  This chapter will focus on 
adapting that material to be suitable as an injectable intraocular lens. 
 
The chapter will begin with a short focus on current available materials before 
introducing the novel injectable analogue material. 
 
I must express thanks to Umair Hussain, a MSc student who conducted his project 
within the Biomaterials Research Unit, who is responsible for testing some of the 
compositions detailed in this chapter. 
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6.2 Current Materials 
 
The crystalline lens of the eye has an elastic modulus ranging between 70Pa at birth 
and 2700Pa in later years(17).  To understand the properties and mechanical behaviour 
of current materials it is necessary to refer to both the material and the glass transition 
temperature of these materials.  There are three types of typical IOL material, rigid 
poly (methylmethacrylate) PMMA, foldable acrylic and silicone based. PMMA and 
foldable acrylic materials typically have a high glass transition temperature.  PMMA 
is usually in the range of 118-113.5oC, acrylic materials 15.5oC and 14oC and silicone 
materials -91.7oC to -119.6oC(57).  It is for this reason that PMMA and acrylic 
materials tend to be lathe cut whilst due to their low Tg silicone materials must be 
moulded. 
 
Samples of Bausch and Lomb acrylic and silicone based IOLs were received and 
testing on the Bohlin CVO rheomoeter using a 10mm parallel plate with a roughened 
surface to help grip the lens.  Samples were oscillated between 5 and 20Hz at three 
temperatures to ascertain the effect of temperature on properties.  The results 
displayed in the figures below were recorded at 10Hz.  Figure 6.2.1 reports the elastic 
modulus of the two types of lens. 
 
 
 Fig 6.2.1 The elastic modulus of Bausch and Lomb acrylic and silicone based IOLs 
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As demonstrated in figure 6.2.1, the temperature range studied does not seem to affect 
the elastic behaviour of the silicone lens, this is due to the temperature of testing 
being significantly higher than that of the materials glass transition temperature.  
However with regards the acrylic material, which is essentially still within range of its 
Tg, the properties vary with temperature.  It is important to state here that the glass 
transition temperature whilst a specific value, changes within the material occur over 
a 30oC temperature range  This illustrates problems that may occur on insertion of the 
lens and its subsequent unfolding in relation to the temperatures at which this occurs.  
For example, lenses may be folded at approximately 20oC which is significantly close 
enough to the Tg of the material to induce creases and prove detrimental to the lenses 
ability to unfold correctly once implanted in the eye.  
  
Figure 6.2.2 below demonstrates the viscous modulus of the same lenses which again 
display a similar pattern to that of the elastic modulus in response to temperature. 
 
 
Fig. 6.2.2 The viscous modulus of Bausch and Lomb acrylic and silicone IOLs 
  
Figure 6.2.3 below shows a comparison of the two, clearly demonstrating a more 
flexible structure at 40oC, attributable to the material being clear of its glass transition 
temperature. 
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Fig 6.2.3 A comparison of the elastic and viscous modulii of Bausch and Lomb 
acrylic and silicone IOLs 
 
In comparison, analysis of an acrylic based material which has a Tg within the range 
of use exhibits completely different properties.  This is demonstrated in figure 6.2.4 
 
 
Fig 6.2.4 The rheological behaviour of an acrylic IOL material with a Tg in the range 
of use 
 
Here it can clearly be seen that around its temperature of folding, the material has a 
much higher stiffness, which will affect both folding and unfolding.  However at ‘in 
0	  
500	  
1000	  
1500	  
2000	  
2500	  
3000	  
3500	  
4000	  
4500	  
25	   34	   40	  
M
od
ul
us
	  (P
a)
	  
TesJng	  temperature	  oC	  
Viscous	  modulus	  
ElasJc	  modulus	  
0.00E+00	  
5.00E+06	  
1.00E+07	  
1.50E+07	  
2.00E+07	  
2.50E+07	  
3.00E+07	  
25	   34	   40	  
M
od
ul
us
	  (P
a)
	  
Temperature	  of	  tesJng	  oC	  
Viscous	  
ElasJc	  
Towards the Development of an Injectable Accommodating IOL 
144 
eye’ temperature the stiffness bears almost no comparison to that of its folding 
temperature.  A DSC trace for this material is shown in figure 6.2.5. 
 
Fig 6.2.5 A DSC trace for a acrylic IOL material with Tg ~ 24oC  
 
The trace illustrates the Tg as 24oC, however the shape of the trace also demonstrates 
that the range is between 18oC and 30oC.  This explains the reduction in stiffness of 
the material as temperature increases.  The chains have more energy to rotate and thus 
occupy a much lower energy configuration. 
 
Introducing the current materials has given an insight into the problems which are 
incurred during manufacture and use of an IOL.  To develop a successful injectable 
alternative there are a set of requirements which must be met: 
 
o Material must be injectable into the cavity 
o Must be retained within the cavity until complete polymerisation has occurred 
o Must completely fill the cavity so as to reduce the possibility of posterior 
capsular opacification 
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It is logical now to discuss the proposed injectable alternative. 
 
6.3 An injectable IOL 
 
One of the primary steps within cataract surgery is the use of a viscoelastic to 
maintain the viability of the cavity before and during surgery.  This protects the 
epithelium from damage and prevents the front and back surfaces of the capsular bag 
from coming into contact with each other.  Discussions with surgeons have indicated 
that it is not feasible to dry the cavity before injection of the proteoglycan analogue.  
Therefore displacement or incorporation of the viscoelastic into the pregel was agreed 
as a logical and workable progression.  Initial work on an injectable IOL based solely 
on the compositions used for the intervertebral disc application resulted in a 
composition which was not viscous enough to be maintained within the cavity of the 
eye.  This was discovered upon injection of the material into an excised sheep eye 
which had its lens surgically removed.  The pregel solution did not remain within the 
cavity due to its low viscosityTherefore it was proposed to incorporate the 
viscoelastic – hyaluronic acid (HA) into the previous developed proteoglycan 
analogue. 
 
6.3.1 Incorporation of hyaluronic acid into the “disc” gel 
 
Hyaluronic acid is an anionic non-sulfated glycosaminoglycan distributed widely 
throughout connective, epithelial and neural tissues.  It is unique amongst the 
glycosaminoglycans due to its un-sulfated form, and also to the high molecular weight 
it reaches which is often in the millions.  Present in the extracellular matrix 
hyaluronan contributes significantly to cell proliferation and migration.  Its structure 
is illustrated below in figure 6.3.1 
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Fig 6.3.1 The structure of hyaluronic acid 
 
Due to the high molecular weight of the material it is highly viscous in nature.  For 
example the commercial Healon GV ocular viscoelastic device used in this research 
has a viscosity of 3,000,000 mPa.  The incorporation of hyaluronic acid into the 
material will help increase the viscosity and thus improve the retention in the capsular 
bag prior to polymerisation. 
 
Based on the general composition represented in table 6.3.1, attempts were made to 
incorporate HA into the composition. 
 
Table 6.3.1 The generic analogue composition 
Gel NaAMPs (50%) 
 
KSPA 
 
H2O 
 
Crosslinking 
agent 
Initiator 
 
Initiator 
(g) 
I1 3.7g 
1.6 x 10-2 mol 
1.4g 
6 x 10-3 
mol 
3.6g 
0.2 
mol 
PEG 575DA 
0.1g 
1.7 x10-4 mol 
AA 0.1M 
0.65g 
6.5 x 10-5 
mol 
Oxone 
0.1M 
0.65g 
6.5 x 10-5 mol 
I2 3.7g 
1.6 x 10-2 mol 
1.4g 
6 x 10-3 
mol 
3.6g 
0.2 
mol 
PEG1000DMA 
0.1g 
1 x 10-4 mol 
TEMED 
0.4M 
0.65g 
2.6 x 10-4 
mol 
KPS 
0.18M 
0.65 
1.2 x 10-4 mol 
 
Hyaluronic acid was supplied as a 100% solid from Sigma Aldrich.  The aqueous 
solubility was 0.005g/ml.  Three different levels of HA were added to each 
composition as detailed in table 6.3.2 below, the composition of the gels is as table 
6.3.1 
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Table 6.3.2 The incorporation of HA 
Gel HA 
(g) 
I1a 0.034g 
I1b 0.027g 
I1c 0.02g 
I2a 0.034g 
I2b 0.027g 
I2c 0.02g 
 
Each gel was prepared in a similar manner as described in section 2.2.1, except for the 
additional component of HA.  This was dissolved between the aqueous component 
and the 50% aqueous NaAMPs component before transferring into the respective 
Redox A and Redox B solutions.  All reactions were carried out via injection into a 
petri dish to allow immediate de-selection of unsuitable systems.  Each composition 
formed successfully.  Molar concentrations of hyaluronic acid are not reported due to 
its extremely high molecular weight. 
 
Once polymerised, 20mm discs of each sample were cut out for rhelogical testing.  
Figure 6.3.1. shows effect on the elastic and viscous modulii of decreasing amounts of 
HA in system I1. 
 
 
Fig 6.3.1 The elastic and viscous modulii of gel I1 containing decreasing amounts of 
HA 
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The results displayed in figure 6.3.1 suggest that at higher levels of HA, the material 
is behaving as a reinforcing agent, for instance as an interpenetrant.  This  effect 
decreases as HA content is reduced.  It could also be proposed that the presence of 
HA is improving the ability of the material to polymerise, therefore a stronger 
network is formed in composition B. 
 
Figure 6.3.2 below demonstrates the rheological behaviour of system two with 
decreasing amounts of HA  
  
Fig 6.3.2 The elastic and viscous modulii of gel I2 containing decreasing amounts of 
HA 
 
The results dictated in figure 6.3.2 for the TEMED and KPS initiated system suggests 
different results to that of the AA/Oxone.  The amount of HA added does not appear 
to have such a drastic effect on the mechanical strength, which supports the theory 
that in the previous gel, HA was behaving as an interpentrant thus improving the 
effectiveness of the polymerisation.  Here with the TEMED/KPS system it appears 
that HA is just behaving as bulk. 
 
This evidence is further supported by the swelling behaviour of the two different gels 
in phosphate buffered saline and 10% PEG 35000 solution.  Figure 6.3.3 below 
represents the AA/Oxone initiated gels I1a,b,c.  Discs of 20mm diameter were cut 
from the petri dish and swollen in the required media until they appeared to reach 
equilibrium. 
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Fig 6.3.3 The swell capacity of gels I1a,b,c, in PBS and 10% PEG 35000  
 
The results appear to suggest that there is an optimal inclusion level of HA which 
facilitates a greater degree of swell behaviour, illustrated by the greatest swell 
achieved at 0.027g inclusion.  This may correspond with the HA acting as an 
interpenetrant and becoming part of the actual gel structure. Figure 6.3.4. below also 
supports this theory as the swell behaviour of the TEMED/KPS system does not seem 
so dramatically different between concentrations of HA including.  This reiterates the 
fact that the HA must be behaving in bulk within the system as opposed to part of the 
structure.  
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Fig 6.3.4 The swell behaviour of I2 a,b,c gels in PBS and 10% PEG35000 
 
Sample I1a was tested for compressive strength after swelling of 3ml aliquots of the 
gel within dialysis bags immersed in three solutions of varying osmolarities for 72 
hours.  The procedure is detailed in section 2.3 and the results shown below in figure 
6.3.5 
 
 
Fig 3.6.5 The response under compression of gel I1a after swelling in varying osmotic 
media 
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The responsiveness of the material is clearly demonstrated, although in comparison to 
similar material without HA, shown in figure 3.6.6, the response and compressive 
strength is slightly less.  This could be due to the inability of the polymer chains to 
respond with HA as part of the structure, being almost restrained by its inclusion. 
 
 
Fig 3.6.6 The compression behaviour of an NaAMPS/KSPA TEMED/KPS gel with 1% 
crosslinking agent PEG1000DMA swollen in varying osmotic media 
 
6.4 The incorporation of a commercially available viscoelastic into the gel 
composition  
 
During cataract surgery a viscoelastic consisting of hyaluronic acid is used to 
maintain viability of the lens cavity.  This is injected into the lens capsule during 
removal via phacoemulsification and acts to lubricate the surfaces and prevent them 
coming into contact.  Previous experiments used solid hyaluronic acid to assess 
whether this could be viably incorporated into the gel composition.  The next logical 
step was to investigate the incorporation of a commercially available viscoelastic – 
Healon which is readily used  in cataract surgey, into the gel in place of the solid HA 
previously used.  For this the gel composition remained similar to previous, however 
the water content was replaced with commercial Healon, and is represented in table 
6.4.1. 3.6g of Healon was used to replace the water component of the gel 
composition.  The molar component of Healon is not reported due to its extremely 
high molecular weight ~ 40 million. 
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Table 6.4.1 Replacement of water with Healon 
Gel NaAMPs (50%) 
(g) 
KSPA 
(g) 
Healon 
(g) 
PEG575DA 
(g) 
AA 0.1M 
(g) 
Oxone 0.1M 
(g) 
I3 3.7g 
1.2 x 10-2 mol 
1.4g 
6 x 10-3 
mol 
3.6g 
 
0.05g 
8.7 x 10-5 mol 
0.65g 
6.5 x 10-5 
mol 
0.65g 
6.5 x 10-5 mol 
  
An injectable gel was reproducibly formed with this composition.  The ability of the 
gel to polymerise appeared greater than that synthesised from the HA previously used.  
Therefore it was advantageous to analyse the rheological behaviour of the gels.  As 
before a 20mm disc of the gel was extracted for testing on the rheometer.  In order to 
compare the rheological behaviour to that of the currently available IOLs the material 
was tested at a range of temperatures.  The results, recorded at 10Hz are demonstrated 
in figure 6.4.1  
 
 
Figure 6.4.1 The rheological behaviour of gel I3 containing Healon, tested at a range 
of temperatures 
 
It is clear to see that the material displays a much lesser dependence on temperature in 
comparison to currently available IOL materials.  With the crosslinker level at 0.5% 
the material displays mechanical properties in line with that of natural lens tissue 
which is in the range of 308kPa. 
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The swell behaviour of the gel was investigates in both PBS and 10% PEG 35,000, 
the comparison with that of the gels containing solid HA is shown below in figure 
6.4.2. 
 
 
Fig 6.4.2 The swell capacity of gels I1a,b,c, in PBS and 10% PEG 35000 compared to 
I3 containing Healon. 
 
The results show interestingly that the swell capacity is in between the 0.02g and 
0.027 g inclusion.  It would be expected that in the 3.6g Healon there was 
approximately 0.018g HA.  The swell behaviour may be increased due to this being 
homogenised to a greater degree in the commercial solution than the laboratory 
prepared solution. 
 
6.5 Discussion 
 
The aim of the work detailed in this chapter was to adapt the existing proteoglycan 
analogue to the application of an injectable intraocular lens.  The complications with 
current materials was first demonstrated.  Understandably the properties of the acrylic 
IOL material were effected by testing temperature due to encroachment on the region 
of the glass transition temperature.  It was proposed that this could be rectified by the 
use of the analogue material.  The ability of HA to participate as part of the polymer 
structure was discovered to be more apparent when using the AA/Oxone initiator 
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system.  This could be due to HA acting as an interpenetrant as opposed to just acting 
in bulk, which it appears to do when used in the TEMED/KPS system. 
 
The material was demonstrated to still be osmotically responsive, although not to 
quite the same degree as the intervertebral disc analogue.  This is probably 
advantageous, as excess pressure exerted once within the eye could be detrimental to 
the structure of the capsular bag. 
 
A composition based on the general gel composition replacing the water content with 
commercially available Healon appears to offer the best solution.  At 0.5% 
crosslinking agent this material has an elastic modulus well within the acceptable 
limits of elasticity in order to allow the eye to accommodate. 
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Chapter Seven 
 
Development of a Radio-opaque Macromer for Incorporation into the 
Proteoglycan Analogue  
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7.1 Introduction   
 
When injecting an implant into any body site it would of course be advantageous for 
the structure to be visible throughout its lifetime in situ.  As has been detailed in 
section 4.6.1, free histodenz has been added to gels and does not appear to 
detrimentally effect the formation and mechanical properties used at 15% per total gel 
volume and below.  However due to the hydrated nature of the gels, as fluid is 
exchanged once the gel is in its target implant area, the potential for the dye to leach 
out is quite high.  This would prevent the visibility of the implant throughout its 
lifetime.  Therefore the research detailed within this chapter focuses on the addition of 
a reactive double bond to the histodenz structure to enable it to form part of the 
polymer. 
 
7.2 The reaction of N-hydroxymethyl acrylamide (NMA) and histodenz 
 
The structure of histodenz is shown in figure 7.2.1.  As you can see it possesses six, 
almost identical hydroxyl groups.  The idea was to create a structure that is capable of 
bonding with the polymer but does not have multifunctionality which has the 
potential to interfere with gelation time.  Therefore N-hydroxymethyl acrylamide was 
added at a ratio of 1:6 to histodenz to facilitate the addition to only one hydroxyl 
group.  
 
Fig 7.2.1 The structure of histodenz 
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In a 15ml glass sample vial 0.6g of histodenz was dissolved in 5ml 0.3% HCl solution 
(the acid catalyst). To this 0.21g 48% NMA in aqueous solution was added.  The 
mixture was purged of oxygen with nitrogen for 10 minutes.  After this was 
completed the vial was sealed, with a needle inserted into the lid to allow any gases 
created during the reaction to escape, and placed in a 60oC waterbath for 2.5 hours.  
The proposed reaction scheme is detailed in figure 7.2.2 
 
 
Fig 7.2.2 The reaction of histodenz with NMA 
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The FTIR spectra below, figure 7.2.3 illustrates histodenz in blue and NMA 48% 
aqueous solution in red. 
 
Fig 7.2.3 The FTIR spectrum of histodenz(blue) and NMA 48% solution (red) 
 
The allocation of the important functional groups is shown below in table 7.2.1 
 
Table 7.2.1 FTIR analysis of histodenz and NMA 48% solution 
Chemical Peak position 
(cm-1) 
Functional group 
Histodenz 3237 OH alcohol 
Histodenz 3066 CONH amide 
Histodenz 2930 NH amide 
NMA 3283 OH alcohol 
NMA 2977 CONH amide 
NMA 1640 C=O amide 
NMA 1020 C=CH deformation 
 
FTIR analysis of the sample after reaction was conducted, the main area of interest 
being the presence or absence of an –O- linkage.  The spectra is shown in figure 7.2.4. 
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Fig 7.2.4 The spectrum of histodenz (pink) and histodenz-nma reaction (red) 
 
Clearly as the reaction was conducted in aqueous solution, the detail of the spectra has 
been reduced.  Unfortunately there appears to be no peak visible in the region of 
1750-1730 or 1300-1000 that would demonstrate the formation of an ester linkage.  
The sharp peak at 1640 can be attributed to the presence of amide. 
 
As NMA is known to react in both acidic and basic conditions, the experiment was 
repeated using potassium hydroxide at 0.3%, with all other conditions kept similar.  
The FTIR spectra of this reaction is shown in figure 7.2.5. 
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Fig 7.2.5 The spectra of histodenz –NMA reaction conducted in basic conditions 
 
Again it the absence of a peak denoting the ester linkage is illustrated. 
 
Experiments were repeated adding NMA in excess of histodenz to prompt a reaction, 
however the analysis observed via FTIR did not differ.  To ascertain whether the 
inconclusive nature of the FTIR spectra was due to the dilute nature of the reaction, 
the next process was the addition of the acid catalysed histodenz –NMA into a linear 
polymer. 
 
The Histodenz- NMA sample was sent away for mass spectrometry analysis.  The 
spectra is shown in figure 7.2.6. 
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Fig 7.2.6 The mass spec analysis of the histodenz-NMA reaction 
 
The relative molecular masses of histodenz and NMA are 821.14 and 101.10 
respectively.  The spectra above clearly shows a peak at 821.906 which can be 
assigned to unreacted histodenz.  However there does not appear to be much evidence 
of the NMA on its own or reacting with itself.  The next peak of relevance is at 
1680.753 which could be histodenz reacting with itself with the addition of NMA. 
 
The results are still inconclusive, for future work it may be advantageous to increase 
the level of NMA used in the reaction to maximise the potential of reaction with 
Histodenz.  This is in contrast to the method used here where a 6:1 histodenz to NMA 
was used to facilitate addition to one OH group. 
 
Alternative methods are mentioned in further work. 
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7.3 The addition of histodenz-NMA into a linear polymer 
 
A typical linear polymer composition was used, consisting of 6g 3-sulphopropyl 
acrylate potassium salt (KSPA), 11.3g sodium 2-acrylamido-2-methylpropane 
sulphonic acid (NaAMPs)(58%) 6g N-methyl N-vinyl acetamide (NMVA) and 20g of 
a 20% aqueous mix of histodenz-NMA in the ratio of 1:1 w/w.  All components were 
added to a 60:40 200ml solvent mix of acetonitrile to water (water content was 
adjusted to allow for the water in the composition and initiator) in a round bottom 
flask set up for a typical reflux reaction. The system was brought up to temperature 
~60oC whilst under mechanical stirring, and a constant stream of nitrogen was 
provided to the solution.  Once temperature had been reached at stabilised a solution 
of potassium persulfate was added to correspond to 2% of the monomer content.  The 
reaction was kept at 60oC for 2.5 hours.   
 
After the reaction had occurred the result was a highly viscous solution.  This was 
allowed to cool and precipitated out using an excess of acetone.  As histodenz is also 
not soluble in acetone, it was possible that some residual histodenz remained within 
the precipitated compound.  To alleviate the possibility of this, the precipitate was 
washed with water, which may have reduced the yield, but hopefully removed any un-
reacted histodenz.  A sample of the solid was then sent to Medac for elemental 
analysis.  The results are represented in table 7.3.1. 
 
Table 7.3.1 The elemental analysis of a linear polymer containing histodenz  
Element Percentage (%) 
C 2.91 
H 11.65 
N 0.51 
S 0.68 
I 1.28 
Na 0.17 
 
To calculate the efficacy of the reaction, 2g of the monomer mixture was histodenz.  
This corresponds to 9% of the overall composition.  The molecular weight of a 
histodenz molecule is 821.4, with iodine being 126.9.  There are three iodine per 
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molecule of histodenz, this corresponds to 380.7, which is 46% of 821.4.  So 46% of 
9% is 4.14%.  This is the incorporation that would give a 100% success rate of 
inclusion in the polymer.  The analysis results gave an average value of 1.28% which 
is approximately a 30% success rate. 
 
These results proved that histodenz was able in some way to react with a polymer 
structure.  It cannot be confirmed that this was entirely NMA or another structure.  
This is in part to the aqueous nature of the reactions, histodenz has poor solubility in 
organic media, and also due to the similarity between hydroxyl groups.  This is 
illustrated by the NMR spectra of a 20% aqueous solution of histodenz, shown in 
figure 7.3.1. 
 
Figure 7.3.1 Water suppresion NMR analysis of histodenz 
 
The OH groups are clearly represented between three and 4 ppm and it is impossible 
to distinguish between the six groups. 
 
Due to this encountered difficulty, coupled with the apparent undersirability in the US 
of having a radio-opaque implant, alternative methods were proposed. 
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8.0 Summary and conclusions 
 
The central aim of the work detailed in this thesis was to design a tissue analogue 
material based on the natural sulfated proteoglycan structure.  The material had to be 
deliverable via injection to the required site of application.  The advantages of an 
injectable repair system for the nucleus pulposus of the intervertebral disc is the 
ability for the procedure to be carried out in a similar manner to that of a typical 
discogram.  This has the potential to save time as a typical discogram procedure 
requires a minimum of 15 minutes for completion.  The availability of a minimally 
invasive alternative to surgical disc repair would make the procedure available to 
those not able to withstand major surgery.  It is important to note however that the 
procedure is only suitable if the annulus fibrosus of the intervertebral disc is intact as 
this would need to contain the prostheses.   
 
Requirements of the system 
 
With respect to the injectable intraocular lens application, the delivery of a material 
that is capable of polymerising in situ as oppose to a solid lens, results in the 
availability of a much more elastic material.  Current materials have high stiffness 
imposed by their manufacturing constraints, in particular their ability to withstand 
lathe cutting.  This stiffness means that whilst the opacified lens can be removed, the 
ability of the eye to accommodate is never restored and the result is usually the patient 
still requiring glasses and/or contact lenses.  The injection of an osmotically 
responsive proteglycan analogue which has been modelled on the natural tissue, has 
the potential to amend the issue of accommodation. The ability of the material to 
incorporate hyaluronic acid, which is the most commonly used viscoelastic to 
maintain cavity viability during surgery, is an added advantage as it would allow a 
much more simplified procedure.  The incision size would be minimal, required only 
to allow phacoemulsification to occur, so has the potential to be less that 1.8mm, 
which is currently the smallest viable incision to deliver a hydrophilic foldable acrylic 
lens.  The pre-gel would be a substitute for the viscoelastic prior to polymerisation in 
situ.  The use of an under hydrated pre-gel would enable the polymer to be hydrated 
in situ thus allowing it to swell to fill the cavity, yielding the potential to minimise 
posterior capsular opacification.  As with the intervertebral disc application, 
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simplifying the procedure and lessening the size of the required incision would 
improve available of the operation to those unsuitable for traditional cataract removal 
and intra-ocular lens insertion. 
 
This required a material for both applications, that was deliverable via a low viscosity 
pre-gel through a small bore needle, which would then polymerise efficiently and 
completely in situ.  The pre-gel system must be stable for storage within a surgical 
environment for at least 1 month, and once polymerised within the target tissue, it 
must be stable to both enzymatic and hydrolytic degradation in addition to the 
physical forces it is subjected to over an extended time period.  The resultant material 
must be biomimetic and exhibit mechanical properties similar to those of the target 
tissue.  A particularly important requirement is that the material must be osmotically 
responsive and must maintain hydration levels under load.  Residual monomer 
content after polymerisation must be minimal and no displacement or leaching of the 
material must occur throughout its lifetime once implanted.  
 
The biomimetic target and synthetic analogues 
 
The specific proteoglycan target structures -the nucleus pulposus and crystalline lens-
that will be replaced by the analogue are chondroitin sulfate and keratan sulfate.  
Proteoglycans are protein structures which are covalently bound to 
glycosaminoglycans that consist of a disaccharide repeat unit containing either 
glucosamine or galactosamine.  Chondroitin sulfate in particular consists of a chain of 
alternating sugars N-acetylgalactosamine and glucuronic acid.  A chondroitin chain 
can be variably sulfonated along its structure, and is a major component in the ability 
of the target tissue to withstand compression.  
 
The monomers used to mimic these structures were sodium 2-acrylamido 2- methyl 
propane sulfonic acid (NaAMPs) and the potassium salt of 3-sulphopropyl acrylate 
(KSPA).  The presence of a sulfonate group within their structure supplies the ability 
of the polymer material to mimic the behaviour of the sulfate group within natural 
tissue.  Initial investigations to produce a homopolymer of NaAMPs produced a 
material with an extremely high swelling capacity, typically 400% in water and 250% 
in phosphate buffered saline.  This can be attributed to the presence of both the amide 
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and the sulfonate groups.  Acrylamide monomers are known to polymerise effectively 
and efficiently and this was illustrated via the rapid polymerisation, ~2 minutes in the 
presence of ambient oxygen at room temperature.   
 
Due to the commercial availability of NaAMPs as only a 50% or 58% solution this 
affects the w/w solid content of the resultant gel, for this reason the addition of a 
comonomer was investigated.  Inclusion of a neutral monomer such as 
acryloylmorpholine or poly (ethylene glycol) acrylate with NaAMPs as a comonomer 
successfully results in gelation.  However the swell capacity of the resultant gel is 
diminished due to the reduction in its ionic nature.  This affects both the percentage of 
water that can be polymerised as part of the gel, and the subsequent ability of the gel 
to imbibe water.  This is also apparent in the rheological behaviour of the materials, 
resulting in a much higher stiffness in comparison to a NaAMPs homopolymer.  This 
can in part be attributed to the increase in monomer content and the reduction of water 
content.  Not only is there less water included to behave as a plasticiser, but also not 
enough to act as a spacing device between crosslinks.   
 
Therefore it was logical to investigate the inclusion of another sulfonated monomer.  
3-Sulfopropyl acrylate potassium salt (KSPA) was an ideal candidate due to its 
commercial availability and use in prior hydrogel applications such as wound 
dressings.  As an acrylate, KSPA is also readily polymerisable, although not as 
reactive as NaAMPs.  A copolymer composition of the order 1:1 NaAMPs:KSPA 
produced the most reproducible polymerisation under redox conditions.  The 
reactivity ratios of NaAMPs:KSPA have been reported by Boote as 0.55:1.70(53) in 
photopolymerisation.  KSPA is less reactive than NaAMPs, demonstrated by its 
inability to form a homopolymer under redox conditions.  However in a copolymer 
system KSPA is incorporated into the chain under mild redox conditions so its 
inclusion controls the time taken for complete polymerisation to ocurr.  When more 
aggressive initiating systems were utilised such as transition metals and peroxides, 
often an instantaneous nucleus of gelation was formed.   
 
In this case it can be proposed that NaAMPs was rapidly polymerised excluding both 
KSPA and some water from the polymerisation resulting in an unsuitable system.  
When KSPA content was increased to a ratio of 3:2 to NaAMPs, although gelation 
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was effective, it was not reproducible.  Therefore in an ascorbic acid oxone system 
the ratio is kept similar to 1:1 depending on the concentration of the NaAMPs used 
(58% or 50%).  
 
The swell capacity of the copolymer was slightly less than that of the NaAMPs 
homopolymer.  This is an ideal result as a less aggressive swell capacity reduces the 
possibility of damage to the surrounding tissues once the prostheses is in situ, this is 
particularly important in the IOL application.  The reduction can be attributed to the 
absence of an amine group on the KSPA structure.  To improve responsiveness and 
functionality further it may have been ideal to include a monomer which was 
disulfonated such as sulphopropyl itaconate dipotassium salt (KSPI).  The addition of 
two sulfonate groups per monomer unit would have allowed the natural structure to be 
more successfully mimicked.  However, as was expected after the lesser reactivity of 
KSPA, it was not possible to copolymerise with KSPI under redox conditions. 
 
Initiators and crosslinking agents  
 
The preferred initiator systems were ascorbic acid and Oxone and N’N’N’N 
tetramethylenediamine and potassium persulfate pair.   This latter system successfully 
and reproducibly produced gels in a similar manner to the ascorbic acid and oxone 
system.  Three possible crosslinking agents were investigated for use in the 
copolymer system.  Poly(ethylene glycol) diacrylate Mn 575 (PEG575DA), poly 
(ethylene glycol) dimethacrylate Mn 1000 (PEG1000DMA), and Nelfilcon; a 
modified poly (vinyl alcohol).  The latter is a multifunctional macromer, which has 
more reactive sites per unit weight in comparison to previous di-functional 
crosslinking agents.  The copolymerisation reactions were carried out using PEG 
diacrylate, demonstrating its effectiveness as a crosslinking agent.  Due to its 
relatively short chain length, it was possible to incorporate quite small percentages 
circa. 0.5% w/w in comparison to that of PEG dimethacrylate which with a chain 
length of 1000, it was not possible to include at such low levels.  Both di-functional 
crosslinking agents produced efficient reproducible gels and their inclusion did not 
appear to alter the polymerisation time in any way.  However in the case of the 
macromer, not only was it difficult to handle due to its viscous nature, it tended to 
induce a nucleus of gelation almost immediately even in small quantities circa 0.5% 
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under mild initiation conditions.  Its use often resulted in incomplete gelation as the 
macromer rapidly reacted with NaAMPs, excluding some KSPA and water.  This was 
caused by the increased available sites for propagating radicals on the macromer 
chain in comparison to a difunctional crosslinking agent.  At higher levels of 
macromer, complete gels were formed, with much higher mechanical strength due to 
the rapid creation of short chains.  Synuresis was a common occurrence during 
polymerisation due to the increased rate of polymerisation and the subsequent initial 
exclusion of water from the polymer structure.  As expected the swell behaviour of a 
macromer containing copolymer was diminished due to the increased number of 
crosslinks and thus reduced mobility of the chains to swell.  All of these factors make 
nelfilcon an unsuitable crosslinking agent for this application. 
 
An important factor affected by composition and initiator system is the residual 
monomer concentration in the remaining polymer. The two systems investigated were 
the AA/ Oxone system and the TEMED potassium persulfate.  Both systems produce 
a complete gel in approximately 5 mins.  The residual monomer content as analysed 
by refractive index appears to be slightly lower at 0.27% for the TEMED initiated 
system than the ascorbic acid/oxone system at 0.4%.  This could be due to the former 
being a more effective initiation system which is also demonstrated by its slightly 
faster polymerisation time. 
  
Stability considerations 
 
When refining the system for application in the intervertebral disc, the main factors to 
consider were as follows: 
 
o Efficient and reproducible gelation 
o Polymerisable in a timescale which allows for injection 
o Stable under storage for at least one month 
o Exhibits the required mechanical properties 
 
The two systems to be further refined were both NaAMPs/KSPA copolymers but with 
different initiation systems.  One the AA/ Oxone pair, and the other the TEMED and 
potassium persulfate pair.  Prior to these investigations the gel components had been 
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assembled as one when required.  To be deliverable via injection, whether added to a 
single syringe prior to use or utilising a dual syringe, need to be stored as a two-pack 
pregel system.  To focus first on the ascorbic acid and Oxone system, it was 
discovered early on that as Oxone is the more aggressive initiator  of the pair it could 
not be kept in a solution with NaAMPs as even refrigerated in the absence of light, 
premature initiation occurred within the storage vessel in excess of 7 days.  This did 
not occur if stored with an aqueous solution of KSPA, not surprising giving its lesser 
reactivity.  Therefore ascorbic acid was combined with NaAMPs, this was stable as 
long as the solution was protected from light and refrigerated, this was as expected as 
ascorbic acid is known to be photoactive.  The next factor was the inclusion of the 
crosslinking agent.  It was discovered that this could not be stored with NaAMPs as 
the combination of both a quite reactive monomer and possible oxidative degradation 
of the ascorbic acid often resulted in gelation within the storage vessel.  This could 
not be reproducibly controlled, resulting in the incorporation of the crosslinking agent 
into the aqueous KSPA solution containing oxone.  This produced two equal volume 
stable pregel solutions, redox A and redox B. 
 
To summarise redox A was comprised of: 
 
o Ascorbic acid 0.1M 
o NaAMPs (50%) 
o Water 
 
Redox B: 
 
o Oxone 0.1M 
o KSPA 
o Water 
o Crosslinking agent ~PEG575DA 
 
These solutions were prepared in the presence of ambient oxygen and not degassed.  
Degassing of components was found to induce polymerisation in less than one 
minute, entirely insufficient for the injectable disc application.  Under ambient 
oxygen conditions polymerisation of this system after injection using a 19gauge 
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needle and 2.5ml syringes was in the region of 5-7 minutes with a storage stability of 
1 month.  
 
Understandably the exact amount of oxygen dissolved within a system cannot be 
controlled so there is a potential for the reproducibility of the stored systems to be in 
doubt.  For this reason the use of a stabiliser such as dipicolinic acid was investigated 
to ascertain whether solutions could be purged of oxygen and their polymerisation 
controlled by other means.  This was not successful, the additive appeared to alter the 
polymerisation, often hindering it all together.    
  
A similar process was adopted with the TEMED and potassium persulfate initiated 
system.  Due to the higher concentration of persulfate in comparison to oxone 
(potassium persulfate was used at 0.18M and oxone at 0.1M) on occasion there was a 
small nucleus of gelation formed within the KSPA and crosslinker solutions.  For that 
reason the redox A and redox B pregel solutions for this composition was as follows.   
 
Redox A: 
 
o NaAMPs (50%) 
o KSPA 
o Water 
o TEMED 0.4M 
 
Redox B: 
 
o Water 
o KPS 0.18M 
o Crosslinking agent ~ PEG1000DMA 
Unlike the ascorbic acid and oxone system this cannot be used as a 1:1 ratio, instead it 
is used at a ration of 3:2 redox A to redox B 
 
This system is stable under refrigerated storage in the absence of light for circa 6 
weeks.  As expected this system has slightly better storage stability due to the 
replacement of ascorbic acid with an amine initiator which is capable of producing 
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radicals in a much more controlled manner.  This system gels within 3-5 minutes, 
allowing for injection during surgical manipulation of intervertebral disc repair. 
 
Whilst investigating the injection of pre-gel solutions, it was discover that syringe size 
and needle size has an effect on gelation time.  In general the longer the needle and 
the smaller the diameter, the quicker the polymerisation occurs.  This was attributed 
to both shear forces and potentially metal mediated catalysis by the needle and was 
clearly demonstrated by polymerisation occurring in the region of 3 minutes with the 
use of a 22 gauge 178mm length discography needle.  This was in comparison to a 
needle with a diameter of 0.5mm and a length of 16mm producing gelation within 30 
seconds, an unsuitable time frame for the application. 
 
Mechanical property considerations 
 
The mechanical properties of the materials were investigated thoroughly via rheology.  
The properties of the analogue can be manipulated via three main factors, monomer 
composition, crosslink ratio, and water content.  With respect to the intervertebral disc 
application, the elastic modulus of the intervertebral disc has been reported in the 
literature to range between 7 and 20kPa.  Both gel compositions have been reported to 
have an elastic modulus within this range.  Ascorbic acid and oxone redox pair 
produce the most uniform gel and reproducible elastic behaviour when used at 0.1M, 
which supports both the initiation studies and subsequent stability studies.  The use of 
TEMED and KPS at 0.4M and 0.18M respectively visually appeared to produce the 
most efficient and reproducible gelation.  This was supported by the recorded 
mechanical properties. 
 
The use of PEG 575 diacrylate as a crosslinking agent was ranged from 0.25% to 2% 
and produced gels with elastic modulii ranging between 4kPa and 29kPa.  The use of 
PEG 1000 dimethacrylate between 0.5% and 2% resulted in a range between 3.5kPa 
and 11kPa.  Mechanically there is little preference between the two crosslinking 
agents, similar low stiffness can be obtained from the use of both just at 0.25% and 
0.5% respectively. 
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The effect of polymerised water content also has an effect on the mechanical 
properties of the gel, a 20% increase in water content was reported to have the 
potential to reduced mechanical strength by 2kPa.  
 
Injection into excised disc samples which were then analysed via DMA for 
comparison to the properties of the disc sample with intact nucleus and removed 
nucleus were conducted.  The disc segment containing the gel showed some 
restoration of properties close to that of the segments containing the natural disc.  This 
suggests than the gel does have the potential to restore disc height and function. 
 
Adaptations to the system 
 
In order to adapt the intervertebral disc analogue for suitability as an injectable IOL, it 
was necessary to incorporate the viscoelastic material that is required during surgery.  
A viscous material is necessary to prevent the surfaces of the lens capsule from 
coming into contact with each other and causing damage.  This was initially 
investigated using HA derived from bovine vitreous humour.  HA appeared to behave 
differently within the hydrogel depending on the nature of the intiation system. When 
gels were polymerised using ascorbic acid and oxone, HA appeared to become part of 
the structure, as an interpentrant.  This was illustrated by the recorded increase in 
elastic behaviour of the gels in response to the amount of HA added.  In the case of 
the TEMED potassium persulfate initiated system, there appeared to be less of a 
dependence on the amount of HA used within the gel composition.  This was also 
apparent in the material’s swell capacity. The HA gel displayed a lesser degree of 
swelling pressure in comparison to a similar composition in the absence of HA.  This 
is advantageous as any excess pressure within the lens capsule has the potential to do 
damage to the tissue.  Overall the most successful composition appeared to be one 
which incorporated the surgical viscoelastic Healon in place of water.  This gel 
exhibited elastic behaviour in the region of 3kPa, flexible enough to allow natural 
accommodation to occur once injected into the eye. 
  
Surgical procedure would ideally require the injectable gel to be radio-opaque to 
allow its visualisation during surgery and its lifetime.  There are many radio-opaque 
agents however the only commercially available to us was histodenz.  Initially 
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attempts were made to modify this into a radioopaque macromer which would also 
have the potential to act as a crosslinking agent.  Due to the symmetrical nature of the 
histodenz structure and its difficult solubility, this was not successful. Currently it is 
hoped that the histodenz will be visible at 5% within the gel and it will remain in the 
gel long enough to see the gel outline for as long as is needed.  Current US opinion 
from interested parties has suggested preference for the gel to be available without a 
radio-opaque. 
 
Further work 
 
With respect to the intervertebral disc the natural progression would be the 
development of a suitable surgical delivery system, prior to testing in animal subjects.  
For the IOL application, the next step would involve an in-vivo eye model to ascertain 
the ability of the pre-gel to remain within the capsular bag prior to its complete 
gelation.  The addition of an optional UV initiation step to completely cure the gel 
could also be explored in a similar manner to the way crosslinking can occur within 
the eye. 
 
Further work is being carried out within the Biomaterials Research Unit to 
functionalise a radio-opaque macromer based on the addition of N-methylol 
acrylamide to diatrizoic acid and or 2,5 iodobenzoic acid.  It is also proposed to 
synthesise a new radio opaque from an iodinated benzoyl chloride as is shown in 
figure 8.1 
                            
Fig 8.1 Iodinated benzoyl chloride 
 
In order to create a more iodinated structure a di-iodinated benzoic acid shown below, 
can be converted to a benzoyl chloride by reaction with CHCl3 and SOCl2. 
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Fig 8.2 Diiodobenzoic acid 
 
The project will involve reaction of an iodinated benzoyl chloride with a monomer 
containing a hydroxyl group to yield an ester under pyridine or NaOH (to react with 
the HCl formed).  This would then need to be purified and the yield assessed, then 
characterised using FTIR and NMR. 
 
Another approach involves the reaction of the iodinated benzoyl chloride with 
NaAMPs either in the ratio of 1:2 or using NaOH to ‘mop up’ the HCl produced, to 
synthesise a benzamide.   
 
The second stage of the project will involve the conversion of the synthesised 
iodinated ester or amide into a macromer.  Primarily NMA N-(hydroxyl methyl)- 
acrylamide, is attached to the ester by heating in solution, at 60oC for 2hrs under an 
acid or base catalyst to provide a reactive double bond. 
 
Fig 8.3 N- (hydroxy methyl) acrylamide 
 
Via the selection of appropriate hydrophilic monomers such as tris hydroxyl methyl 
methyl acrylamide, this is then reacted to form the macromer.  This macromer will 
then need to be purified and characterised again by FTIR and NMR and its radio-
opacity assessed. 
 
A further alternative would involve the direct addition of NMA to 2,5, -diiodobenzoic 
shown in figure 8.1 and/or ditriazoic acid the structure of which is shown below in 
figure 8.4 
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Fig 8.4 Diatrizoic acid 
 
The functionalisation reactions are extremely time consuming and were not a major 
focus of the work detailed in this thesis, more an advantageous addition. Hence they 
feature significantly in the suggestions for further work. 
 
 177 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 178 
 
(1) Apple D.J., Mamalis M., Olson R.J., Kincard M.C. (1989) Intraocular Lenses: 
Evolution, Designs, Complications, and Pathology.  Baltimore, MD.  
Williams and Wilkins 
(2) Wichterle, O and Lim D, (1960) Hydrophillic gels for biological use.  Nature, 
185, 117-118 
(3) Berger J., Reist M., May JM., Felt O., Gurny R., (2004) Structure and 
interactions in chitosan hydrogels formed by complexation or aggregation for 
biomedical applications. European Journal of Pharmaceutics and 
Biopharmaceutics. 57, 1035-52 
(4) Peppas NA., Bures P., Leobanding W., Ichikawa H., (2000) Hydrogels in 
pharmaceutical formulations.  European Journal of Pharmaceutics and 
Biopharmaceutics 50 (1) 27-46 
(5) Tighe B.J., (2002) Chapter 5 “Softlens Materials in Efron N., (Ed) Contact 
Lens Practice, Butterworth Heineman  
(6) Tonodekauiu S., Prasitsilp M., Thakornyuitkam B., Pothsree T., Pateepasen 
R., (2004) Preparation of acrylic grafted chitin for wound dressing 
applications. Biomaterials, 25, (7-8) 1453-1460 
(7) Chen J., Yong Y., Qian P., Ma Z., Wu W., Sing P., Wang X., Li J., (1993) 
Drug carrying hydrogel base wound dressing. Radiation Physics and 
Chemistry  42 (4-6) 915-918 
(8) Hoffman A.S., (2002) Hydrogels for biomedical applications. Advanced Drug 
Delivery Review, 43, 3-12 
(9) Corkhill P.H., Hamilton C.J., Tighe B.J., (1989) Synthetic Hydrogels VI. 
Hydrogel composites as wound dressings and implant materials, Biomaterials 
10 (1) pp.3-10 
(10) Eidelson S.G., (1999) Available at: 
http://static.spineuniverse.com/displaygraphic.php/137/dp_latcutaway-BB.jpg 
Date accessed 9/12/2010 
(11) University of Virginia Health System: Spinal Centre (2010) Available at:  
http://www.uvaspine.com/images/syndicated/AxialViewOfDisc_labeled.jpg 
Accessed 9/12/2010 
 179 
(12) Stoeckelhuber M., Brueckner S., Spohr G., Welsch U., (2005) Proteoglycans 
and collagen in the intervertebral disc of the rhesus monkey (Macaca mulatta) 
Ann Anat 187 pp 35.42 
(13) Berthet Colominas C., Miller A., Herbage D., Ronziere M.C., Tocchetti D., 
(1982) Structural studies of collagen fibres from intervertebral disc.  
Biocheimica et Biophysica Acta 706 (1) pp. 50-64) 
(14) Ljubimov, A.V., Alba, S.A., Burgenson, R.E., Ninomiya, Y., Sado, Y., Sun, 
T-T., Nesburn A.B., Kenney, M.C., Magues, E., (1998) Extracellular matrix 
changes in human corneas after radial keratotomy.  Exp Eye Res 67, pp.265-
272. 
(15) http://en.wikipedia.org/wiki/Image:Schematic_diagram_of_the_human_eye_e
n.svg (2010) Date accessed 9/12/2010 
(16) Abolmaali, A., Schachar, R.A., Le, T., (2007) Sensitivity study of human 
crystalline lens accommodation Computer Methods and Programs in 
Biomedicene 85, 77-90 
(17) Augusteyn R.C., (2008). Growth of the lens: in vitro observations. Clin. Exp. 
Optom. 91.3.pp226-239 
(18) Coghlan S.D., Augusteyn R.C. (1977) Changes in the distribution of proteins 
in the aging human lens.  Exp. Eye. Res 25.pp603-611 
(19) Fagerholm PP., Philipson BT., Lindstrom B., (1981) Normal human lens: the 
distribution of protein. Exp Eye Res, 31, pp.615-620 
(20) Tones C., Atchinson DA., Meder R., Pope JM., (2005) Refractive index 
distribution and optical properties of the isolated human lens measured using 
magnetic resonance imaging (MRI) Vision Research 45 2352-2366 
(21) Torzilli, P.A., Arduino, J.M., Gregory, J.D., Bansal, M., (1997) Effect of 
proteoglycan removal on solute mobility in articular cartilage. J. 
Biomechanics 30(9) pp.895-90 
(22) Bullough, P., Fellow, J., (1968) The significance of the fine structure of 
articular cartilage. J.Bone and Joint Surgery. 50B pp.852-857. 
(23) http://www.google.co.uk/imgres?imgurl=http://kentsimmons.uwinnipeg.ca/c
m1504/Image122.gif&imgrefurl=http://kentsimmons.uwinnipeg.ca/cm1504/c
ellwall.htm&h=600&w=749&sz=98&tbnid=jXpr-uo4-
0T2_M:&tbnh=113&tbnw=141&prev=/images%3Fq%3Dextracellular%2Bm
atrix&zoom=1&q=extracellular+matrix&usg=__J41a0-
 180 
DzYvbq4HJU3zPCKy-
MP7Y=&sa=X&ei=_uCPTeX4KqiJ4gb0jKX9Cw&ved=0CEoQ9QEwBA 
Accessed 8/11/2010 
(24) Rostand K.S., and Esko J.D., (1997) Microbial adherence to and invasion 
through proteoglycans’ Infect.Immun., 65, 1-8 
(25) Schmidtchen, A., Frick, I. and Bjorck L., (2001)  Dermatan sulfate is released 
by proteinases of common pathogenic bacteria and inactivates antibacterial 
alpha fusion.  Mol. Microbiol. 39, 708- 713 
(26) Iatridis JC., Gwynn I., (2004) Mechanisms for mechanical damage in the 
intervertebral disc annulus fibrosus Journal of Biomechanics 37 pp.1165-1175 
(27) Adams, M.A., Dolan, P., (2005). Perspective: Spine biomechanics. 
Biomechanics 38 p.1972-1983   
(28) Maniadakis, N., and Gray, A., (2000). The economic burden of back pain in 
the UK Pain, 84 p.95-103 
(29) Moffett, KJ., Richardson, G., Sheldon, T., Maynard, A. (1995) Back pain: its 
management and cost to society. Discussion Paper 129, York: York 
University, Centre for Health Economics 
(30) Strasser A., (1999) Available at 
:http://www.spineuniverse.com/conditions/herniated-disc/chiropractic-care-
back-pain-non-invasive-treatment Date accessed 9/12/10 
(31) St John Providence Health System (2010)  Available at: 
http://www.stjohnprovidence.org/StaywellTesting/img.aspx?7481 Date 
accessed 09/10/2010 
(32) Pope R.E., (2010) The ProDisc-L. Available at:  
http://www.spinesurgeon.com.au/modalities/artifiscial_discs/ProDiscL_combi
ned.jpg Date accessed 09/12/2010 
(33) Malhotra, R., (ed.) (2008) Cataract, Edinburgh, Butterworth Heinemann 
(34) Lloyd, A.W., Dropcova, S., Mikhalovsky, S.V., Denyer, S.P., Gard P.R., 
Hanolan, G.W., Ollift. C., Muir, A., Jones. S., Rosen. P., Riding, M.A., 
(1996) Biocompatible Coating for IOLs. Vision Research 36, 73 
(35) Available from http://doctor-hill.com/iol-main/polypseudophakia.htm, 
Accessed 7/7/2010 
(36) Walling, C., (1957) Free radicals in solution, New York, Wiley; Chapman 
and Hall 
 181 
(37) Sarac A.S., (2009) Redox Polymerisation Prog Polym Sci 24 pp.1149-1204 
(38) Narain H., Jagadale S.M., Ghatage N.D., (1981) Studies of redox 
polymerisatio I. Aqueous polymerisation of acrylamide by an ascorbic acid 
peroxydisulfate system. J Polym Sci 19:1225 
(39) Wayne, C.E., Wayne, R.P., (1996) In Photochemistry, New York, Oxford 
University Press  
(40) Decker, C., (2002) Kinetic Study and New applications of UV Radiation 
Curing. Macramol. Rapid. Commun. 23, pp1067-1093. 
(41) Dietliker, K.K., (1991) Chemistry and Technology of UV and EB 
formulations for coatings, inks and paints, vol 3 Photoinitiators for radical and 
cationic polymerisation. SITA Technology Ltd London (3) 
(42) Decker, C., (2002) Kinetic Study and New applications of UV Radiation 
Curing. Macramol. Rapid. Commun. 23, pp1067-1093. 
(43)  Sovak, M.,(Ed) (1984) Radiocontrast Agents. Springer Verlag, Berlin 
Germany 
(44) Nukina et al Sanyo Chemical Industries Ltd (1973) Method for preparing 
salts of sulfoalkyl esters US Patent 3,759,985  
(45) IARC (1974) Some aromatic amines, hydrazine and related substances, N-
nitroso compounds and miscellaneous alkylating agents.  IARC monographs 
on the evaluation of carcinogenic risk to humans Vol 4. International Agency 
for Research on Cancer, Lyon, France pp.286 
(46) IARC (1999), Hormonal contraception and post menopausal hormonal 
therapy. IARC monographs on the evaluation of carcinogenic risk to humans 
Vol 71. International Agency for Research on Cancer, Lyon, France pp.1095 
(47) Harrison et al, Haas Company (1970) Process for manufacturing sulfonated 
amides US Patent 3,544,597 
(48) Narain H., Jagadale S.M., Ghatage N.D., (1981) Studies of redox 
polymerisatio I. Aqueous polymerisation of acrylamide by an ascorbic acid 
peroxydisulfate system. J Polym Sci 19:1225 
(49) DuPont (2010) Denture Cleaners. Available at: 
http://www2.dupont.com/Oxone/en_US/uses_apps/denture_cleansers.html 
Accessed 21/09/2010 
 182 
(50) Buhler, N., Haerri, H.P., Hofmann, M., Irrgang, C., Muhlebach, A., Muller, 
B., and Stockinger, F., (1999) Nelfilcon A, A New Material for Contact 
Lenses, Chimia 53, 269-274 
(51) Bilmeyer F.W., (1984) Textbook of Polymer Science. Wiley 
(52) Flory P.J. (1953) Principles of Polymer Chemistry. Cornell University Press, 
London pp.77 
(53) Boote, N.D., (2007) Photopolymerisation of Sheet Hydrogels: A Mechanistic 
Study. PhD. Birmingham:Aston University 
(54) Miller, C.H., Arenberg, J.K., Altshuluer, J.H., (1989) Fibrin glue delivery 
system US004874368 
(55) Anipsitakis, G.P., Dionysiou, D.D., (2004) Radical generation by the 
interaction of transition metals with common oxidants. Environ Sci Technol 
38 (13) 3705-3712 
(56) Dada et al. (2010) Dilute aqueous peracid solutions and stabilisation method 
US 2010/0021558 
(57) Tehrani, M., Dick, H.B., Paklua, T., Wolf, E., (2004)  Material Properties of 
Various Intraocular Lenses in an Experimental Study. Ophthalmologica 218 
(1)  
(58) Young, N., (2003) The Development of a Biomimetic Repair System for 
IVD, BRU Aston University MSc project 
 
 
